{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "62efcfe9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "***Using Therapy Database Endpoint: http://localhost:8000***\n"
     ]
    }
   ],
   "source": [
    "from therapy.query import QueryHandler\n",
    "import psycopg2\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import pandas as pd\n",
    "\n",
    "q = QueryHandler()\n",
    "conn = psycopg2.connect(\"dbname=dgidb\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4a0b3183",
   "metadata": {},
   "source": [
    "### Tables to create\n",
    "\n",
    "* histogram of # of claims per drug\n",
    "* see if ^^ changes after new normalization routine\n",
    "* nonnormalizable drugs\n",
    "* nonnormalizeble drugs by source\n",
    "* nonnormalizable claims\n",
    "* nonnormalizable claims by source"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6c61fe87",
   "metadata": {},
   "source": [
    "# Look at previously un-grouped terms"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b9ff5397",
   "metadata": {},
   "outputs": [],
   "source": [
    "# previously non-normalized terms\n",
    "cur = conn.cursor()\n",
    "cur.execute(\"\"\"\n",
    "SELECT d.name, d.nomenclature, d.primary_name, s.full_name\n",
    "FROM   drug_claims d\n",
    "LEFT JOIN sources s ON d.source_id = s.id\n",
    "WHERE d.drug_id IS NULL;\n",
    "\"\"\")\n",
    "old_unnormalized_drugs = cur.fetchall()\n",
    "cur.close()\n",
    "\n",
    "total = 0\n",
    "by_source = {}\n",
    "normalized = 0\n",
    "for drug_claim in old_unnormalized_drugs:\n",
    "    total += 1\n",
    "    if q.normalize(drug_claim[0]).match_type > 0:\n",
    "        normalized += 1\n",
    "        if drug_claim [3] in by_source:\n",
    "            by_source[drug_claim[3]][\"normalized\"] += 1\n",
    "        else:\n",
    "            by_source[drug_claim[3]] = {\n",
    "                \"normalized\": 1,\n",
    "                \"failed\": 0\n",
    "            }\n",
    "    elif q.normalize(drug_claim[2]).match_type > 0:\n",
    "        normalized += 1\n",
    "        if drug_claim [3] in by_source:\n",
    "            by_source[drug_claim[3]][\"normalized\"] += 1\n",
    "        else:\n",
    "            by_source[drug_claim[3]] = {\n",
    "                \"normalized\": 1,\n",
    "                \"failed\": 0\n",
    "            }\n",
    "    else:\n",
    "        if drug_claim [3] in by_source:\n",
    "            by_source[drug_claim[3]][\"failed\"] += 1\n",
    "        else:\n",
    "            by_source[drug_claim[3]] = {\n",
    "                \"normalized\": 0,\n",
    "                \"failed\": 1\n",
    "            }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "2483ff75",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "colors = sns.color_palette('pastel')[0:2]\n",
    "plt.rcParams[\"figure.figsize\"] = (10,10)\n",
    "fig, ax = plt.subplots()\n",
    "ax.pie([(normalized/total), (1 - (normalized/total))], labels=[\"Normalized\", \"Failed\"], autopct='%.0f%%')\n",
    "f = fig.suptitle(\"Normalization of previously un-grouped claims\", fontsize=30)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "f349455f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1626.82x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.set_theme(style=\"whitegrid\")\n",
    "norm_df_in = [[name, 'normalized', v['normalized']] for name, v in by_source.items()]\n",
    "failed_df_in = [[name, 'failed', v['failed']] for name, v in by_source.items()]\n",
    "\n",
    "sources_df = pd.DataFrame(norm_df_in + failed_df_in, columns=[\"name\", \"type\", \"count\"]).sort_values(by=[\"name\", \"type\"], ascending=False).replace({\n",
    "    \"CIViC: Clinical Interpretation of Variants in Cancer\": \"civic\",\n",
    "    \"Catalogue Of Somatic Mutations In Cancer\": \"cosmic\",\n",
    "    \"Clearity Foundation Biomarkers\": \"clearity biomarkers\",\n",
    "    \"Clearity Foundation Clinical Trial\": \"clearity trials\",\n",
    "    \"Database of Curated Mutations\": \"dcm\",\n",
    "    \"Drug Target Commons\": \"dtc\",\n",
    "    \"FDA Pharmacogenomic Biomarkers\": \"fda\",\n",
    "    \"Guide to Pharmacology\": \"gtp\",\n",
    "    \"MyCancerGenome Clinical Trial\": \"mcg trial\",\n",
    "    \"My Cancer Genome\": \"mcg\",\n",
    "    \"NCI Cancer Gene Index\": \"nci\",\n",
    "    \"OncoKB: A Precision Oncology Knowledge Base\": \"oncokb\",\n",
    "    \"PharmGKB - The Pharmacogenomics Knowledgebase\": \"pharmgkb\",\n",
    "    \"Targeted Agents in Lung Cancer (Commentary, 2014)\": \"talc\",\n",
    "    \"The ChEMBL Bioactivity Database\": \"chembl\",\n",
    "    'The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication (Rask-Andersen, Masuram, Schioth 2014)': \"druggable\",\n",
    "    'The Jackson Laboratory Clinical Knowledgebase': 'jax',\n",
    "    'Therapeutic Target Database': \"ttd\",\n",
    "    'Trends in the exploitation of novel drug targets (Rask-Andersen, et al., 2011)': 'tendt'\n",
    "})\n",
    "big_sources = [\"gfp\", \"nci\", \"pharmgkb\", \"druggable\", \"jax\", \"ttd\", \"tendt\", \"gtp\"]\n",
    "sources_df_big = sources_df[sources_df[\"name\"].isin(big_sources)]\n",
    "sns.set(font_scale=2)\n",
    "p = sns.catplot(data=sources_df_big, kind=\"bar\", x=\"name\", y=\"count\", hue=\"type\", ci=\"sd\", \n",
    "                palette=\"dark\", alpha=.6, height=10, aspect=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "19648f8e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<seaborn.axisgrid.FacetGrid at 0x12aef6070>"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABjcAAANPCAYAAACW9400AAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjUuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/YYfK9AAAACXBIWXMAAAsTAAALEwEAmpwYAAC/B0lEQVR4nOzdeZid4+E//vfMZJlEEIlsVAkiaARBUq2tqFRpLa1UmiKx1O7TqqXUR2lQVdROFaWxBZ+iKk3tW6pBLLGGiDWSCIlEJJOZzMzvD7/Mt2kWmUhy8mRer+tyXc7z3M9z3uccc2ac93nuu6y+vr4+AAAAAAAABVFe6gAAAAAAAACNodwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJqVOsDK4OOPZ6Surr7UMQAAAACAlUyHDquWOgKskFy5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCalToAAAAAAFAsNXNqM6uqutQxFqlVZYs0b1ZR6hjAMqLcAAAAAAAaZVZVdX5/xX2ljrFIJx61W5q3aVXqGMAyYloqAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFAKUW789a9/Tffu3fPMM88scP9bb72V448/PjvuuGM233zzfO9738uQIUNSV1e3wPGTJk3K6aefnl122SU9e/ZM3759c/nll6e6unpZPgwAAAAAAGApWOHLjeeeey6DBw9e6P7XXnstP/zhD3PvvfdmrbXWyvbbb5+JEyfmrLPOykknnTTf+IkTJ6Zfv34ZOnRoVltttey000757LPPcskll+SQQw5JTU3Nsnw4AAAAAADAl9Ss1AEW5Z///GdOOeWUzJw5c4H76+vrc9JJJ2XGjBk577zzstdeeyVJpkyZkoEDB+aee+7Jt7/97fTt27fhmDPOOCMTJ07M//zP/+Soo45KksycOTNHH310/vWvf2XIkCE5+OCDl/2DAwAAAAAAlsgKeeXGxIkTc9JJJ+W4445LXV1d1lxzzQWOGzFiRMaMGZPevXs3FBtJ0q5du5xxxhlJkiFDhjRsHzduXB555JF89atfzRFHHNGwvXXr1jn77LNTUVGRG2+8cdk8KAAAAAAAYKlYIcuNiy66KHfffXd69OiRoUOHZv3111/guMcffzxJsuuuu863r1evXmnfvn1GjRqVGTNmJEmeeOKJ1NfX51vf+lbKy+d96GuttVY23XTTjB8/PmPHjl3KjwgAAAAAAFhaVshyY/3118/vfve73H777enevftCx80tITbaaKMF7u/atWvq6ury5ptvzjO+W7duC73fJHn99deXODsAAAAAALBsrZBrbvz0pz9drHEffvhhkqRDhw4L3D93+0cffTTP+I4dOy7WeAAAAAAAYMWzQl65sbhmzZqVJKmsrFzg/rnb5y5I3tjxAAAAAADAimeFvHJjcVVUVCRJysrKFjmurq5uicYvrvbt2zRqPAAAAAAU2azqmlRWNi91jEVq3qJZOnRYtdQxgGWk0OVGq1atkiRVVVUL3D93+yqrrNKo8a1bt25Ujo8/npG6uvpGHQMAAAAARVVTPSdVVTWljrFINdVzMnnyp6WO8aUpaGDBCj0t1dy1Mxa2RsbkyZOT/L+1NBZ3/MLW5AAAAAAAAEqv0OVGt27dkiRjx46db199fX3GjRuXioqKbLDBBl84PknefPPNJMlGG220LOICAAAAAABLQaHLje233z5J8uCDD86379lnn82UKVOy1VZbpU2bNvOMf/jhh+dbV+ODDz7Iq6++mrXXXjsbbrjhMk4OAAAAAAAsqUKXG7179063bt0yYsSI3HbbbQ3bp0yZkjPPPDNJMmjQoIbt66yzTrbffvuMGzcuF198ccP2mTNn5rTTTkttbe084wEAAAAAgBVPoRcULy8vzznnnJODDjoo//u//5s77rgjHTt2zFNPPZVp06alX79+2Xnnnec55te//nX69++fq666Kg899FC6du2aZ599NpMnT84OO+yQ/v37l+jRAAAAAAAAi6PQV24kSc+ePXP77benb9++eeeddzJixIistdZaOfPMM3PGGWfMN36dddbJ7bffnn333TdTpkzJI488ktVXXz2/+MUvctlll6VZs0L3PQAAAAAAsNIrq6+vry91iKL7+OMZqavzNAIAAADQNEyfMSu/v+K+UsdYpBOP2i2rtWlV6hhfWocOq5Y6AqyQCn/lBgAAAAAA0LQoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhdKs1AGWlrvvvjs33XRTXn/99dTV1aVr167Zd99985Of/CQVFRXzjH3rrbdy6aWXZtSoUfnkk0/y1a9+Nf369cuAAQNSXq7vAQAAAACAFdlKUW6cd955ufbaa9OiRYtss802qaioyDPPPJNzzjknTz31VC677LKUlZUlSV577bUMGDAgM2bMSK9evbLZZptl5MiROeuss/LCCy/k/PPPL/GjAQAAAAAAFqXw5cZrr72W6667Lu3atcvNN9+crl27JkkmTZqU/v3754EHHsh9992Xvn37pr6+PieddFJmzJiR8847L3vttVeSZMqUKRk4cGDuueeefPvb307fvn1L+ZAAAAAAAIBFKPwcTE8++WTq6+vz/e9/v6HYSJJOnTrlxz/+cZLk6aefTpKMGDEiY8aMSe/evRuKjSRp165dzjjjjCTJkCFDll94AAAAAACg0QpfbsydbmrSpEnz7Zs6dWqSpG3btkmSxx9/PEmy6667zje2V69ead++fUaNGpUZM2Yso7QAAAAAAMCXVfhyY/vtt09ZWVmGDx+eq6++OlOmTMn06dNzxx135C9/+UtWX331/OAHP0iSjB07Nkmy0UYbLfBcXbt2TV1dXd58883llh8AAAAAAGicwpcbG2ywQQYPHpzKyspccMEF2XbbbbPNNtvkV7/6Vb72ta9l6NCh6dKlS5Lkww8/TJJ06NBhgeeau/2jjz5aPuEBAAAAAIBGK3y5kXw+pdS2226b1q1b5+tf/3q+8Y1vZJVVVsmLL76Ym2++OfX19UmSWbNmJUkqKysXeJ6522fOnLl8ggMAAAAAAI3WrNQBvqznn38+Bx98cNZee+38/e9/z9prr53k8zU4jjnmmPzlL39JmzZt8j//8z+pqKhI8v/W6ViYurq6RmVo377NkoUHAAAAgAKaVV2TysrmpY6xSM1bNEuHDquWOgawjBS+3DjnnHPy2Wef5eyzz24oNpKkU6dOufDCC/Od73wn119/fX7605+mVatWSZKqqqoFnmvu9lVWWaVRGT7+eEbq6uqX8BEAAAAAQLHUVM9JVVVNqWMsUk31nEye/GmpY3xpChpYsEJPS1VVVZXRo0dntdVWS8+ePefbv84666Rr166ZOXNm3nnnnXTs2DHJwtfUmDx5cpKFr8kBAAAAAACUXqHLjU8//TT19fUpL1/4w5g7FVVNTU26deuWJBk7dux84+rr6zNu3LhUVFRkgw02WDaBAQAAAACAL63Q5Ub79u3Ttm3bfPLJJxk9evR8+ydNmpQ333wzzZs3z/rrr5/tt98+SfLggw/ON/bZZ5/NlClTstVWW6VNG2toAAAAAADAiqrQ5UZ5eXl++MMfJkl+9atfZdKkSQ37pkyZkhNOOCE1NTX5wQ9+kFVWWSW9e/dOt27dMmLEiNx2223zjD3zzDOTJIMGDVq+DwIAAAAAAGiUsvr6+kKvhD179uwceuiheeqpp9KyZctss802KSsrywsvvJDp06dniy22yJ///Oe0bt06STJ69OgcdNBBmTlzZjbffPN07NgxTz31VKZNm5Z+/fpl8ODBjc5gQXEAAAAAmpLpM2bl91fcV+oYi3TiUbtltTatSh3jS7OgOCxY4cuN5PP1NG6++ebcfffdGTduXOrq6rLeeutlzz33zMCBA9OiRYt5xo8dOzaXXHJJRo4cmerq6qy77rrZf//9s99++zWs0dEYyg0AAAAAmhLlxvKj3IAFWynKjVJTbgAAAADQlCg3lh/lBixYodfcAAAAAAAAmh7lBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAolEaXGx988EE+/vjjxRr75ptv5uGHH250KAAAAAAAgIVp1tgDdt5552y99da58cYbv3DsySefnPfffz///ve/lygcAAAAAADAf1tkuVFbW5vq6uqG2/X19Q3bq6qqGm7/t/r6+nzwwQd57733Mnv27KUYd+HGjx+fyy+/PE888USmTJmSNdZYIzvttFOOO+64dOjQYZ6xb731Vi699NKMGjUqn3zySb761a+mX79+GTBgQMrLzdQFAAAAAAArskWWGx988EH22GOP1NTUNGwrKyvL888/ny233HKx7mCzzTb7cgkXw4svvphBgwbl008/zUYbbZTNNtssL730Um677bb8+9//zh133JHVV189SfLaa69lwIABmTFjRnr16pXNNtssI0eOzFlnnZUXXngh559//jLPCwAAAAAALLlFXqawzjrr5OCDD059fX3DP0nmub2ofzp16pTTTjttmT6A6urqnHDCCfn0009z2mmn5Z577snll1+e++67L3379s27776bSy+9tCH3SSedlBkzZuS8887LLbfckssuuyz//Oc/071799xzzz355z//uUzzAgAAAAAAX84XrrlxzDHHZL/99kvyeTmw6667ZrPNNstFF1200GPKy8vTunXrhqsllqVhw4bl7bffzve+970ccMABDdtbtmyZU045JaNGjcpbb72VJBkxYkTGjBmT3r17Z6+99moY265du5xxxhnp379/hgwZkr59+y7z3AAAAAAAwJL5wnKjWbNmWXvttRtu77PPPunates820rpvvvuS5IMGjRovn1dunTJiBEjGm4//vjjSZJdd911vrG9evVK+/btM2rUqMyYMSNt2rRZRokBAAAAAIAv4wvLjf/229/+dlnkWGKvvPJKmjdvno033jgTJkzIPffck3fffTdt27bNbrvtlp49ezaMHTt2bJJko402WuC5unbtmo8//jhvvvlmNt988+WSHwAAAAAAaJxGlxtzffTRR3nxxRczY8aM1NbWLnLs3nvvvaR3s0jV1dWZMGFCOnfunOHDh+dXv/pVZs2a1bD/T3/6Uw455JCcdNJJSZIPP/wwSdKhQ4cFnm/u9o8++miZ5AUAAAAAAL68Rpcb9fX1+e1vf5ubb775C0uNuZZVuTFjxowkybRp03LyySfnO9/5To4++ui0b98+TzzxRM4888xce+21WXfddfOjH/2oofiorKxc4Pnmbp85c+YyyQsAAAAAAHx5jS43brnllvzlL39J8nkZ8JWvfCUtW7Zc6sEWR3V1dZJk1qxZ2W677XL++ec37Pvud7+b1q1b5/DDD8/ll1+efv36paKiIklSVla2yPPW1dU1Kkf79tbnAAAAAKDpmFVdk8rK5qWOsUjNWzRLhw6rljoGsIw0uty44447UlZWloMPPjg/+9nP0rx56d7E/vMKjP79+8+3f6eddkqnTp0yadKkvP3222nVqlWSpKqqaoHnm7t9lVVWaVSOjz+ekbq6+kYdAwAAAABFVVM9J1VVNaWOsUg11XMyefKnpY7xpSloYMHKG3vAuHHjsuaaa+aEE04oabGRJKuuumpDhq985SsLHLPWWmslSaZOnZqOHTsmWfiaGpMnT06y8DU5AAAAAACA0mt0udGyZcusueaaXzi10/JQUVGRDTbYIEkyadKkBY6ZW2S0b98+3bp1S5KMHTt2vnH19fUZN27cPOcEAAAAAABWPI0uN3r06JG33357hVl0e4cddkiSDB8+fL5948aNy/jx49OxY8ess8462X777ZMkDz744Hxjn3322UyZMiVbbbVV2rSxhgYAAAAAAKyoGl1u/PSnP01VVVV++9vfLos8jbb//vundevWueuuu3LPPfc0bJ82bVpOO+201NXVZcCAASkvL0/v3r3TrVu3jBgxIrfddlvD2ClTpuTMM89MkgwaNGi5PwYAAAAAAGDxldXX1zdqJeyXX345d955Z2666aZsuOGG2W677dKpU6dFrr8xYMCALx10UYYNG5YTTzwxc+bMyde+9rV07Ngxzz//fKZOnZqvf/3rueaaaxryjR49OgcddFBmzpyZzTffPB07dsxTTz2VadOmpV+/fhk8eHCj79+C4gAAAAA0JdNnzMrvr7iv1DEW6cSjdstqbVqVOsaXZkFxWLBGlxsbb7xxysrKMvewxVl749VXX12ydI3w6quv5sorr8zTTz+dzz77LOuss0722muvDBo0aL7iZezYsbnkkksycuTIVFdXZ911183++++f/fbbLxUVFY2+b+UGAAAAAE2JcmP5UW7AgjVr7AHbbLPNssjxpW2yySa55JJLFmvshhtuuNhjAQAAAACAFUujy40hQ4YsixwAAAAAAACLpdELigMAAAAAAJSScgMAAAAAACiURk9LtcsuuzRqfFlZWR544IHG3g0AAAAAAMACNbrcGD9+/GKNKysrS319faMDAQAAAAAALEqjy42rrrpqoftmzZqVyZMn58EHH8zIkSNz7LHH5sADD/xSAQEAAAAAAP5To8uNnXba6QvHHHjggbngggty2WWXZfPNN8922223JNkAAAAAAADms8wWFD/22GPTpk2bXHPNNcvqLgAAAAAAgCZomZUbLVq0yFe/+tW89NJLy+ouAAAAAACAJmiZlRvV1dV5//33LSoOAAAAAAAsVcuk3Jg0aVJ++ctfZtq0adl0002XxV0AAAAAAABNVKMXFN92220Xuq++vj7V1dWZNWtWkqSsrCwHHXTQkqcDAAAAAAD4L40uN6ZOnbpY41ZfffUce+yx2XXXXRsdCgAAAAAAYGEaXW785S9/WeT+ioqKrL766ll//fVTXr7MlvQAAAAAAACaqEaXG717914WOQAAAAAAABZLo8uN/1RfX5+XX345b7/9dj777LO0bt066667br72ta+loqJiaWUEAAAAAABosMTlxv/93//lkksuyYcffjjfvrZt2+Z//ud/sv/++3+pcAAAAAAAAP9ticqN888/P9dee23q6+vTokWLrL/++mndunU+/fTTvPXWW5k6dWrOPPPMvPPOOzn55JOXdmYAAAAAAKAJa3S58eSTT+aaa65JixYt8otf/CI/+tGPUllZ2bB/1qxZGTp0aC688MJcf/31+da3vmWdDgAAAAAAYKkpb+wBf/nLX1JWVpbBgwfnoIMOmqfYSJJWrVpl4MCB+c1vfpP6+vrcfPPNSy0sAAAAAABAo8uN559/Ph06dMhee+21yHF77713OnTokOeff35JswEAAAAAAMyn0eXGp59+ms6dOy/W2C5duuTjjz9udCgAAAAAAICFaXS50a5du7zzzjupq6tb5Lja2tq88847WWONNZY4HAAAAAAAwH9rdLmxzTbbZPr06bn22msXOe7aa6/NtGnTss022yxxOAAAAAAAgP/WrLEHHHLIIRk+fHj+8Ic/ZMKECenfv3+6devWsP/111/PLbfckqFDh6aioiKDBg1aqoEBAAAAAICmrdHlxqabbppTTz01Z511Vm655ZbccsstadasWVq3bp2ZM2dmzpw5qa+vT3l5eU499dT06NFjWeQGAAAAAACaqEZPS5UkAwYMyPXXX58+ffqkoqIiNTU1mTZtWmpqalJeXp6vf/3ruf766zNgwIClnRcAAAAAAGjiGn3lxlybb755+vXrlyuuuCLvvfdePvvss7Ru3TqjRo1KbW1tNt5446WZEwAAAAAAIMkSXrnxr3/9KzvuuGNOOOGEfPrpp+nevXt69eqVjTfeOPfff39++9vf5jvf+U6efPLJpZ0XAAAAAABo4hpdbowePTo//elPM23atGy44YapqamZZ/93v/vdbL755pkyZUqOOuqojBs3bqmFBQAAAAAAaHS58ac//Slz5szJoEGD8re//S1f+cpX5tnfr1+/3HrrrTn00EMza9as/PGPf1xqYQEAAAAAABpdbowaNSrt2rXLCSecsMhxP/vZz7L66qvnX//61xKHAwAAAAAA+G+NLjc+/fTTrLXWWqmoqFjkuGbNmmWdddbJJ598sqTZAAAAAAAA5tPocqNjx4557733Ultbu8hxdXV1GT9+fNq2bbuk2QAAAAAAAObT6HKjT58+mT59eq688spFjvvzn/+cqVOnpnfv3kscDgAAAAAA4L81a+wBAwcOzN///vdcfvnleeutt7LvvvumW7duad26dWbNmpWxY8fm7rvvzt/+9rc0a9Yshx566LLIDQAAAAAANFGNLjc22mij/OY3v8npp5+ee++9N8OGDZtvTH19fZo1a5bBgwdnk002WSpBAQAAAAAAkiWYlipJ9t5779x9993Zb7/90qFDh9TX1zf807Zt23zve9/LHXfckX322Wdp5wUAAAAAAJq4Rl+5MVfXrl0zePDgJEl1dXWmTp2aVq1aZbXVVltq4QAAAAAAAP7bEpcb/6lFixbp1KnT0jgVAAAAAADAIi3RtFQAAAAAAAClotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAozUodAEqlZk5tZlVVlzrGIrWqbJHmzSpKHQMAAAAAYIWi3KDJmlVVnd9fcV+pYyzSiUftluZtWpU6BgAAAADACsW0VAAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAAArhXfffTc1NTWljsFyoNwAAAAAAKDQampqctFFF2WPPfZIdXV1qeOwHDQrdQAAAAAAAPgyJk2alCuvvLLUMViOXLkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAACF9ctf/jK77LJLw+1evXqle/fu6dOnT7p3755rr712ocfuuuuu6d69e5555pkkyQEHHJDu3bvn+eefz8MPP5x+/fpliy22yHbbbZdjjz02L7300kLP9d577+X000/PzjvvnB49eqRPnz45/PDD8+STTy69B0sDa24AAAAAACudVVvUprxqSqljLFRFy1apKWtV6hgrhfXWWy89evRoKB623HLLlJWV5Zvf/GYuvfTS3HvvvTnkkEPmO+7ZZ5/Ne++9l6985SvZaqut5tl3991355ZbbknLli2zwQYb5IMPPsh9992Xhx9+OL///e+z++67zzP+8ccfz3HHHZeZM2emVatW6datW6ZMmZJHHnkkjzzySI499tgcc8wxy+5JaIKUGwAAAADASqe+Zlaeu23FXWB6y/7HJJXKjaXhiCOOyJ577tlw9ca1116bVVZZJVOmTMmVV16Zl19+OePGjcv6668/z3H33HNPkuT73/9+ysrK5tl38803Z7vttsv555+fNdZYIzU1NTn//PNz/fXX59RTT81WW22Vjh07Jknef//9/OxnP8vMmTNz1FFH5cgjj0yLFi2SJA8++GBOOumkXHrppdl4442z6667Luuno8kwLRUAAAAAACuddu3aZfvtt0+S3HvvvfPsq6mpyT/+8Y8kn5cb/61Lly659NJLs8YaayRJmjdvnlNOOSW9e/fOzJkzc+ONNzaMve666zJjxozsvffe+Z//+Z+GYiNJdtlll/ziF79Iklx22WVL9wE2ccoNAAAAAABWSnvttVeS5O9///s825944olMnTo1m2++ebp27TrfcT/4wQ/SunXr+bb/8Ic/TJI8/PDDDdseeuihJMkee+yxwAx77LFHysrK8uqrr2by5MlL9kCYj2mpAAAAAABYKe2yyy5ZbbXV8vbbb+ell15Kjx49kiR/+9vfkvy/8uO/zR333zbaaKMkybvvvpskmTFjRiZMmJAk+cMf/pArr1zwVGgVFRWZM2dO3nrrrXTo0GHJHxANlBsAAAAAAKyUWrRokd133z1Dhw7N3//+9/To0SMzZszIQw89lObNm8+3MPhcq6222gK3r7LKKkmSqqqq1NTU5LPPPmvY98orr3xhnk8//XQJHgULotwAAAAAAGCltddee2Xo0KH5xz/+kZNPPjkPPvhgqqqqsvPOO6ddu3YLPKaqqmqB22fMmJEkadOmTZo3b55Wrf7fovBPPvnkQs/H0mfNDQAAAAAAVlpbbbVVvvrVr2bixIl56aWXGtbIWNiUVEkyduzYBW5/7bXXkiQbbrhhks+v8JhbaIwbN26Bx9TW1uZf//pX3nnnndTW1i7x42BeK2W58cknn2T77bdP9+7dF7j/rbfeyvHHH58dd9wxm2++eb73ve9lyJAhqaurW85JAQAAAAD4ssrL/99H3fX19fPtn1tk3H///RkxYkRWW2217Lzzzgs939133z3feerr63PHHXckSXbdddeG7TvuuGOS5NZbb13gue65554MGjQoe++9d2bOnLmYj4gvslKWG2eeeWY+/PDDBe577bXX8sMf/jD33ntv1lprrWy//faZOHFizjrrrJx00knLOSkAAAAAAF9W69atG/79gw8+mG//XnvtlbKysgwZMiSffvppvvOd76RFixYLPd/LL7+cM844I7Nnz06SVFdX56yzzsqoUaPSoUOH9O/fv2HsoYcempYtW+aee+7JH/7wh4ZjkuTxxx/Pb37zmyTJfvvtl1VXXfVLP1Y+t9KtufH3v/89w4YNW+C++vr6nHTSSZkxY0bOO++8hrZuypQpGThwYO655558+9vfTt++fZdnZAAAAAAAvoS2bdumc+fOmThxYn7yk59knXXWybnnnptu3bolSdZZZ5306tUro0aNSrLoKamSpFu3brn11lszbNiwrLvuunn33Xczbdq0rL766rnooovSpk2bhrEbbrhhfve73+Wkk07KVVddlSFDhqRr166ZOnVqxo8fnyT5xje+kRNOOGEZPfqmaaW6cmPSpEn5zW9+ky233DIVFRXz7R8xYkTGjBmT3r17z/Mfb7t27XLGGWckSYYMGbK84gIAAAAAsJRccskl2WyzzVJVVZX33nsv77777jz7534mvPbaa2errbZa5Ln233//XHDBBVl77bXz+uuvZ5VVVsmPfvSj/PWvf83WW2893/jdd989d911V374wx+mbdu2GTNmTKZOnZrNNtssp556aq6++upFXilC461UV2786le/SnV1dX73u99l9913n2//448/nmTe+dDm6tWrV9q3b59Ro0ZlxowZ8zRvAAAAAACs2DbffPOGNTEWZO5SBnOnqPoie+65Z/bcc8/Fvv8NNtggZ5999mKP58tZaa7cuPnmm/P444/nhBNOyLrrrrvAMXNXuN9oo40WuL9r166pq6vLm2++ucxyAgAAAACwfNXV1eWuu+5KWVlZ9t1331LHYSlYKa7ceOedd/L73/8+2267bQYMGLDQcXObuQ4dOixw/9ztH3300dIPCQAAAADAclNdXZ1x48alVatWueqqq/L+++/nW9/6VtZZZ51SR2MpKHy5UVtbm5NPPjnl5eU555xzFnk50axZs5IklZWVC9w/d/vMmTOXflAAAAAAAJaburq6edZerqyszEknnVTCRCxNhS83rrnmmjz33HM566yzstZaay1y7NxFxr9oPrW6urpGZWjf3vocRTSruiaVlc1LHWORmrdolg4dVi11DAAAAIB5FOFzlfKysrSqXHEXcG7RollW9bnPMlVZWZkePXrk9ddfT7du3XLKKadk/fXXL3UslpJClxuvvfZaLr300uy0007Zb7/9vnB8q1atkiRVVVUL3D93+yqrrNKoHB9/PCN1dfWNOobSq6mek6qqmlLHWKSa6jmZPPnTUscAAAAAmEcRPlepq6/PrKrqUsdYqOrF/NzHF1+/nP/7v/9r1PghQ4YsoyQsbYUuN/7whz+kpqYmNTU1OeGEE+bZN/fqi7nbTz311HTs2DGvvvpqPvroo2ywwQbznW/y5MlJFr4mBwAAAAAAUHqFLjfmro0xYsSIhY655557kiQ/+9nP0q1btzz66KMZO3Zs+vTpM8+4+vr6jBs3LhUVFQssPgAAAAAAgBVDocuNRV0itOmmm6a2tjZjxoxp2Lb99tvnmmuuyYMPPpgBAwbMM/7ZZ5/NlClT0rt377RpYw0NAAAAAABYUZWXOsDy1Lt373Tr1i0jRozIbbfd1rB9ypQpOfPMM5MkgwYNKlU8AAAAAABgMRT6yo3GKi8vzznnnJODDjoo//u//5s77rgjHTt2zFNPPZVp06alX79+2XnnnUsdEwAAAAAAWIQmVW4kSc+ePXP77bfnkksuyciRI/PGG29k3XXXzfHHH5/99tuv1PEAAAAAAIAvsNKWG6+88spC92244Ya55JJLlmMaAAAAAABgaWlSa24AAAAAAADFp9wAAAAAAAAKRbkBAAAAAAAUykq75gYAAAAAQFMx5ZPPMuOz2aWOsdjarNIy7dquUuoYhTZy5MgceOCB2XbbbXP99dcvdFspbbrppqmtrc2YMWOW+rmVGwAAAAAABTfjs9m58Kr7Sx1jsR1/xLeVG3wpyg0AAAAAAFgJ9OzZM8OGDUvr1q1LHWWZU24AAAAAAMBKoFWrVtlggw1KHWO5UG4AAAAAAFBol156aS677LJcddVVqa2tzTXXXJMxY8akWbNm2WabbXLcccdl4403nueYZ599Ntdee21GjRqVGTNmpGPHjtlhhx1yxBFHpHPnzg3j3n///eyyyy7p27dvvv3tb+f3v/99Pvnkk3Tr1i233npr/vd//zd33nlnhg0blmeeeSY33nhj3nnnnbRr1y777LNPjjnmmNTU1OTSSy/N3//+90yfPj1du3bNkUcemW9/+9vzZJozZ07uuOOO3HvvvXn99dczY8aMtGnTJj169MjAgQOz/fbbL/J5WNCaG927d//C5++3v/1t9t1334bbL7zwQq6++uqMGjUqn332WdZaa6185zvfyWGHHZY2bdrMd/xjjz2WP/3pT3n11VdTUVGRnXfeOSeccMIX3u+XodwAAAAAAGClcPvtt+fBBx/MhhtumO222y4vv/xyHnzwwYwcOTJ33313vvKVryRJbrrpppx11lmpq6vLFltskU6dOuW1117LLbfckuHDh+faa6/N1772tXnO/corr+SBBx5Iz549061bt6yyyipp3rx5w/7f/e53eeyxx7LVVlulT58+GTlyZK644op8+umneeWVV/Laa6+lV69e+eyzz/Lss8/mmGOOydVXX50dd9wxSVJfX5+jjz46jzzySNZYY41svvnmadasWcaMGZMnnngiI0aMyGWXXZZdd921Uc/J9773vQVunzx5cv7973+noqIi66+/fsP2v/71rznttNNSX1+fHj16pEuXLhk9enSuuuqqPPTQQxkyZEjatm3bMP6WW27JmWeemfLy8vTu3TuVlZUZPnx4nn/++dTX1zcqa2MoNwAAAAAAWCk8+OCDOeOMM9K/f/8kSXV1dQ477LD8+9//zq233poTTjghr7zySs4666y0bNkyV1xxRb7xjW8kSerq6nLFFVfk0ksvzbHHHpvhw4enRYsWDed+7733MnDgwJxyyikN4//TE088kWuuuSbbbbddkuShhx7KkUcemSFDhuSrX/1qhg0b1nBFyB/+8IdcddVVGTp0aEO5MXz48DzyyCPZcsstc/3116eysrLhfs4999zccMMNuemmmxpdbpx//vnzbauqqsqAAQOSJL/4xS+yxRZbJEnefPPNnH766WndunX++Mc/ZquttkqS1NTUZPDgwRk6dGgGDx6cCy64IEkyYcKEnHvuuamsrMx1112XXr16JUkmTpyYgw46aL7naGkqX2ZnBgAAAACA5ahXr14NxUaStGjRIv369UuSjB07NkkyZMiQ1NXV5cgjj2woNpKkvLw8xxxzTHr37p3x48dn2LBh853/wAMPnGf8f9p1110bio0k2XnnnRsW9j7qqKPmmeqqb9++SZJ33323YVtdXV3DdE5zi42597PffvslST744IPFfSoW6dRTT81LL72UPffcM4ccckjD9htuuCE1NTU57rjjGoqNJGnevHlOO+20dOrUKcOGDcukSZOSJHfeeWeqqqpy4IEHNhQbSdK5c+f86le/WipZF0a5AQAAAADASmHzzTefb9uaa66ZJJk5c2aS5Omnn06S7L777gs8xx577DHPuLlWW221rL322gu977lXP/ynudM3bbLJJvNsX3XVVZMks2fPnud+r7zyymy99dYN22bOnJnRo0fnn//8Z5LPr6D4sq666qrce++9+drXvpazzz57nn0jR45MkvTp02e+41q0aJHevXunrq4uzzzzTJL/9xztsMMO843/5je/OU9Js7SZlgoAAAAAgJXC3NLgP1VUVCRJw/oPH374YZIstKiYuy7HRx99NM/21VZbbZH3vfrqq8+3raysLEnmWaPiP7f/t+nTp+fWW2/N448/nnHjxjVkWNj4xnrggQdy0UUXpV27drn88svnKx8mTpyYJPn+97+/yPNMmDAhyf97Ljt16jTfmIqKinTu3Dlvv/32Ukg+P+UGAAAAAAArhcUpAb5okeva2tokmWe9jWT+aaj+W7NmX+7j9tdffz0HHXRQpkyZkjXXXDObbbZZNthgg2y66aZZd91184Mf/OBLn//EE09Ms2bNcskll6RLly7zjZn72Pfcc89FPpfrrrtuki9+vr/sc7LIcy+zMwMAAAAAwAqmY8eOef/99/P+++83fEj/n95///0kSfv27ZdrrsGDB2fKlCk5+uijc+yxx85THIwZM+ZLnXvq1Kk58sgjM3PmzJx++unZZpttFjiuY8eOGT9+fE488cR51ghZmE6dOuWNN97I+PHjs84668y3f/LkyV8q96JYcwMAAAAAgCZj7gf7w4cPX+D+f/zjH0mS3r17L7dMSTJ69OgkyRFHHDHfFREjRoxI8vmi4401d4Hw999/Pz/84Q8zYMCAhY6du97Ho48+usD9hxxySH70ox81ZN12222TfD7d1X97/vnnM23atEbnXVzKDQAAAAAAmoyf/OQnqaioyJVXXpknn3yyYXt9fX0uu+yyPP3001l77bXzrW99a7nmmnulxIMPPjjP9kceeSSXXnppknkXIF9cZ511Vp566qlsvfXW+fWvf73IsQcccEDKy8tz4YUXNiwanvy/5+aJJ57I+++/n4033jhJss8++2S11VbLrbfeOk8hMmXKlC+8ry/LtFQAAAAAADQZPXr0yCmnnJKzzz47AwcOzJZbbplOnTrltddey9tvv5127drloosuSqtWrZZrroEDB+aMM87Iz3/+89x4441p37593nzzzYwdOzZdunRJWVlZpk+fnurq6vnWA1mYRx99NLfeemuSpEuXLhk8eHBmz5493xUgG2ywQY488shsttlmOfnkk3PuuefmJz/5STbddNOsvfbaef311/P222+nsrIyF198ccP9t2/fPmeffXaOP/74HH744dl6663Ttm3bjBw5MquuumrWXHPN+RZmX1qUGwAAAAAANCkHHHBANtlkk1xzzTV57rnn8vLLL6dLly4ZOHBgDj744HTq1Gm5Z+rfv39at26dG264Ia+++mrmzJmTtddeO4ceemgOO+ywnHLKKXnooYfy2GOPZdddd12sc3788ccN/37PPfcsdFzv3r1z5JFHJvm8ZNl0003z5z//Oc8991zeeOONdO7cOfvss08OP/zwdO3adZ5jd9ttt9x444254oor8vzzz6e2tjbbbrttTj311Bx00EFL8EwsnrL6L1oani/08cczUlfnaSya6TNm5fdX3FfqGIt04lG7ZbU2y7chBgAAAPgiRfhc5cyjv5EXb7uy1DEWasv+x6Sust0XjuvQYdXFOt+UTz7LjM8aP2VRqbRZpWXatV2l1DEoMFduAAAAAAAUXLu2qygLaFIsKA4AAAAAABSKcgMAAAAAACgU01ItJzVzajOrqrrUMRapVWWLNG9WUeoYAAAAAACwSMqN5WRWVfUKv8jSiUftluYWrwYAAAAAYAVnWioAAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJqVOgAAAAD8p+b1s1I7e1apYyxURctWqSlrVeoYADCPqulTUzNrZqljLLbmrVqncrU1ltr53njjjZx99tl58cUXM2fOnPTs2TNDhgxZ7OPff//97LLLLvnqV7+a+++/P0kycuTIHHjggdl2221z/fXXL7Ws/2nTTTdNbW1txowZs0zOvzJTbgAAALBCqZ09K8/dclmpYyzUlv2PSSqVGwCsWGpmzczooVeUOsZi6/mjo5ZquXHkkUfmvffey/rrr5+NNtooXbt2XWrnZsWk3AAAAAAAoLCmTJmS9957L61bt85dd92Vli1bNvocnTp1yrBhw9KiRYtlkJBlQbkBAAAAAEBhVVdXJ0nWWGONJSo2kqR58+bZYIMNlmYsljHlBgAAAAAAhXTAAQfkqaeeSpKMHz8+3bt3T5I8+OCD6dy5c+64447ce++9ef311zNjxoy0adMmPXr0yMCBA7P99ts3nGdBa24sygsvvJCrr746o0aNymeffZa11lor3/nOd3LYYYelTZs2841/7LHH8qc//SmvvvpqKioqsvPOO+eEE05YSs9C06TcAAAAAACgkL7xjW9k9dVXz/3335/WrVtnl112SZK0bt06Rx99dB555JGsscYa2XzzzdOsWbOMGTMmTzzxREaMGJHLLrssu+66a6Pv869//WtOO+201NfXp0ePHunSpUtGjx6dq666Kg899FCGDBmStm3bNoy/5ZZbcuaZZ6a8vDy9e/dOZWVlhg8fnueffz719fVL66locpQbAAAAAAAU0pFHHpmJEyfm/vvvzxprrJHzzz8/SfKPf/wjjzzySLbccstcf/31qaysTJLU1dXl3HPPzQ033JCbbrqp0eXGm2++mdNPPz2tW7fOH//4x2y11VZJkpqamgwePDhDhw7N4MGDc8EFFyRJJkyYkHPPPTeVlZW57rrr0qtXryTJxIkTc9BBB6Wurm5pPRVNTnmpAwAAAAAAwNJUV1fXMPXT3GIjScrLy7PffvslST744INGn/eGG25ITU1NjjvuuIZiI/l8zY7TTjutYWHySZMmJUnuvPPOVFVV5cADD2woNpKkc+fO+dWvfrWkD48oNwAAAAAAWMnsscceufLKK7P11ls3bJs5c2ZGjx6df/7zn0k+v9qisUaOHJkk6dOnz3z7WrRokd69e6euri7PPPNMkuTpp59Okuywww7zjf/mN785T/FC45iWCgAAAACAlc706dNz66235vHHH8+4cePy0UcfJUnKysqW+JwTJ05Mknz/+99f5LgJEyYkST788MMkSadOneYbU1FRkc6dO+ftt99e4jxNmXIDAAAAAICVyuuvv56DDjooU6ZMyZprrpnNNtssG2ywQTbddNOsu+66+cEPfrBE562trU2S7LnnnossSdZdd90kX1ykNGvmI/ol5ZkDAPgSaubUZlZVdaljLFSryhZp3qyi1DEAAACWq8GDB2fKlCk5+uijc+yxx85TMowZM2aJz9uxY8eMHz8+J554Yjp37vyF4zt16pQ33ngj48ePzzrrrDPf/smTJy9xlqZOuQEA8CXMqqrO76+4r9QxFurEo3ZL8zatSh0DAABguRo9enSS5Igjjpjv6okRI0Yk+XzR8cbaeuutM378+Dz66KP50Y9+NN/+Qw45JDNmzMivfvWr9OzZM9tuu22eeOKJPPDAA/n6178+z9jnn38+06ZNa3QGPmdBcQAAAAAAVipzr6p48MEH59n+yCOP5NJLL02SzJ49u9HnPeCAA1JeXp4LL7ywYdHwJKmvr89ll12WJ554Iu+//3423njjJMk+++yT1VZbLbfeemseffTRhvFTpkzJr3/960bfP/+PKzcAAAAAAFipDBw4MGeccUZ+/vOf58Ybb0z79u3z5ptvZuzYsenSpUvKysoyffr0VFdXp0WLFot93s022ywnn3xyzj333PzkJz/JpptumrXXXjuvv/563n777VRWVubiiy9uOGf79u1z9tln5/jjj8/hhx+erbfeOm3bts3IkSOz6qqrZs0112xY6JzGceUGAAAAAAArlf79++e8887LpptumldffTWPPPJI6urqcuihh+auu+5Knz59MmfOnDz22GONPvfAgQPzl7/8Jd/61rfywQcfNJx7n332yV133ZWtt956nvG77bZbbrzxxuywww55/fXX8+STT6ZPnz658cYb07p166X1kJscV24AAAAAABRc81at0/NHR5U6xmJr3mrpfajfuXPnBS4Svtdee2WvvfZa4DFXXnnlPLe/8pWvzHeOPn36LHTx8d69e6d3796LnXGLLbbI1VdfPd/2+++/f7HPwbyUGwAAAAAABVe52hqpXG2NUseA5ca0VAAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAArFguKwAlu1RW3Kq6aUOsZCVbRslZqyVqWOAQAAAAA0McoNWIHV18zKc7ddWeoYC7Vl/2OSSuUGAAAAALB8mZYKAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAolGalDgDAiqtmTm1mVVWXOsZCtapskebNKkodAwAAAIDlTLkBwELNqqrO76+4r9QxFurEo3ZL8zatSh0DAAAAgOXMtFQAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAolGalDrA01NbW5pZbbsmdd96ZcePGpba2Nuuss06++93v5tBDD03Lli3nGf/iiy/m8ssvz4svvpiZM2dmww03zIEHHpjvfe97JXoEAAAAAADA4ip8uVFbW5ujjjoqjzzySFq3bp3NN988zZo1ywsvvJBLLrkkjz76aG644Ya0atUqSTJixIgcfvjhqauryzbbbJNWrVrlySefzAknnJCxY8fm5z//eYkfEQAAAAAAsCiFLzduv/32PPLII+nevXv+9Kc/pVOnTkmSKVOm5Kijjspzzz2XK664Ir/4xS9SVVWVE088MUly3XXX5etf/3qS5N13380BBxyQq666Kt/+9rfTo0ePkj0eAAAAAABg0Qq/5sadd96ZJDn11FMbio0kadeuXc4444wkyb333pskufvuu/Pxxx/ne9/7XkOxkSRf/epXc8IJJyRJhgwZspySAwAAAAAAS6Lw5cYaa6yR9ddfPz179pxv33rrrZck+fDDD5Mkjz/+eJJkl112mW/st771rVRUVOSxxx5bdmEBAAAAAIAvrfDTUl111VUL3ffiiy8mSTp37pwkeeONN5IkG2200Xxj27Rpk44dO2bChAn56KOPsuaaay6DtAAAAAAAwJdV+Cs3Fqa+vj4XX3xxkmS33XZLkkyePDlJ0qFDhwUeM3f7Rx99tBwSAgAAAAAAS2KlLTcuvPDCPP3001lzzTVz6KGHJklmzZqVJKmsrFzgMXO3z5w5c/mEBAAAAAAAGq3w01ItyMUXX5yrr746LVq0yEUXXZR27dolSSoqKlJfX5+ysrJFHl9XV9eo+2vfvs0XjplVXZPKyuaNOu/y1rxFs3TosGqpYyw3RXhNysvK0qqyRaljLFSLFs2yahP6b6YpWtF/Tpra+xYrJj8nAEvfp5Om+zsYYAW3ov8dnPhcBVZ2K1W5MWfOnPzmN7/J0KFD07Jly1x66aXZZpttGva3atUq06dPz+zZs9OyZcv5jq+qqkqSrLLKKo26348/npG6uvpFjqmpnpOqqppGnXd5q6mek8mTPy11jOWmCK9JXX19ZlVVlzrGQlU3sf9mmqIV/eekqb1vsWLycwKw9JVXz/F3MMAKbkX/OzhZeT5X8WUlWLCVZlqqzz77LEcccUSGDh2a1VZbLddee2123HHHecZ07Ngxyf9be+O/fdGaHAAAAAAAQOmtFOXGtGnTcsABB+Txxx9Ply5dctNNN81zxcZc3bp1S5K8+eab8+2bMWNGPvzww7Rr1y5rrrnmMs8MAAAAAAAsmcKXG9XV1fnpT3+al19+ORtuuGFuvfXWbLTRRgscu/322ydJHnjggfn2PfTQQ6mtrZ3vag8AAAAAAGDFUvhy45JLLsnzzz+fLl26ZMiQIencufNCx/bt2zft27fPnXfemUcffbRh+3vvvZcLLrggZWVlGThw4HJIDQAAAAAALKlCLyg+derUDBkyJEnSrl27nHPOOQsde/7556dNmzYZPHhwjjvuuBx++OHZZpttssoqq+Tf//53Zs2alZ///OfZeOONl1d8AAAAAABgCRS63Hj66adTVVWVJHn55Zfz8ssvL3Ts+eefnyTZZZddMmTIkFx++eV54YUXUl9fn+7du2fgwIHZfffdl0tuAAAAAABgyRW63Nhtt90yZsyYRh/Xq1evXHvttcsgEQAAAAAAsKwVfs0NAAAAAACgaVFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCalToAALD4aubUZlZVdaljLFSryhZp3qyi1DEAAACAlZxyAwAKZFZVdX5/xX2ljrFQJx61W5q3aVXqGAAAAMBKzrRUAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAApFuQEAAAAAABSKcgMAAAAAACgU5QYAAAAAAFAoyg0AAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFIpyAwAAAAAAKBTlBgAAAAAAUCjKDQAAAAAAoFCUGwAAAAAAQKEoNwAAAAAAgEJRbgAAAAAAAIWi3AAAAAAAAAqlWakDAAAAsHzVzKnNrKrqUsdYqNUr6ksdAQCAFZxyAwAAoImZVVWd319xX6ljLNSZR3+j1BEAAFjBmZYKAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFEqzUgcAAFYeq7aoTXnVlFLHWKSKlq1SU9aq1DEAAACAL0G5AQAsNfU1s/LcbVeWOsYibdn/mKRSuQEAAABFZloqAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhWJBcWCFUTOnNrOqqksdY5FaVbZI82YVpY7B/2/VFrUpr5pS6hiLVNGyVWrKLF4NACzaiv63sL+DAYAVjXIDWGHMqqrO76+4r9QxFunEo3ZL8zY+qF5R1NfMynO3XVnqGIu0Zf9jkkr/zQAAi7ai/y3s72AAYEVjWioAAAAAAKBQlBsAAAAAAEChKDcAAAAAAIBCseYGAAArFYvyAix9q7aoTXnVlFLHWKiKlq1SU2ZNkJXZiv77PfE7HmB5U24AALBSsSgvwNJXXzMrz912ZaljLNSW/Y9JKr23rsxW9N/vid/xAMubaakAAAAAAIBCUW4AAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUigXFAQBWYqu2qE151ZRSx1ikipatUlNm8U0AAAAWn3IDAGAlVl8zK8/ddmWpYyzSlv2PSSqVGwAAACw+01IBAAAAAACFotwAAAAAAAAKRbkBAAAAAAAUijU3AAAAAOBLWrVFbcqrppQ6xkJVtGyVmjLrnAErD+UGAAAAAHxJ9TWz8txtV5Y6xkJt2f+YpFK5Aaw8TEsFAAAAAAAUinIDAAAAAAAoFOUGAAAAAABQKMoNAAAAAACgUJQbAAAAAABAoSg3AAAAAACAQlFuAAAAAAAAhaLcAAAAAAAACkW5AQAAAAAAFEqzUgcAKJJVW9SmvGpKqWMsVEXLVqkpa1XqGABQKM3rZ6V29qxSx1gov9+BBfHeBUBTp9wAaIT6mll57rYrSx1jobbsf0xS6X8gAKAxamfPynO3XFbqGAvl9zuwIN67AGjqTEsFAAAAAAAUSpMtN/71r3/lwAMPTJ8+fdKrV68ccMABeeyxx0odCwAAAAAA+AJNstz461//mkGDBuW5555Lz549s+WWW+a5557LYYcdlqFDh5Y6HgAAAAAAsAhNbs2NSZMm5de//nVWXXXV3Hzzzdloo42SJKNHj86gQYNy9tlnZ6eddkqnTp1KnHT5s1AyAAAAfK5mTm1mVVWXOsZCrV5RX+oIAFBSTa7cuOmmm1JdXZ3DDz+8odhIkp49e+awww7LH/7whwwdOjTHHXdcCVOWhoWSAQAA4HOzqqrz+yvuK3WMhTrz6G+UOgIAlFSTm5bq8ccfT5Lsuuuu8+2bu83aGwAAAAAAsOJqUuVGfX19xo4dm/Ly8qy//vrz7V9vvfVSXl6esWPHpr7e5Z0AAAAAALAialLlxrRp01JdXZ22bdumRYsW8+1v1qxZ1lhjjcyaNSufffZZCRICAAAAAABfpEmtuTFr1qwkSatWC1+3obKyMkny2WefpU2bNot13vLysi8c06xZedqvscpina9Uyps1S+Vqa5Q6xkKVV1Qki/FcLy6vyZfnNVnxNLXXZEV/PRKvyYrIa7LiaWqvSbNm5Yv19yPLT3lFxQr9c7K0f0aSFf/nZEV/7/KarHi8Jiuepvb7PfGarIia2msCTU1ZfROaf2nSpEnZYYcdsvbaa+ehhx5a4Jidd94548ePz6OPPprOnTsv54QAAAAAAMAXaVLTUrVu3TpJMnv27IWOqaqqmmcsAAAAAACwYmlS5UabNm3SunXrTJ06NXPmzJlv/5w5czJ16tS0bNkyq622WgkSAgAAAAAAX6RJlRtlZWXZcMMNU1tbm7fffnu+/W+99Vbq6uqy0UYbLf9wAAAAAADAYmlS5UaSbL/99kmSBx54YL59c7ftuOOOyzUTAAAAAACw+JpcubHvvvumZcuW+dOf/pSXXnqpYfuLL76Ya665JpWVlfnxj39cwoQAAAAAAMCilNXX19eXOsTydtNNN+U3v/lNmjdvnj59+iRJRo4cmTlz5uR3v/td9tprrxInBAAAAAAAFqZJlhtJ8vDDD+eaa67JK6+8khYtWqR79+458sgjs+2225Y6GgAAAAAAsAhNttwAAAAAAACKqcmtuQEAAAAAABSbcgMAAAAAACgU5QasIP7xj3/kuuuum2fbk08+mSOOOCLDhg0rUSqSZMKECXnhhRfy8ssv5+OPPy51HABWAtXV1amtrS11DFhhjR49OsOHD897771X6ihN0tNPP52JEyc23H7xxRdz2GGHZc8998wpp5ySDz74oITpmrYpU6bMc/vDDz/MSy+9VKI0/DfvXaU3evTo/O1vf5tn2/PPP5/BgwfnhRdeKFEqYFmx5kYTcNVVV32p44844oillIQFqampyfHHH58HHnggXbt2nafIuOmmmzJ48OCUlZXl+9//fs4999yUlZWVMG3TMWfOnPz5z3/OLbfckgkTJsyzb/31189BBx2Ufv36lSjdyu3ggw9e4mPLyspy7bXXLsU0UDy1tbWZOnVqampq8p9/5tXV1WX27Nn56KOP8vDDD+eXv/xlCVM2HZ988kkuvvjiTJ8+PRdccEHD9vvvvz+nnXZadt9995x00klp3bp1CVM2PdOnT897772X2bNnL3Jcr169llOipuvJJ5/MlVdemUMPPTQ77LBDkuTnP/95hg8fniQpLy/PoYcemp///OeljNlkVFVV5ac//WmefvrpnHPOOdlnn30yadKk7L777pk1a1bD75UOHTrkrrvuSvv27UucuOl44YUXcuqpp6Zt27a56aabGrbfc889Oemkk7L++uvnD3/4QzbaaKMSpmw6vHeteOrr63POOefkxhtvTLdu3eYpOIYOHZpf//rXKS8vzxFHHJHjjjuuhEmBpalZqQOw7F100UVL9IF4fX19ysrKlBvL2C233JL7778/m2yySX7xi1/Ms2///fdPt27dcu655+Zvf/tbevTokQMOOKBESZuO2bNn55BDDsmoUaNSX1+ftddeO507d06SjB8/Pm+++WZ+/etfZ+TIkfN8UMXS8a9//WuJj1X+LV+L863NsrKyNGvWLKuuumoqKyuXQ6qmq76+Puedd15uvfXWVFVVfeF45cayN2XKlOy///559913s+66686zr6amJrNnz87QoUPzzDPP5Oabb85qq61WoqRNR1VVVU455ZTcd999qaurW+TYsrKyvPLKK8spWdP0/PPP57DDDkttbW123XXX7LDDDrn//vvzj3/8I61atcoOO+yQZ555JldffXU23XTT9O3bt9SRV3rXX399nnrqqay33npZZ511kiQ333xzZs6cmZ122iknnHBC7rnnnvzxj3/MVVddlV/96lclTtw0vP766znggANSXV2d7bfffp59Xbp0ydZbb52nn346+++/f26//fZssMEGJUraNHjvWjHdfffdGTJkSDp37jzf5yZ9+/ZNixYtcskll+TKK6/Meuutl+9///slSgosTa7caAIuvfTSL/WB3zHHHLMU0/Df9t5773z44Ye577770qZNmwWOmTZtWnbbbbd06tRpvssrWfouv/zyXHrppdliiy1y1llnZcMNN5xn/+jRo/OrX/0qY8eOzWmnnZYBAwaUKOnK6amnnvpSx/fu3XspJeGLbLzxxo36/dK+ffvstttu+fnPf55VV111GSZrmuZe7Zcka6yxRmpra/Ppp5/mK1/5SqZPn55p06YlSdZZZ50MGDAgAwcOLGHapuGcc87JX/7yl/zwhz/MSSedNF95MXv27Jx11lm5/fbbM3DgQIXTcvC73/0uf/7zn9OsWbNssMEGX1goDRkyZDkla5qOO+643HfffTn99NPzox/9KBUVFTnqqKPy8MMP57e//W323nvvTJw4Mbvvvns233zzXH/99aWOvNKb+5zff//9Db+rd99997z99tu566670r179yTJHnvskerq6tx///2ljNtkzP1ZOffcc7P33nsvcMxdd92VX/7yl/nud7+bCy+8cPkGbGK8d62Y+vXrlzfffDPDhg1Lp06dFjhm7uuy0UYbZejQocs5IbAsuHKjCTj22GNLHYFFePfdd/PNb35zocVGkqy++urp1atXRowYsRyTNV1/+9vf0q5du1xzzTULfF169uyZP//5z9l9991z6623KjeWMuVEcfzgBz/ISy+9lDFjxqSioiKbbbZZ1l577dTX12fChAl58cUXM2fOnLRv3z6dOnXKBx98kJtvvjlPP/10br/9dldyLGV33XVXysrKcumll2bXXXfN//3f/+W0007LNddck3XXXTcvvfRSTjzxxEyYMGG+b32ybDz66KNZb731GqaY/G8tW7bMGWeckX//+9+57777lBvLwf33359VVlklt912m282rwCeffbZ9OzZMz/+8Y+TfL4WzZNPPplmzZplt912S5J07tw5vXr1yosvvljKqE3GO++8k2984xsNxcb777+ft956K506dWooNpJkgw02yCOPPFKilE3P6NGjs8UWWyy02Eg+L6ZuvPHGPPnkk8svWBPlvWvF9NZbb6V3794LLTaSz1+XuVc6ASsHC4pjseQSa9WqVcO3aReluro6LVu2XA6JmDBhQrbeeutFFk5rrrlm+vTpk3feeWc5JmNRampq8tBDD5U6RpPy4x//OG+//Xa22mqr3H///bn11ltzwQUX5MILL8wtt9ySRx99NNtvv32qqqpy7rnnZsSIETniiCPyxhtv5Lrrrit1/JXOuHHjsummm2bXXXdNkmyxxRapr69vuBqqR48eufzyy1NdXZ1rrrmmlFGbjIkTJ6Z79+6LvMKpoqIim2yyST788MPlmKzp+uijj7LtttsqNlYQ06ZNy1prrdVw+5lnnsmsWbPSs2fPedahad26dWbOnFmKiE1Os2bN5pmy7bHHHkuSbLvttvOMmz59epo3b75cszVln3zyySI/sJ1r7bXXzowZM5ZDoqbNe9eKqby8PDU1NV84rqKiIuXlPg6FlYUrN5ooiyWvODbbbLM88cQTefXVV7PJJpsscMybb76ZkSNHZptttlnO6ZqmLl26ZNKkSV84btq0aVlzzTWXQyIeeuih3HTTTfnggw/mWyS5vr4+s2fPzrRp01JbW5tXX321hEmblgsvvDCtWrXKH//4xwWWge3bt88ll1ySb3/727ngggvyxz/+MT/72c9yzz33ZPjw4TnqqKNKkHrlNXv27HzlK19puL3uuuumoqIiY8aMadi2/vrrZ4sttsjIkSNLEbHJad++/WKV4BMmTEjbtm2XfSDSrVs3RdIKpFOnTpk4cWLD7YcffjhlZWX55je/2bCtvr4+r732Wjp06FCKiE3OeuutlxdeeCFVVVWprKzMsGHDUlZWlh133LFhzLvvvptRo0Zl0003LWHSpmXttdfOCy+8kNra2lRUVCxwTF1dXV5++eWGtQJZdrx3rZi6d++ep59+OuPHj8/aa6+9wDGTJk3KyJEjs/HGGy/ndMCyoqpsgmbPnp2BAwfmwgsvzAcffJC11lorvXr1Sq9evdKpU6eGxZL/e3Frlo0DDzwwtbW1GTRoUG6++eZMmDAh9fX1qa+vz8SJE3PbbbfloIMOSm1tbQ466KBSx20SBgwYkNGjR+evf/3rQsc8+uijeeaZZ/KjH/1oOSZrmp544okcffTRGTFiRN566628//77GT9+fMM/H3zwQT7++OO0bNky3/rWt0odt0l57rnn0rt370Ve5dSqVav06tVrnku/N95444wfP355RGxS1lhjjXz66acNt5s1a5YuXbrkjTfemGdchw4dMnny5OUdr0n6xje+kTFjxuTOO+9c6Jjhw4fnxRdfTJ8+fZZjsqbrpz/9aUaPHp1//OMfpY5CPv+SzwsvvJD/+7//y4gRI3LXXXclScO0LtXV1Tn//PPz/vvv+xlZTvbYY49MmTIl++67b/r3759nnnkm7dq1y84775wkufrqq/PjH/84c+bMyT777FPitE3HbrvtlokTJ+bMM8/MnDlz5ttfV1eXc889N+PHj2+4gpNlx3vXiql///6ZPXt2Bg0alEcffTS1tbUN++rq6jJixIgMGjQoVVVV/j8eViKu3GiCrrnmmjzzzDNfuFjysGHD0qtXL+sJLGPf+MY38rOf/SwXX3xxBg8e3LAY7H875phjstNOOy3fcE3EPffcM8/ttm3bpmvXrg0/B3vssUfWXnvtVFZW5sMPP8yIESNy++23Z/PNN7c+xHJw/fXXp76+PgcddFD222+/DB8+PFdccUXuuOOONGvWLE888UQuu+yyrL766jn33HNLHbdJadmyZaZOnfqF46ZOnTrftDyNWYicxdOzZ888/vjjef/99xuu4Nhwww3z1FNPZebMmQ3TJIwbN+4LF1Fm6TjkkEMybNiwnHrqqXn00Uez0047pUuXLkk+n7Lqsccey/Dhw1NZWZkjjjiixGmbhm9/+9s5+eSTc/zxx2fo0KHZeOONF3nVjNdl2TrmmGPy73//O6eddlqSz7/p/N3vfrfh/0922WWXfPTRR1l99dVz5JFHljJqk3HQQQflgw8+yF/+8pckn6/9d/755zdMj3vHHXfko48+yqBBg7L//vuXMmqTcvDBB2fYsGG5/fbb88gjj2S77bab5/fJk08+mQkTJqRLly45/PDDS5x25ee9a8W0++6758knn8xtt92WI444Is2bN2+YaeGjjz5qmAFg3333XeT6NUCxlNX/59weNAl9+/bNp59+mvvuu2+h37b96KOPsvvuu6dz587zffDLsvHSSy/l1ltvzdNPP50PP/wwtbW1WXPNNdOrV6/0798/W221VakjrrQ23njj+T5o/c+3xgV9CDt3f3l5eV555ZVlG7CJ+/rXv55VV101999/f5LPC9h+/frlD3/4Q3bfffckySOPPJIjjjgiP/3pT3P88ceXMm6Tcthhh2XEiBH54x//uNAFqp988skcfPDB6dOnT66//vokyc4775xVVlnF75el7Iknnsihhx6adu3a5ZhjjsmPf/zj3H333Tn55JOz00475YADDsjDDz+cG2+8Mdttt511N5aTf/3rXzn55JMzefLkBf6uadu2bX7/+99b5H05ee+99xo+vJ1rYb/ny8rKTHW4HLz33nu58sor89FHH2XrrbfOoEGDGtZyGDhwYFZbbbWcdNJJ80y7x7I3YcKETJ48ORtttFEqKysbtg8fPjwbbLBBunXrVsJ0TdPEiRNzxhlnLHQh929+85s566yzGkoPli3vXSuu++67L7fcckueeeaZhjU4mjVrls022ywDBgzInnvuWeKEwNKk3GiCevbsmZ122imXXHLJIscdc8wxeeyxxzJ69OjllAxK45e//OWX+hb5b3/726WYhv/Wo0eP7LTTTrnsssuSJLNmzcqWW26Zww47bJ7p8/bcc8/U19fn3nvvLVXUJmfUqFE56KCDUlZWlgEDBmTXXXdNly5dUldXlwkTJuThhx/OzTffnJqamlx77bXZeuut88tf/jLDhg3LkUcemeOOO67UD2Gl86c//SkXX3xx+vbtmwsuuCC1tbXp169fXn755ZSVlaW+vj7NmzfPTTfdlJ49e5Y6bpMxc+bMPPjgg3nqqacyefLkzJkzJx06dEivXr2y++67L3JqN5auI488Mg8//HDWWmut7LTTTlljjTUW+TfAMcccsxzTQekdeeSRWW+99XLyySeXOgoLMWnSpPl+n2y55ZZZb731Sh0NVjhTp05NbW1tVl999YbyCVi5KDeaoL59+6Zt27YZOnToIscdcMABGT9+fB566KHllAxgfn369MmWW26Zq666qmHbdtttl8022yxXXnllw7bjjjsujz32WJ5//vkSpGy6/vGPf+T000/Pp59+usBvpbdu3Tqnn3569t5777zzzjvp27dv1lprrdxxxx1p165diVKv3D788MN8/PHH2WSTTZJ8Xghee+21GT16dDp37pwf//jHFlFcAU2fPt10YcvBNttsk1VXXTV///vfG6ZqA/6fLbfcMj169MiQIUNKHQUA4AtZc6MJGjBgQH7729/mr3/9a/bdd98Fjpm7WPLPfvaz5RuuCfjf//3fJT62rKwsv/nNb5ZiGhZk1qxZadWq1ReOq6+vzw033JCBAwcu+1BN2EYbbZTRo0enuro6LVq0SJKsv/76efHFF+cZN2XKlDRr5tfa8rb77rtn2223zV133ZUnn3wyH3zwQebMmZPOnTunT58++cEPfpAOHTokSVq0aJEzzjgj3/3ud32Iuwx17NgxHTt2bLjdqlUr3z4vkV122SW77bbbF34D+oQTTsi///3vPPHEE8spWdNVX1+fHj16KDZK5OCDD17iY8vKynLttdcuxTQsSGVlZcPfW5TOpEmTkiQdOnRIeXl5w+3F1alTp2URi//wwQcf5NZbb80bb7yRWbNmpa6uboHjysrKcsMNNyzndE3D3C+/9e/fP6uvvvo8X4ZbHNbVgpWDT4GaAIslr1huv/32JT5WubF8HHLIIbnmmmsW+cHHmDFjctppp+Wll15Sbixje+yxR84444wMGjQoxx9/fLbaaqtst912efrpp3PZZZfl8MMPz4MPPphRo0bla1/7WqnjNklt27bNwIED5/lZmD17dpo1a5aKioqGbV26dLH4KE3K+PHj8/HHHy9yzIwZMzJ27NhMnz59OaVq2rbaaqu8+uqrDWtqsHz961//WuJjvV7Lx+GHH57zzjsvN910U/r162calxLZcccdU15ennvvvTddu3bNjjvuuNg/A2VlZdYEXMbGjBmTn/zkJ5kxY0a+aDIU713LzkUXXZSysrL07ds3q6++esPtLzL3bwDlBqwcTEvVBFgsecVy5513fqnj99lnn6WUhIXZeOONs8UWW+Saa66Zbx706urqXHbZZbnuuusyZ86cdOnSJQ8//HCJkjYNtbW1Oeqoo/Loo49ml112yeWXX55PP/00u+22Wz755JN5xp533nn53ve+V5qgTdQnn3ySiy++ONOnT88FF1zQsP3+++/Paaedlt133z0nnXSSb0kvA7vssssSH1tWVpYHHnhgKaYhSfr16zffVWWLa5NNNslf//rXpZyI//baa6/lRz/6Ufbcc8+ccsop1jtZzp566qkvdbwvXi175513Xh566KG88847adGiRdZff/2svvrqKS8vn2+sq2mWnZ133jlJcsMNN2SdddZpuL24TC29bB199NF58MEH8/Wvfz39+vXLmmuuOc8Xev7bVltttRzTNR2XXnppysrK8pOf/CRt27ZtuL24XNkMKwflRhNgsWRonF/84he5995706NHj1x33XUN0+eMHDkyp59+et59991UVFTkwAMPzLHHHrtYU1jx5Q0fPjx1dXX57ne/myR544038pvf/CYvvvhiOnfunIEDB7oqYDmbMmVK9t9//7z77rtZd911889//rNh37Bhw3Lqqadm9uzZ2WCDDXLzzTebimopW5x1M5o3b55mzZpl1qxZDdvKy8tTVlaWl19+eVnGa5JefPHF9O/fv+FLInOnqFjQh4LJ5x8MtmjRIuutt17OPPPMbLbZZssta1N14YUXZvTo0Rk5cmQqKioaPrhd0LfTfXBLU9SYNZnKysry6quvLsM0sGLq3bt3VltttQwfPty0uAAlptyAAhkzZky6d+9e6hgrvfr6+vz617/Obf9fe3cekFPa9wH8e9q0SKG0yU63QUgxTIhsoezbkJChmWge21hHmGEsszb2ZWxjKTNhUNllTzUolG0saaFGSdrrvH/MuN9pWvA8Oied7+evuc/53a/vwxv3fX7Xdf0CAvDee+/hu+++w/r16xEYGAhRFGFnZ4cFCxagSZMmckclktWSJUuwbds2DB48GJ999lmx5kVOTg6+/PJL7NmzB2PGjMGsWbNkSlo5/fv87RcvXsDHxwdPnz6Fj48PnJ2d1fNOMjIyEBoaiq+//hqmpqbYuHEjm00SUKlUcHNzw/Lly+WOQn/jg9t3U15eHs6cOfPGq9fpzb3p7hrupiElat26NTp27Ag/Pz+5o9A/LFmyBP369eNRxUQKw+YGUQVw/fp1+Pv7IyEhAXl5eUWODRNFETk5OUhJSUFSUhKPCZPQihUrsGnTJvXOJyMjI8yYMQODBg2SORlRxdCzZ08IgoDg4OBSdwgWFBSgV69eKCgo4BEJ5Wzp0qXYuXMnAgMD0ahRoxJr4uLi4Orqij59+mDx4sUSJ1SevXv3ok6dOjyOogLhg9uK58SJE9ixY0eZn4OfPXuGgoICNptI8dLT0xEXF4ecnJwy6+zs7CRKpEzDhw/Hixcvis03JXm9PJK9fv366NevH/r27QsrKyu5YxFROeP+OYXKzc3FmTNn8PDhw1d+MOKQpfIVFRWFUaNGFfkyJwhCiXNRuFNAWjNmzIChoSG+//57aGlpYcuWLW+04pP+O+PGjYMgCFiyZAnMzMwwbty4134vjxCRVlJSEpycnMo8+lBTUxNNmzZlY0MCBw8eRLt27UptbACAtbU13n//ff55lJPZs2cXu3bp0iX88ssvr3zvy7/3qHyxWVGxnD17Ft7e3q8cyGtgYIB27dpJlIpeevLkCSIiIpCUlIQ6deqgW7duiI6Ohkql4qBxiWVnZ2P27Nk4cuSI+sjD0nCgePkbP348Jk2ahICAAAwdOlTuOPS3efPm4eDBg7h69Sq+++47/PDDD7Czs0O/fv3Qq1cvGBoayh2RiMoBmxsKlJCQgFGjRiExMbHMOlEUIQgCmxvlbMOGDcjNzUXPnj0xcOBAhIaGYvfu3Vi7di0KCwtx9uxZ7N69G/Xr18eePXvkjlsp/f7776Xea9u2LVxdXXHgwAF8+umnWLRoUbEvc1wZ9XadP38egiAgMzNT/fp1/S/zhejN1axZEw8ePHhlXWJiIoyNjcs/kMJlZmaWOczypby8POTl5UmQSHn27t1b7No//14q6QHuywUNbG5IJzc3F9u2bcOff/6JmTNnqq+fOHEC3333Hdzc3ODp6VnqrBR6e7Zs2QJRFOHh4YEhQ4YgJCQEq1evxi+//AItLS2cPXsWK1euhJGREZYuXSp3XMVIT0/HokWLEBwcrH6Q7urqim7dumHx4sWIj4+Hn58fWrduLXNS5fjhhx8QHBwMLS0tNGnShEdLykxbWxvOzs7w9fXF/v37YWtri2rVqpX6XYTPVKQxatQo9bOugwcPIigoCBEREYiMjMQXX3wBJycnuLm5oXPnzmzQElUibG4o0NKlS5GQkIB69eqhY8eOZf4jTOXv8uXLqFWrFr7++mtoa2ujatWq2LlzJ/Ly8tCtWzd06dIF7733HubOnYstW7ZgwoQJckeudD788MPX+hl48OABxowZU+QaV0a9fdu2bQMAWFpaFnlNFU+HDh3w66+/Yu/evRgwYECJNSEhIYiOjkafPn0kTqc8DRs2xMWLF/HgwQPUrVu3xJpr164hLCyMTdly8u/ZGqIoYsOGDbh79y5cXFzg7OwMKysraGpqIjk5GadOnUJgYCCaN2+O6dOny5RaWV68eAFPT09cvXoV1tbWRZobf/75J27fvo1vv/0WZ8+exYYNG6CjoyNj2srv2rVrsLa2Vu966tSpE1auXIkHDx7AxcUFTZo0QYMGDeDl5YWNGzdi6tSpMieu/F68eAF3d3fcvHkTZmZmaNu2bZGjdwwMDJCcnIxx48Zh3759pf57Q2/X0aNHYWBggICAADRs2FDuOIo3ceJE9eKEyMhIREZGlvh9kgtG5WFhYYGPPvoIH330Ee7du4dDhw4hKCgIR44cwdGjR1GtWjX06tULCxculDsqEb0FbG4oUGRkJCwtLbF3717o6enJHUfx0tLS4OjoqF458PLoqevXr6Nbt24AgEGDBmHNmjUICgpic6McODg4yB2B/uHfR4bk5eWhadOmqFGjhkyJqDSenp4ICgrCnDlzEBoaCicnJ1hYWAD468iq06dPIyQkBLq6uvxSJ4HRo0djxowZGDVqFHx8fNCpUyeYmZlBFEUkJCTg2LFjWL16NQoLC/lvSTlxc3Mr8nrnzp24e/cuvvnmG/Tu3btYfdeuXeHs7AwvLy9ERkbC3t5eqqiKtXnzZly5cgUdO3bErFmzitwbMmQIOnTogEWLFuH06dNYv349Jk2aJFNSZcjIyCjy//eNGzcGANy4cQMuLi4AACcnJzRq1AjHjx9nc0MCGzZswM2bNzFs2DDMnTsXOjo6RZobmzZtwsqVK7Fy5UqsW7eOO84kkpKSAkdHRzY2Kghvb28uEH1H1K9fH5MmTcKkSZNw5MgRLFmyBElJSQgICGBzg6iSYHNDgXJyctCmTRs2NioIfX39IseIGBoawtjYGHfv3i1S17RpU5w9e1bqeIqwfft2uSNQGebMmQNNTU3OCKiA6tevj5UrV2LmzJkICQnB4cOHi9wXRRHGxsZYsWKF+oEVlR9XV1fcunULGzduxPz580us0dTUxJw5c+Do6ChxOmXatm0bWrZsWWJj46XOnTvD3t4eAQEBmDhxooTplCkkJAQWFhZYtWpVibsyrKys4Ofnh+7du+PAgQNsbpQzAwMD5Ofnq1/r6enBxMQEd+7cKVLXoEEDnD59Wup4ihQcHAxLS0vMnz+/1KMOJ02ahAMHDiAyMlLidMrVuHFjPHnyRO4Y9LfJkyfLHYFeU2xsLIKDgxESEoKHDx9CFEWYmJigb9++ckcjoreEzQ0FsrOzw82bN9VbJEle9evXx40bN1BYWKg+27l+/fq4du1akbqX8weIlObp06fo0qWL3DGoFB06dMDhw4dx7NgxXLp0CSkpKcjPz4epqSns7Ozg4uKCqlWryh2zUho9ejTs7e3h4+MD4K+ZWp6enujevTv8/f0RERGhfhBiZmaGDh064MMPPyxz4Di9XYmJibCxsXllnbGxMaKjoyVIRPHx8ejYsWOZx01VqVIFtra2CA0NlTCZMjVp0gRRUVHIzc1V/5k0aNCg2M/D06dPoaXFr65SSExMRJcuXV45w8nGxoY/IxKaMGECJk+ejODgYPWuJqo4Hj9+jJSUFOjo6KBmzZrccS6zO3fuICgoCEFBQXjw4AFEUYSenh769u0LNzc3fPDBB5yrRVSJ8BOiAk2bNg3Dhw/H4sWLMW3aNO7gkFn37t3x9ddfY9q0aZg6dSqsra3Rtm1brF+/HoGBgRg4cCCioqIQFhaGBg0ayB1XUW7fvo2tW7ciPDwcycnJ0NHRgYmJCdq1a4chQ4ZApVLJHVERbG1tERUVhRcvXsDAwEDuOFQCfX19uLm5FTuSh8pXVFQUatasqX7t7OwMNzc3LFu2DLa2tjImo5csLS0RERGBzMxM6Ovrl1jz9OlTXLx4kefWS8TQ0PC1Vj8/e/aM/+ZIoE+fPliwYAHGjh2LqVOnok2bNnB0dER4eDhWrlyJiRMn4vjx44iMjESzZs3kjqsIBgYGSEpKemVdfHw8f0Yk1L17d8ycORNTp06Fv78/VCoVjI2NS63ncaDS8Pf3x6ZNmxAXF1fkeqNGjTBy5EgMHz5cpmTKtGrVKoSEhODOnTsQRREaGhro0KEDXF1d0aNHj1I/ixHRu43NDQWysbHB3LlzMW/ePOzduxd169Yt9YORIAjYtGmTtAEVZtSoUQgKCkJwcDCysrKwdu1ajBo1Ctu2bcPcuXPx3Xff4c8//0RhYSGGDBkid1zFCAwMhK+vL/Ly8tTXMjMzkZaWhjt37iAgIAC+vr4YPHiwjCmVYeHChZg0aRL69++P/v37Q6VSwcjIqNTVNhyULK1du3YhICAADx48QG5ubpm1/96RRv8bLS0t3Lp1C3l5edDW1oYoihBFUe5Y9A+urq7w8/PDxIkT8eWXXxZrYMTGxmLOnDnIyMjA0KFDZUqpLG3atEFISAjOnTuHDz74oMSaiIgIREZGonPnzhKnU54hQ4bg5MmTCA0NxU8//YQ2bdpgxIgR2Lx5M1atWoVVq1apaz08PGRMqhx2dnY4deoUrly5glatWpVYExERgRs3bqBr167ShlOwuLg4bN++HaIo4uLFi7h48SIHWMts7ty5CAwMVB9zVLt2bRQWFuLRo0e4ffs2Fi5ciKioKM6lkdCPP/4IAFCpVHBzc0Pfvn1Rq1YtmVMRUXkTRH4LVpzz589jwoQJRc63LY0gCIiJiZEglbLl5OTg559/hq6uLkaOHAkAuHjxIubNm4dHjx5BV1cXo0ePxn/+8x9un5RAVFQURowYAS0tLXz00Ufo06eP+sNqXFwcgoKCsGnTJhQUFMDf358rCcuZSqWCIAivdZSeIAi4ceOGRMnoZZPvdT9KxMbGlnMiZRkzZgzCwsKgp6eH6tWrIz4+Hvr6+qhevfor3ysIAo4dOyZBSmXLzc2Fp6cnwsPDIQgCrK2tYWZmBuCvVc+JiYkQRREuLi747rvvZE6rDNHR0RgxYgQ0NDTg7u6OLl26wNzcHACQlJSEM2fOYNu2bcjNzcX27dvZMJdISEgICgsL1fNpbt++jUWLFiE6Ohrm5uYYM2YMV0BL5OrVq/jwww9hYGCATz/9FG3btoWrqytcXV0xffp0nD59Gt988w3S09Oxbdu2IgPhqfx8/PHHOHnyJCwtLeHk5ITq1auX+bmY84LK16FDhzBt2jRYW1tjyZIlcHBwKHL/5Xf5+Ph49RwnKn8rVqxAv3790KRJE7mjEJGE2NxQoKFDhyIqKgo9evRA7969X/nBqG3bthKmU57Zs2fDzs6u1F0ZT58+hbGxMdavX4+LFy9iy5Yt0gZUIB8fHxw9ehTr1q1Dp06dSqw5ffo0JkyYAFdXV6xYsULihMri7u7+RvUcEC8dV1dX/PHHH1iwYAF69uyJatWqyR1JUe7cuQMvLy88evQIANRNwNfBxQvSycvLw7Zt2+Dv74+HDx8WudeoUSN4eHhwZ6bE9u3bh4ULFyIrK6vYZ2BRFKGjowNfX18MGjRIpoRE8nq5g7m0xXCCIGDmzJncTSMhBwcHGBoa4uDBgzxapwIYNWoUoqOjcfDgQVhbW5dYExcXhz59+sDBwYGnYRARlSM2NxSodevWqF+/PgIDA+WOQvj/LZPLly8vs+7lys+oqCiJkilXhw4dUKdOHezevbvMuuHDhyMxMZHDFEmxWrVqhTZt2vALm8yePn2K3NxcODk5oUePHpg7d+5rve/lDgKSzuPHj/HkyRMIggAzMzOYmprKHUmxkpKSsHfvXvVcrfz8fJiYmMDOzg6DBw8u9WEVkVLcvXsXW7duxaVLl5CUlISCggKYmprCwcEB7u7uaN68udwRFcXe3h4dOnSAn5+f3FEIfx1x2Lp1a2zcuLHMuvHjx+PatWu4ePGiRMmUZe3atQCAESNGwMjISP36dfH4NqLKgTM3FMjAwACWlpZyx1Cs6dOnFxtkef78eYwePbrU92RkZCAmJoZ/bhJJT09XH1FRFnNzcx6BJIF9+/bB2toabdq0KbPu2LFjuH79Oj799FOJkpGZmRlnPFQANWrUAPDXqs5mzZqxaVGBmZmZ8c+ngjA3N8fHH3+Mjz/+WO4oijJu3DgIgoAlS5bAzMwM48aNe+33chagtBo2bIhFixaVWfM6R4bS29GmTRvExMTw97yCyM/Ph56e3ivr9PT0kJ2dLUEiZfr+++8hCAJ69uwJIyMj9euX30/++bPyz2ucTUNUubC5oUBdu3bF4cOH8fz5cxgaGsodR3G6dOmCadOmqV8LgoCUlBSkpKSU+T4tLS1Mnjy5vOMRgFq1auHmzZuvrIuNjYWJiYkEiZRt1qxZ6Nev3yubG/v378eZM2fY3JDQoEGDsHr1avzxxx9o0KCB3HEUj0eyERU3e/bs//q9Lx/C09tz/vx5CIKAzMxM9evXxQe60oiMjHzlZy4AuHHjBubNm8fTACQyZcoUDBs2DPPmzcPs2bNRtWpVuSMpWp06dRAZGYns7Gzo6uqWWJOVlYWIiAjuBCxH3t7eEARBPW/u5WsiUhYeS6VAqampGDZsGAwMDDBlyhS0bNkSRkZGcsdSlMuXL6OwsBCiKGLUqFFwdHQsdeWgIAioUqUKateuzT8nifj6+iIgIADTpk3D+PHjS6xZv349vv32WwwdOvSVq9rozWzatAlZWVnq1ytXroSNjU2Zg/gyMjKwe/du6Orqctu3hAoLCzFt2jScP38eHh4eUKlUMDY2LrWeg3mJSGoqlarYtZcPPkr7GvTPVZ2cTfN2Xbp0CQDQsmVLVKlSRf36dXEWYPmzs7PDunXrig1IfiknJwd+fn7YunUrCgoK+DMikW+//RZRUVEICwuDpqYmGjRoACMjI2hraxer5S6n8rd69Wr4+fmhR48eWLZsWbFdHFlZWfjss89w7NgxTJo0Cd7e3jIlVaaoqCjcv38fbm5u6mtXrlzBgQMH4OrqilatWskXjojeOjY3FGj48OFIT0/HvXv31NcEQYCGhkaJ9deuXZMqmiK9aqA4SS8xMRGurq548eIFHB0d0atXL1hZWQEAHj16hJCQEJw7dw6GhobYu3ev+h69HatWrcKPP/5Y5OESUPpDqH/y8PD4n1bp0pvJycnBZ599hsOHD79ylZQgCDzGjYgk99tvvxV5LYoiNmzYgLt378LFxQXOzs6wsrKCpqYmkpOTcerUKQQGBqJ58+aYPn067O3tZUquDOfOnUPTpk3Vx+uR/Jo1awYdHR2sXr0a7du3L3LvwoULmD9/Ph49egQNDQ24u7tj1qxZMiVVlpIataVhY7b8ZWdnY/Dgwbhz5w6MjY3RuXPnIt8XT58+jbS0NDRu3Bj+/v4cAi8RURSxZMkS/Pzzz2jcuHGRzwD+/v7w9fWFhoYGvLy84OPjI2NSInqb2NxQoDf5YAT8dfQOkdJcvXoVkyZNQnJycrGHtqIoolatWvjhhx/QunVrmRJWXrm5udi8ebN6d5Ofnx+aNm2KHj16lFj/cndT3bp10aVLF25FltAXX3yBHTt2QBAENGzYUL0lvDQ8NomI5LZz50588cUX+Oabb9C7d+8Sa0JDQ+Hl5YX//Oc/mDhxosQJlaVz587Q1NTEiRMn5I5Cfztx4gSmTJkCQRCwcuVKODo64tmzZ1i6dCn27dsHURTRqlUrLFiw4I2/V9J/j7ucKp7U1FR8/vnnOHbsWLF7giDA2dkZixYtYvNWQvv27cOsWbNgbm4Ob2/vIgtI09LScPLkSfj5+SEpKQnLli0rsrODiN5dbG4QEZUiJycHQUFBiIiIwJMnT9RNDQcHB7i4uJR6viq9XV27dkWPHj24MrACcnR0RE5ODrZv384HHET0TujVqxeMjY2xe/fuMuvc3d2RkJCA48ePS5RMmVq0aIEuXbrAz89P7ij0D2FhYfDy8kJBQQHGjRuHPXv24M8//4SRkRGmT5/OHedE/xAfH1/s+6K9vT1q164tdzTFGTp0KO7evYugoCCYmZmVWJOUlAQXFxc0adIE/v7+EickovLAgeJERKWoUqUKXF1dMWDAAPW1Z8+eoaCggI0NCXE1Z8WVkZGBDh06sLFBRO+MxMRE2NjYvLLO2NgY0dHREiRSNltbW0RFReHFixcwMDCQOw79rV27dti6dSs++ugjrFu3DoIgYODAgZg+fTpXoVdAUVFRSEhIQLNmzTi8WgZWVlY8priCuHfvHtq2bVtqYwMAzM3NYW9vj/DwcAmTEVF5YnND4a5evYpLly4hKSkJKpUKQ4YMwcmTJ9GyZUt+cCVFi4uLwxdffIGCgoIiA/nOnTuHGTNmoEOHDli8eDFq1aolY0oieTVq1AjJyclyxyAiem2WlpaIiIhAZmZmqWegP336FBcvXkTdunUlTqc8CxcuxKRJk9C/f3/0798fKpUKRkZGpc4CtLOzkzihctna2uLnn3/GuHHjkJqaivbt2/P7ocwuXLiANWvWYPz48ejUqRMAYMqUKQgJCQEAaGhoYPz48ZgyZYqcMRUlNjYWDx8+RE5OTpl1rq6uEiVSNg0NDeTl5b2yTlNTs9R/Z4jo3cPmhkI9evQIM2bMwJUrV9TXXF1dMWTIEKxatQq3b9/GihUrSj3jnqgyi4+Px5AhQ5CWloamTZsWuWdgYAALCwucOXMGgwYNwi+//FLmyhCiymzChAnw8fHB3r17i+xwIiKqqFxdXeHn54eJEyfiyy+/LNbAiI2NxZw5c5CRkYGhQ4fKlFI5+vbtC0EQIIoiVq5cWWatIAi4ceOGRMmU4/PPPy/zfsOGDXHx4kXMmjULZ8+ehY6OjvqeIAhYtGhReUckAFeuXMFHH32EgoICdOvWDZ06dcLRo0cRHBwMPT09dOrUCREREVi/fj3ee+899OzZU+7IlVpaWhomTpyIqKio16pnc0MaNjY2CA8PR3x8fKm7aR4/foywsDDuPCeqRNjcUKCnT5/C3d0diYmJaN68ORwdHbF27Vr1/caNG+P69euYMmUK9uzZg/fee0/GtETSW7lyJdLS0jB58mR8/PHHRe517twZnTt3xqpVq/Djjz/ixx9/xJdffilTUiJ56evro3PnzpgzZw527tyJli1bwtjYGFpaJX+88PLykjghEVFR48ePx4ULFxAeHo5evXrB2tpavUghPj4eiYmJEEURLi4uGDlypMxpKz8HBwe5Iyjenj17XquuoKAA+/fvL3KNzQ3p/PTTT8jPz8f8+fMxbNgwAMDevXshCAJ8fX3Rv39/9SyBXbt2sblRzpYvX46rV6/CyMgIbdq0QbVq1SAIgtyxFG/EiBG4dOkSxo4di7lz58LR0RGampoAgMLCQly4cAGLFy9Gdna2+ueIiN59HCiuQF9++SV+/vlnTJkyBRMnTgQAqFQquLm5Yfny5QCAwMBAzJkzB7169cL3338vY1oi6XXr1g1Vq1bFvn37yqzr27cvnj17hjNnzkgTjKiCUalU6hW3//TvL3eiKEIQBMTExEgZj4ioRHl5edi2bRv8/f3x8OHDIvcaNWoEDw8PDkwmxdi7d+//9H7u3JSGo6MjLC0tERAQAADIzc1Fu3btkJ+fj7CwMPUxe56enoiOjsalS5fkjFvpOTk5IScnB4cOHeJxbRXM/PnzERAQAEEQoK2tDRMTEwBASkoK8vLyIIoiBg4ciCVLlsiclIjeFu7cUKATJ06gQYMG6sZGSQYOHIitW7e+9jZLosokOTkZzZs3f2Vdw4YNOeyaFM3b25ur1IjonaOtrQ1PT094enri8ePHePLkCQRBgJmZGUxNTeWOpyj79u2DtbU12rRpU2bdsWPHcP36dXz66acSJVOOfzcnbt26hYYNG6pXO1PF8OzZM9jb26tfR0REICsrC23atCkyP0hfXx+ZmZlyRFSUZ8+eoWPHjmxsVECLFi2Co6Mjdu3ahYiICCQkJAAAtLS00KpVK4wcORJ9+/aVOSURvU1sbihQcnIyunbt+sq6unXr4tSpU+UfiKiCMTMzQ2xs7Cvr/vjjD/VKECIlmjx5stwRiIj+J2ZmZpydJaNZs2ahX79+r2xu7N+/H2fOnGFzQwKffPIJtLW1ERwcLHcU+gczMzMkJSWpX588eRKCIOCDDz5QXxNFEbGxsWzSSqB58+a4f/++3DGoFD169FDPj01NTUVBQQGMjIygra0tczIiKg9sbiiQsbFxsS34Jbl37x6MjIwkSERUsTg5OWH79u1YvXo1PvnkkxJrNm/ejNu3b3PYqARerrYpiyAI0NLSgqGhIXR1dSVIRURERG9q06ZNyMrKKnItNja2zGHiGRkZOHPmDP99l8jjx4/RuXNnuWPQv7Ro0QIhISH49ddfYW5urj4+9+UD3NzcXPzwww949OgR+vXrJ2NSZZg8eTLGjh2LjRs3Yvz48XLHoTJUr15d7ghEVM7Y3FCg999/HwcPHsTx48fh7OxcYs2xY8dw+/ZtbtcjRfL09MShQ4fw448/4tSpU+jcuTMsLCwAAElJSThz5gyuXLkCIyMjDkiWQNeuXd/o6KOaNWuiR48emDJlCgwNDcsxGREREb2J7OxsrFy5Uj2vSRAE3Lp1Czdv3nzlezn8VRoNGjTAnTt3UFBQwKOpKpBJkybh4sWLmDdvHoC/dmn07t0bjRo1AgA4OzsjJSUFRkZG+Pjjj+WMqght27aFr68vfH19sWfPHjRp0gTGxsYl1gqCgEWLFkkbkIhIQThQXIH++OMPDBo0CHl5eXB3d0e7du3g5eWFbt26Ydy4cQgNDcXmzZshiiL27NkDlUold2QiycXGxmLmzJm4efNmkQfrL//KrF+/Pr799ls0bdpUroiKMXfuXFy7dg03b96EpqYmWrRoASsrK4iiiMTERERHRyM/Px81a9aEmZkZEhISkJaWhsaNG2PPnj1c6UlERFRB5ObmYvPmzSgsLIQoivDz80PTpk3Vq8//TRAEVKlSBXXr1kWXLl0450kCsbGxmDBhAiwtLTF8+HCoVCoYGxuX+nvPY92kExcXhzVr1iAlJQX29vYYO3as+pidMWPGoFq1avjss89Qu3ZtmZNWftevX4eHhwcyMjJeWSsIAmJiYiRIRUSkTGxuKNTZs2cxdepUpKenF/ugKooi9PT08NVXX6FXr14yJSSSnyiKuHz5Mi5duoTk5GTk5+fD1NQUdnZ2aN++Pb9gS+T69ev48MMP0bx5c6xYsQKWlpZF7v/555+YNWsWfv/9d+zatQsNGzbEjz/+iLVr18LHx6fUo8WIiIhIXl27dkWPHj0wa9YsuaPQ39q3b4+cnJxix4eVRBAE3LhxQ4JURBWLh4cHwsLC0LJlS/To0QPVq1cv87vhgAEDJExHRKQsbG4o2NOnT/HLL78gLCwMSUlJKCgogKmpKRwcHDBs2DCuwiGiCsHT0xPXr1/HsWPHULVq1RJrsrKy0L17dzRr1gzr1q0D8Nf2fAMDA/z2229SxiUiIiJ6Z3Xt2vWN6k+cOFFOSag0SUlJCA8PR0pKCnR0dFCzZk04ODigZs2ackdTDDs7O5ibm+PAgQM8vo2ISGacuaFgNWrUwIQJEzBhwgS5oxARlery5ctwdHQstbEBAHp6erCzs8PZs2fV11QqFS5evChFRCIiIqJKgc2KiisjIwO+vr4IDg7Gv9eoamhooGfPnvD19YWRkZFMCZVDW1sbDRs2ZGODiKgCYHODiKgER48exaZNm3D79m1kZWUV+wLxErfjl78qVaogNTX1lXWpqanFtoPz6DAiIiIietfl5OTAw8MD169fh6GhITp16oTatWujoKAAcXFxOHfuHIKCgvDgwQPs3r1bPYuDyscHH3yA8PBw5ObmQkdHR+44RESKxuaGQt28eRM7duzAzZs3kZ6ejsLCwlJrDx8+LGEyIvkdO3YMPj4+6oaGIAjQ0NCQOZVyNW/eHOfOncOZM2fQsWPHEmsuXLiAiIgItGvXTn0tJiYGFhYWUsUkIiIiqjSePHmCxMRE5OXlFVnkU1hYiJycHKSkpODkyZP48ccfZUypHFu3bsX169fh5OSEr7/+utiO5oyMDEyfPh2hoaHYsWMHxowZI09QhZg2bRoGDRoEb29vzJo1Cw0bNpQ7EhGRYnHmhgJFRUVh1KhRxT6olkQQBMTExEiUjKhiGD58OK5cuYKPP/4YI0eOhImJidyRFC0yMhIeHh4QBAEjR45Et27dYGFhgcLCQiQmJuLkyZPYuXMn8vLysGnTJtjb22PWrFkICgrCxx9/DB8fH7n/JxARERG9E3JzczF9+nQcPXr0ter5XVEabm5uSE5OxvHjx6Gvr19iTWZmJpydnWFhYYHAwECJEyrLtGnT8OjRI0RFRQEADAwMUK1atVJ3zHDBKBFR+eHODQXy8/NDbm4uunbtCg8PD1hYWPCsSKJ/iI2NRfPmzfHpp5/KHYUAtGnTBitWrMD8+fOxZcsWbN26tch9URShr6+PhQsXon379njw4AEOHToES0tLjBo1SqbURERERO+eTZs24ciRI9DS0oJKpUJqaioSEhLQrl07pKen49atW8jPz0eDBg0wdepUueMqxoMHD9CpU6dSGxsAoK+vD3t7e5w7d07CZMp06NChIq8zMjKQkZFRYi2PySUiKl9sbihQVFQU6tati5UrV/KoHaISVKlSBWZmZnLHoH9wcXFB+/btsW/fPly4cAEJCQnIz8+Hubk52rVrh0GDBsHU1BQAoKOjgwULFqB3796oVq2azMmJiIioNBEREbC3t5c7Bv1DSEgINDQ0sHPnTtja2uLgwYOYMWMGZs2aBZVKheTkZPj4+CA6Ohq1atWSO65iaGlpISsr65V1WVlZfJgugePHj8sdgYiI/sbmhgLl5eXBxsaGjQ2iUrRp0wbXrl3jgLgKxtjYGGPGjClyhnBOTg60tLSK7D6zsLDA8OHDZUhIREREb2LUqFGoW7cu+vXrh/79+8PS0lLuSIr38OFDtGzZEra2tgAAW1tbiKKI33//HSqVCqampvj+++/RrVs3bNy4EX5+fjInVgYbGxtEREQgMTGx1Jly8fHxCA8PR7NmzSROpzxWVlZyRyAior/x6bYCqVQq3L17V+4YRBXW1KlTkZ6ejoULFyIzM1PuOAQgLS0NCxcuxLRp04pcP336NDp06IAFCxbwz4qIiOgd4+zsjPj4ePj5+aFbt24YM2YM9u/fj+zsbLmjKVZ+fn6RHcy1a9eGlpYWbt26pb5mZmYGOzs7XL58WY6IijRs2DBkZ2fD09NTPefhn65evYrx48cjNzcXQ4cOlSEhERGRPLhzQ4EmTpwILy8vbN26FR4eHnLHIapwAgMD0bp1awQGBuLQoUNo2LAhqlWrVuIWb0EQsGnTJhlSKsfTp08xfPhwPHz4EHXr1i1yLy8vDzk5OfD390dERAR27tzJo6iIiIjeEatWrUJaWhoOHjyIvXv34uLFiwgLC8OiRYvQq1cvDBgwgMdWSczU1BR//vmn+rWGhgasrKyKNDcAwMjICKmpqVLHU6x+/frh9OnTOHToEIYNGwZzc3P17oFHjx7h8ePHEEURvXv3Rv/+/eUNqxC7du1CQEAAHjx4gNzc3DJrr127JlEqIiLlEURRFOUOQeVr7dq1xa799ttvuHfvHlq2bInWrVvD0NCw1GOqvLy8yjsiUYWiUqleu1YQBMTExJRjGlqyZAm2bduGwYMH47PPPivWvMjJycGXX36JPXv2YMyYMZg1a5ZMSYmIiOh/cffuXezduxcHDhzA48ePIQgCrK2t0b9/fx5bJZFp06YhJCQE/v7+aN68OQDAx8cHp06dwqlTp1CjRg0UFhaiZ8+eyMnJwenTp2VOrByiKGL79u3YunUr4uPji9yztLTEmDFj4O7uzpkbEggICICvry9e93FabGxsOSciIlIuNjcUQKVSFfuAU9IfuyAI6usv/5sPbkmJLl269Eb1bdu2LackBAA9e/aEIAgIDg4u9ctaQUEBevXqhYKCApw4cULihERERPS2RUVFITAwEAEBAervJe3bt8eHH34IZ2dnueNVWlFRURg+fDi0tbUxfvx4TJ48GSdOnMAnn3wCW1tbDB48GKdOncLJkyfRvXt3ztyQWFRUFO7fv4+2bdviyZMnEEURubm5CAkJgaurK1q1aiV3REVwdXXFH3/8gQULFqBnz57cOU5EJCMeS6UA3t7eXL1B9Ab+2axISkpCeHg4UlJSoKOjg5o1a8LBwQE1a9aUMaGyJCUlwcnJqcy/xzQ1NdG0aVM2NoiIiN5x6enpCA4OxpEjRxAWFobCwkLo6uqiSZMmuHDhAs6fP4/WrVtj5cqVqFGjhtxxKx1bW1ssX74cX3zxBeLi4gAAXbt2hZOTE06dOoXo6GiIoggjIyP85z//kTesgoiiiMWLF2PHjh1o3Lgx3NzcYG5uDgDw9/fHjh07sGvXLnh5ecHHx0fmtJVfXFwc3n//fQwZMkTuKEREisfmhgJMnjy5xOsvV324ubmpr125cgUHDhzgqg9SvIyMDPj6+iI4OLjYTicNDQ307NkTvr6+MDIykimhctSsWRMPHjx4ZV1iYiKMjY3LPxARERG9VXl5eTh16hT279+P0NBQ5OfnQxRFtGrVCgMHDkTv3r1RtWpVxMfHY9GiRQgNDcW8efOwevVquaNXSn379kWPHj2QkpKivrZ69Wrs378fUVFRsLCwQL9+/YoMHqfytX//fvz8888wNzeHu7t7kXs9e/aEjo4O/Pz8sGbNGtSrV6/Id3x6+8zMzF77SCoiIipfPJZKgURRxJIlS/Dzzz+jcePG+O2339T3/P394evrCw0NDa76IMXKycnBiBEjcOPGDRgaGqJTp06oXbs2CgoKEBcXh3PnziEjIwPNmjXD7t27oa2tLXfkSm3evHn49ddfsWTJEgwYMKDEmpCQEPznP/9Bnz598M0330ickIiIiP4bERER+O2333D48GGkp6dDFEWYmJigX79+GDhwIBo2bFjsPVlZWbC3t4eOjg4uX74sQ2oi6Q0dOhR3795FUFBQqU2lpKQkuLi4oEmTJvD395c4obKsX78eq1evRmBgIBo0aCB3HCIiRePODQXav38/tm/fzlUfRKXYunUrbty4AScnJ3z99deoWrVqkfsZGRmYPn06QkNDsWPHDowZM0aeoArh6emJoKAgzJkzB6GhoXBycoKFhQWAv77EnT59GiEhIdDV1YWXl5fMaYmIiOh1jRo1CgCgpaUFZ2dnDBo0CJ06dYKmpmap79HR0YEgCNytWc7S09MRFxeHnJycMuvs7OwkSqRs9+7dQ9u2bcvcLWNubg57e3uEh4dLmEyZxo8fj5iYGIwYMQIeHh5QqVRl/p3EnxMiovLDnRsKxFUfRGVzc3NDcnIyjh8/Dn19/RJrMjMz4ezsDAsLCwQGBkqcUHnOnz+PmTNnIjk5udjsDVEUYWxsjBUrVqBjx44yJSQiIqI35erqikGDBsHNze2152cUFBTg4cOHsLCwgK6ubjknVJ7s7GzMnj0bR44cQWFhYZm1giDgxo0bEiVTtnbt2qFFixbYuHFjmXVeXl64dOkSfv/9d4mSKVNOTg4+++wzHD58+JXzTflzQkRUvrhzQ4G46oOobA8ePECnTp1KbWwAgL6+Puzt7XHu3DkJkylXhw4dcPjwYRw/fhyXLl1CcnIy8vPzYWpqCjs7O7i4uBTbYUNEREQV27p166Cvr//KXRhxcXG4d++eeldH/fr1pQmoQD/88AOCg4OhpaWFJk2aoFq1anJHIgA2NjYIDw9HfHw8rKysSqx5/PgxwsLCoFKpJE6nPMuXL1c3Nho2bIjq1avLHYmISLHY3FAgDQ0N5OXlvbJOU1MTGhoaEiQiqli0tLSQlZX1yrqsrKxXrtSht0dfXx+urq5wdXWVOwoRERG9Bc7OznBzc8OyZcvKrFuxYgUuXLjAhVcSOHr0KAwMDBAQEFDizBOSx4gRI3Dp0iWMHTsWc+fOhaOjo/r4tsLCQly4cAGLFy9GdnY2hg0bJnPayu/w4cMwNDTE9u3b2UwiIpIZmxsKxFUfRGWzsbFBREQEEhMT1bMd/i0+Ph7h4eFo1qyZxOmIiIiI3k0RERH456nIoigiJSWlzKbF8+fPceXKFeTn50sRUfFSUlLg6OjIxkYF4+LiggsXLiAgIABeXl7Q1taGiYkJgL/+zPLy8iCKIgYOHIj+/fvLG1YBMjIy0KFDBz4vISKqANjcUCCu+iAq27BhwzBz5kx4enpi6dKlsLW1LXL/6tWrmDVrFnJzczF06FCZUirLrl27EBAQgAcPHiA3N7fM2mvXrkmUioiIiN7E7t27cejQIfVrQRBw/vx5nD9/vsz3iaIIJyenck5HANC4cWM8efJE7hhUgkWLFsHR0RG7du1CREQEEhISAPy167xVq1YYOXIk+vbtK3NKZWjUqBGSk5PljkFEROBAccWaP38+AgICIAhCmas+lixZInNSInlMmzYNhw4dgiAIMDc3V+9yevToER4/fgxRFNG7d298++23Miet/AICAuDr64vX/ecqNja2nBMRERHRfyM5ORkzZ85U/5t+4cIFmJqaolGjRiXWC4IAHR0d1KtXDxMmTHjtoeP03zt69CgmT56M7777Di4uLnLHoTKkpqaioKAARkZG0NbWljuOohw5cgQ+Pj746quvMGDAALnjEBEpGpsbCnbkyBH1qo+XMzi0tLTQokULrvogxRNFEdu3b8eWLVvUq6JesrS0xJgxY+Du7s6ZGxJwdXXFH3/8gQULFqBnz54cbElERFRJqFQquLm5Yfny5XJHoX/YvHkzli9fjnbt2kGlUpU58N3Ly0u6YEQVxNmzZ7F9+3acPn0azZs3R8uWLWFsbAwtrZIPR+HPCRFR+WFzgwBw1QdRWZKSkvDkyROIoohatWqVOoeDykerVq3Qpk0bbNq0Se4oRERE9BbFx8dDX18f1atXlzsK/S0uLg4eHh5FFveUtJhHFEUIgoCYmBgp4xFVCCqVCoIgFNtZ/u+fFf6cEBGVP87cIADgFwqiMpibm8Pc3FzuGIplZmb22kdSERER0bvj5bGfVHEsWbIECQkJsLS0hJOTE6pXr86dykT/4u3tzZ8LIqIKgjs3iIioQlu/fj1Wr16NwMBANGjQQO44RERE9F9q3rw5AODgwYOoV6+e+vXrunbtWnnEon9wcHCAoaEhDh48CH19fbnjEBEREZWJOzeIiKhCGz9+PGJiYjBixAh4eHi88uxnOzs76cIRERHRa8vPzwcA9Y7Ml6+p4hBFEc2bN2djg+gNPH78GCkpKdDR0UHNmjVRo0YNuSMRESkGmxtERFSh5eXlobCwEM+ePcOPP/5YZq0gCLhx44ZEyYiIiOhNxMbGlvma5NemTRvExMSoZwUQUen8/f2xadMmxMXFFbneqFEjjBw5EsOHD5cpGRGRcvBYKiIiqtC++OIL7NixA4IgoGHDhq+cEbR9+3aJkhEREdH/Yt26dWjUqBGcnZ3ljkJ/i42NxbBhw9C3b1/Mnj0bVatWlTsSUYU0d+5cBAYGQhRFmJiYoHbt2igsLMSjR4/w9OlTCIKAAQMGYMmSJXJHJSKq1NjcICKiCs3R0RE5OTnYvn07VCqV3HGIiIjoLWnXrh1q1aqFAwcOyB2F/vbtt98iKioKYWFh0NTURIMGDWBkZARtbe1itYIgYNOmTTKkJJLXoUOHMG3aNFhbW2PJkiVwcHAocv/ixYuYN28e4uPj4efnh+7du8uUlIio8uOxVEREVKFlZGSgQ4cObGwQERFVMrm5uahbt67cMegf1q9fr/7v/Px83Lp1q9RaHltFSrVr1y5UqVIFP/30E6ytrYvdf//997F582b06dMHu3fvZnODiKgcsblBREQVWqNGjZCcnCx3DCIiInrLevXqhZCQEMTGxnIRQwWxbds2uSMQVXgxMTFwcHAosbHxkrW1Ndq2bYtr165JmIyISHnY3CAiogptwoQJ8PHxwd69ezFgwAC54xAREdFb4uTkhMuXL2Pw4MFo06YNVCoVjIyMoKGhUWK9l5eXxAmVp23btnJHIKrw8vPzoaen98o6PT09ZGdnS5CIiEi5OHODiIgqtLNnz2L79u04ffo0mjdvjpYtW8LY2BhaWiX35/ngg4iI6N2gUqkgCAL+/ZX038cdiaIIQRAQExMjZTzFS0pKQnh4OFJSUqCjo4OaNWvCwcEBNWvWlDsakaxcXV3x559/4sSJE9DV1S2xJisrC127doWJiQnnChERlSPu3CAiogpt/Pjx6gcf0dHRiI6OBlD6gw82N4iIiN4N3t7enNtQAWVkZMDX1xfBwcHFGk8aGhro2bMnfH19YWRkJFNCInm5uLjAz88Pn332GZYtW1ZsF0dWVhY+++wzpKWlYdSoUTKlJCJSBu7cICKiCu3HH398owcfkyZNKsc0RERERJVXTk4OPvzwQ1y/fh2Ghobo1KkTateujYKCAsTFxeHcuXPIyMhAs2bNsHv3bmhra8sdmUhy2dnZGDx4MO7cuQNjY2N07twZVlZWAIBHjx7h9OnTSEtLQ+PGjeHv7w99fX2ZExMRVV5sbhAREREREVGFlpaWBmNjY7ljVHrr16/Ht99+CycnJ3z99deoWrVqkfsZGRmYPn06QkNDMXPmTIwZM0aeoEQyS01Nxeeff45jx44VuycIApydnbFo0SLUqFFDhnRERMrB5gYRERERERHJ4vHjx9i3bx8SEhKQl5dX5BgkURSRk5ODlJQUXLlyRX00JZUfNzc3JCcn4/jx46WuNs/MzISzszMsLCwQGBgocUKiiiU+Ph4RERF48uQJRFFErVq1YG9vj9q1a8sdjYhIEThzg4iIiIiIiCR37949DBs2DM+fP1c3Nf45YPzlsZSiKHK+g0QePHiATp06lXmMjr6+Puzt7XHu3DkJkxFVTFZWVuojqYiISHoacgcgIiIiIiIi5VmzZg3S09PRunVrfP755+jduzcEQcCiRYswb948dO7cGaIoonHjxnyQLhEtLS1kZWW9si4rK4vD4EmRYmNjcf78+RLvRUVF4ZNPPuHfV0REEmJzg4iIiIiIiCQXFhYGY2NjbNy4ESNHjsSQIUMgiiIsLCwwatQorF27Fp9++inu3LmDPXv2yB1XEWxsbBAREYHExMRSa+Lj4xEeHg4bGxsJkxHJq6CgADNnzsSAAQOwbdu2EmsuXLiAEydOYPz48ZgyZQpyc3MlTklEpDxsbhAREREREZHknj59ihYtWqiPQLKxsYEoikVma0ycOBEmJibYu3evXDEVZdiwYcjOzoanpyeioqKK3b969SrGjx+P3NxcDB06VIaERPKYMmUK9u/fDy0tLdStW7fEmk6dOmHIkCHQ1dVFSEgIpk+fLnFKIiLl4cwNIiIiIiIikpyOjg709PTUr2vUqIGqVavi7t276msaGhqwtbVFWFiYHBEVp1+/fjh9+jQOHTqEYcOGwdzcXD1P4NGjR3j8+DFEUUTv3r3Rv39/ecMSSeTw4cM4cuQI6tSpg40bN6JOnTol1jVt2hRffPEFRo4cCS8vLxw9ehQnT55Ely5dJE5MRKQc3LlBREREREREkqtTpw5u3rxZ5Fr9+vVx/fr1Itfy8/ORl5cnZTRF+/rrrzFnzhxYWFggMTERERERiIiIQFJSEiwsLDBnzhx88803csckksyvv/4KDQ0N+Pn5ldrY+CeVSoXvvvsOoijil19+kSAhEZFycecGERERERERSa5z585Yt24dli1bhkmTJsHAwACtW7fG9u3bcfbsWTg6OiIuLg6XLl1S7x6g8icIAkaPHo3Ro0cjKSkJT548gSiKqFWrFiwsLOSORyS5a9euoWnTplCpVK/9ntatW8PGxgZXr14tx2RERMSdG0RERERERCS5sWPHwtLSElu2bMGUKVMAAKNGjYKGhgY++eQTDB8+HP3790d2djZ69+4tc1plMjc3h62tLVq2bMnGBilWenr6f9VgrV+/PtLS0t5+ICIiUuPODSIiIiIiIpKckZERAgICsHLlStSoUQPAX0dVLV26FL6+vrhy5QoAoHfv3vjoo49kTFp5rV27FgAwYsQIGBkZqV+/Li8vr/KIRVSh1KxZE6mpqW/8vvT0dFSpUqUcEhER0UuCKIqi3CGIiIiIiIiIXsrMzMSdO3dgYWEBU1NTueNUWiqVCoIgICgoCPXr11e//qeXjwz+eV0URQiCgJiYGEnzEslh9OjRuHnzJk6fPv3azYrc3Fx07NgR5ubm2L9/fzknJCJSLu7cICIiIiIiItmJooi0tDQIggBjY2PY2trKHanS8/b2hiAIqF69epHXRPT/evfujUuXLmHHjh0YN27ca71n586dePbsGQYOHFjO6YiIlI07N4iIiIiIiEg258+fx08//YTIyEhkZ2fDzc0Ny5Ytg4+PD6ysrPDpp59CV1dX7phEpFAZGRlwcXFBamoqvvzyS/Tv37/M+v3792Pu3LnQ0tLCwYMHUbt2bWmCEhEpEJsbREREREREJIvvv/8e69atgyiK0NLSQn5+Ptzc3LB8+XJ0794djx49QuvWrbF582aeXS+DgoICpKamQktLC0ZGRtzVQYp16dIljB07FoWFhWjRogV69+6N5s2bw8TEBPn5+Xj69CmioqJw9OhRREVFQRAE+Pn5oVu3bnJHJyKq1NjcICIiIiIiIskdPXoUkydPRp06dTB37ly8//77aNmypbq5cfPmTcyePRsxMTGYOXMmxowZI3dkxQgKCsKuXbtw9epV5OXlAQB0dXXh4OAADw8PfPDBBzInJJJeREQEPvvsMyQkJJTa6BNFEXXq1MH8+fPh6OgocUIiIuVhc4OIiIiIiIgk5+7ujujoaAQFBcHS0hLAXwOuXzY3ACA1NRXdunVD3bp1ERgYKGdcRSgsLMT06dMRHBwMURShra2NmjVrAgBSUlKQn58PQRAwfvx4TJs2Tea0RNLLysrC4cOHERISgj/++APJycnQ1NSEqakpmjVrBmdnZzg7O0NHR0fuqEREisCB4kRERERERCS5GzduwMHBQd3YKEn16tVhb2+P33//XcJkyrVz504EBQWhbt26mDNnDj744ANoaf312CA3NxfHjh3DV199hY0bN0KlUqFPnz4yJyaSlp6eHvr37//KuRtERCQNDbkDEBERERERkfIUFha+1gyH/Px85OfnS5CIAgICYGBggO3bt6Nz587qxgYA6OjooHfv3ti+fTt0dHSwZcsW+YISERERgc0NIiIiIiIikkGDBg1w9epVpKenl1qTlpaGqKgoNGjQQMJkynX//n20b98etWrVKrWmXr16aN++PW7duiVhMiIiIqLi2NwgIiIiIiIiyQ0cOBDPnj3D1KlT8fTp02L3U1NTMWPGDGRkZMDNzU2GhMpjYmKCZ8+evbIuLy8PhoaGEiQiIiIiKh2bG0RERERERCS54cOHw9HREWfPnkXXrl0xaNAgAMDly5cxbtw49OjRA2fOnIGdnR0+/PBDmdMqw4ABAxAZGYlz586VWnP9+nWEhYXB1dVVwmRERERExQmiKIpyhyAiIiIiIiLlyc/Px8qVK7Fjxw48f/68yD1dXV0MHjwY06dPh66urkwJK7d/D2rPz8/HggULEBcXh4EDB6JPnz6wsrKCrq4unjx5gnPnzmHt2rVo1KgRvvnmG1hZWcmUnIiIiIjNDSIiIiIiIpJZbm4ubty4gcTERBQWFsLU1BQtWrSAnp6e3NEqNZVKVeJQd1EUSx32/vIRgoaGBm7cuFGu+YiIiIjKoiV3ACIiIiIiIlI2HR0dtGrVCq1atZI7iqI4ODjIHYHonfPxxx+jXr16mDlzptxRiIgUj80NIiIiIiIiKncHDhz4n97PGQ9v3/bt2+WOQPTOuXjxIjIyMuSOQUREYHODiIiIiIiIJDBjxoxSjzp6HWxuEFFFoKurCx0dHbljEBER2NwgIiIiIiIiCfTv3/9/am4QEVUEEydOxPLly7Fjxw4MHToU2trackciIlIsDhQnIiIiIiIiIiJ6DcuXL8eJEyfw4MED6OjooEGDBjAyMoKGhkaxWkEQsGnTJhlSEhEpA5sbREREREREJJuoqCjcv38fbm5u6mtXrlzBgQMH4ObmhpYtW8qYjoioKJVK9dq1giAgJiamHNMQESkbj6UiIiIiIiIiyYmiiMWLF2PHjh1o3LhxkebGzZs3sWPHDuzatQteXl7w8fGRMSkR0f/btm2b3BGIiOhvbG4QERERERGR5Pbv34+ff/4Z5ubmcHd3L3KvZ8+e0NHRgZ+fH9asWYN69eoVaX4QEcmlbdu2ckcgIqK/8VgqIiIiIiIiktzQoUNx9+5dBAUFwczMrMSapKQkuLi4oEmTJvD395c4ofJERETA3t5e7hhE74wnT54gIiICSUlJqFOnDrp164bo6GioVCoOGicikgB3bhAREREREZHk7t27h7Zt25ba2AAAc3Nz2NvbIzw8XMJkyjVq1CjUrVsX/fr1Q//+/WFpaSl3JKIKKT09HYsWLUJwcDAKCwsBAK6urujWrRsWL16M+Ph4+Pn5oXXr1jInJSKq3DTkDkBERERERETKo6Ghgby8vFfWaWpqQkODX12l4OzsrH4o261bN4wZMwb79+9Hdna23NGIKowXL17A3d0dBw8ehImJCfr27Yt/HopiYGCA5ORkjBs3Dg8ePJAxKRFR5cdPiERERERERCQ5GxsbhIeHIz4+vtSax48fIywsDDY2NhImU65Vq1bh7NmzmDdvHpo2bYqLFy9i1qxZ+OCDDzB37lxERETIHZFIdhs2bMDNmzcxbNgwHD16FCtWrChyf9OmTZg0aRKysrKwbt06mVISESkDmxtEREREREQkuREjRiAnJwdjx45FaGgoCgoK1PcKCwtx7tw5jB07FtnZ2Rg2bJiMSZXF2NgYo0aNwq+//opDhw7B09MTVatWxa+//gp3d3f06NEDq1evRkJCgtxRiWQRHBwMS0tLzJ8/Hzo6OiXWTJo0CXXr1kVkZKTE6YiIlIUDxYmIiIiIiEgW8+fPR0BAAARBgLa2NkxMTAAAKSkpyMvLgyiKGDhwIJYsWSJzUoqKikJgYCACAgIgiiIEQUD79u3x4YcfwtnZWe54RJKxtbVFly5d8MMPP6ivqVQquLm5Yfny5eprPj4+CA0NxdWrV+WISUSkCBwoTkRERERERLJYtGgRHB0dsWvXLkRERKh3A2hpaaFVq1YYOXIk+vbtK3NKZUtPT0dwcDCOHDmCsLAwFBYWQldXF02aNMGFCxdw/vx5tG7dGitXrkSNGjXkjktU7gwMDJCUlPTKuvj4eBgYGEiQiIhIudjcICIiIiIiItn06NEDPXr0AACkpqaioKAARkZG0NbWljmZcuXl5eHUqVPYv38/QkNDkZ+fD1EU0apVKwwcOBC9e/dG1apVER8fj0WLFiE0NBTz5s3D6tWr5Y5OVO7s7Oxw6tQpXLlyBa1atSqxJiIiAjdu3EDXrl2lDUdEpDBsbhAREREREVGFUL16dbkjKFpERAR+++03HD58GOnp6RBFESYmJujXrx8GDhyIhg0bFqm3srLC999/D3t7e1y4cEGm1ETSmjBhAk6dOoUJEybg008/Rdu2bQEAoiji8ePHOH36NL755hsIgoCxY8fKnJaIqHLjzA0iIiIiIiIigkqlAvDXsWBOTk4YNGgQOnXqBE1NzVLfU1BQgJYtW8LU1BQnT56UKiqRrAIDA+Hr64v8/PwS7wuCgJkzZ8LDw0PiZEREysLmBhERERERERHB1dUVgwYNgpub22vPzygoKMDDhw9hYWEBXV3dck5IVHHcvXsXW7duxaVLl5CUlISCggKYmprCwcEB7u7uaN68udwRiYgqPTY3iIiIiIiIiAgJCQnQ19eHsbFxmXVxcXG4d+8eOnXqJE0wIiIiohJoyB2AiIiIiIiIiOTn7OyMr7766pV1K1aswLRp0yRIRFQx5ebmYuPGjVi2bFmR6ydOnICrqys2bNiAwsJCmdIRESkHB4oTERERERERKVBERAT+eZiDKIpISUlBeHh4qe95/vw5rly5UuqsAaLK7sWLF/D09MTVq1dhbW2NmTNnqu/9+eefuH37Nr799lucPXsWGzZsgI6OjoxpiYgqNzY3iIiIiIiIiBRo9+7dOHTokPq1IAg4f/48zp8/X+b7RFGEk5NTOacjqpg2b96MK1euoGPHjpg1a1aRe0OGDEGHDh2waNEinD59GuvXr8ekSZNkSkpEVPlx5gYRERERERGRAiUnJ2PmzJnq3RsXLlyAqakpGjVqVGK9IAjQ0dFBvXr1MGHChNceOk5UmfTt2xcvXrzA4cOHS92VkZOTg+7du0NPTw+HDx+WOCERkXJw5wYRERERERGRApmamuKnn35Sv1apVGjfvj2WL18uYyqiii0+Ph4dO3Ys87ipKlWqwNbWFqGhoRImIyJSHjY3iIiIiIiIiAjHjx+Hvr6+3DGIKjRDQ0M8efLklXXPnj2DgYGBBImIiJRLQ+4ARERERERERCQ/KysrVK9eXe4YRBVamzZtcPXqVZw7d67UmoiICERGRqJ169YSJiMiUh7O3CAiIiIiIiJSoObNmwMADh48iHr16qlfv65r166VRyyiCi06OhojRoyAhoYG3N3d0aVLF5ibmwMAkpKScObMGWzbtg25ubnYvn077OzsZE5MRFR5sblBREREREREpEAqlQoAEBwcjPr166tfv67Y2NjyiEVU4e3btw8LFy5EVlYWBEEock8URejo6MDX1xeDBg2SKSERkTKwuUFERERERERERPQGkpKSsHfvXoSHhyM5ORn5+fkwMTGBnZ0dBg8eDGtra7kjEhFVemxuEBERERERERHWrVuHRo0awdnZWe4oRERERK/E5gYRERERERERoV27dqhVqxYOHDggdxQiIiKiV9KSOwARERERERERyS83Nxd169aVOwZRhZeQkIDdu3fj9u3byMrKQmFhYYl1giBg69atEqcjIlIONjeIiIiIiIiICL169UJISAhiY2PfeLg4kVLcvHkTo0aNQkZGBl51GMq/h40TEdHbxeYGEREREREREcHJyQmXL1/G4MGD0aZNG6hUKhgZGUFDQ6PEei8vL4kTEsnPz88Pz58/x/vvv4+hQ4fCxMQEmpqacsciIlIkztwgIiIiIiIiIqhUKgiCUGw1+r9Xn4uiCEEQEBMTI2U8ogqhbdu2qFatGkJCQqClxTXDRERy4t/CRERERERERARvb28eo0P0Cnl5eXjvvffY2CAiqgC4c4OIiIiIiIiIiOg1DB8+HC9evMCBAwfkjkJEpHglH5xJRERERERERFSKtLQ0uSMQyWL8+PG4ffs2AgIC5I5CRKR43LlBRERERERERACAx48fY9++fUhISEBeXl6R+RuiKCInJwcpKSm4cuUKoqOjZUxKJI/Q0FAEBATgxIkTsLOzg62tLapVq1bqkW5eXl4SJyQiUg42N4iIiIiIiIgI9+7dw7Bhw/D8+XN1U+OfA8ZfPrwVRRFGRkYICwuTLSuRXFQqVZGfCwAlNjZEUYQgCIiJiZEyHhGRonD6ERERERERERFhzZo1SE9Ph52dHfr06YPIyEiEhIRg4cKFyM3NxdmzZ3Hq1Ck0btwYe/fulTsukSy8vb1L3aVBRETS4s4NIiIiIiIiIkLnzp2Rk5ODEydOQF9fHxcuXMC4ceOwfv16dOzYEcBfDRA/Pz/Mnz8fI0aMkDkxERERKRkHihMRERERERERnj59ihYtWkBfXx8AYGNjA1EUi8zWmDhxIkxMTLhzg+g1FBYWyh2BiKhS47FURERERERERAQdHR3o6empX9eoUQNVq1bF3bt31dc0NDRga2vLeRukaJmZmThx4gQSEhKQl5dXZP6GKIrIyclBSkoKzpw5g3PnzsmYlIiocmNzg4iIiIiIiIhQp04d3Lx5s8i1+vXr4/r160Wu5efnIy8vT8poRBXG48ePMWLECCQmJha5/nKAeGmviYjo7eOxVERERERERESEzp074+HDh1i2bBlevHgBAGjdujUePHiAs2fPAgDi4uJw6dIlWFlZyRmVSDZr1qxBQkICrK2tMXbsWLRv3x6CIOCTTz7BmDFj1Me5NW7cGBcvXpQ7LhFRpcaB4kRERERERESEZ8+eYeDAgUhISEDHjh2xfv16PHz4EC4uLtDU1MR7772H27dvIzMzE97e3pg0aZLckYkk161bNzx9+hTHjh1DjRo1EBoaCi8vL2zduhVt27aFKIpYuHAh/P398c0336B3795yRyYiqrS4c4OIiIiIiIiIYGRkhICAAAwfPhwtWrQA8NdRVUuXLoWWlhauXLmCFy9ewMXFBR999JHMaYnk8eTJE7Rq1Qo1atQAALz33nsQRRFXr14FAAiCgDlz5qBatWrYtWuXnFGJiCo9ztwgIiIiIiIiIgBAzZo14evrW+Saq6srnJ2dcefOHVhYWMDU1FSmdETy09TUhKGhofq1qakp9PT0cPfuXfU1HR0dtG7dGpcvX5YjIhGRYrC5QURERERERETFiKKItLQ0CIIAY2Nj2Nrayh2JSHaWlpa4f/9+kWt169ZFTExMkWsaGhrIzMyUMBkRkfLwWCoiIiIiIiIiUjt//jzGjx8POzs7dOjQAV999RUAwMfHB8uWLUN2drbMCYnk88EHH+DWrVv4+eef1ddatGiBW7du4fr16wD+ml8TGRkJCwsLuWISESkCmxtEREREREREBAD4/vvv4enpibNnzyIvLw+iKEIURQBATEwMtmzZgnHjxiEnJ0fmpETy8PT0RLVq1bB48WJ8+umnAIAPP/wQoijC09MT06ZNw4ABA5Ceng4nJyd5wxIRVXJsbhARERERERERjh49irVr18La2hrr1q1DZGRkkfsrV65E06ZNcfnyZQ5KJsUyMzPDjh070LFjR/VQ8aZNm2Lq1KlIT0/HoUOHkJCQgFatWmHSpEkypyUiqtwE8eUSDCIiIiIiIiJSLHd3d0RHRyMoKAiWlpYAAJVKBTc3NyxfvhwAkJqaim7duqFu3boIDAyUMy5RhfPo0SNER0fDwsICtra20NDgmmIiovLEgeJEREREREREhBs3bsDBwUHd2ChJ9erVYW9vj99//13CZETvhtq1a6N27dpyxyAiUgy2kImIiIiIiIgIhYWFEAThlXX5+fnIz8+XIBFRxXLixAkEBQWVeC8sLAz9+vVDQEAACgsLJU5GRKRMbG4QERERERERERo0aICrV68iPT291Jq0tDRERUWhQYMGEiYjkldmZibc3d3h7e2NX375pcSasLAw3Lx5E76+vhg5ciTS0tKkDUlEpEBsbhARERERERERBg4ciGfPnmHq1Kl4+vRpsfupqamYMWMGMjIy4ObmJkNCIukVFhbC09MT4eHhqFGjBhwdHUusGzJkCP7zn/+gZs2auHz5Mry9vSVOSkSkPBwoTkREREREREQoKCjAxIkTcfbsWejq6qJhw4a4fv06rK2tYW1tjejoaDx//hxt2rTBli1boK2tLXdkonK3Z88efP7557C1tcW6detQvXr1MuuTkpIwYcIE3L59G8uWLWMjkIioHLG5QUREREREREQA/pqnsXLlSuzYsQPPnz8vck9XVxeDBw/G9OnToaurK1NCIml5eHggMjISwcHBsLa2fq333LlzB66urujQoQM2bdpUzgmJiJSLzQ0iIiIiIiIiKiI3Nxc3btxAYmIiCgsLYWpqihYtWkBPT0/uaESSateuHerXr4/du3e/0fuGDh2KuLg4XLhwoZySERGRltwBiIiIiIiIiKhi0dHRQatWrdCqVSu5oxDJKjMzE2ZmZm/8PisrK9y4caMcEhER0UtsbhAREREREREp0IEDB/6n97u6ur6lJEQVl6mpKZ48efLG70tJSeFOJyKicsbmBhEREREREZECzZgxA4Ig/NfvZ3ODlKBhw4b4/fff8fz5cxgaGr7WezIyMnDt2jU0atSonNMRESkbmxtERERERERECtS/f///qblBpASurq44c+YM1q1bh+nTp7/We9atW4fs7Gx07NixnNMRESkbB4oTERERERERERGVIDc3F/369cP9+/fh7e2NiRMnQltbu8Ta/Px8rF+/Hn5+fjAyMkJwcDBq1KghcWIiIuVgc4OIiIiIiIiI1KKionD//n24ubmpr125cgUHDhyAm5sbWrZsKWM6IundvHkTw4cPR3Z2NszMzNCtWze0aNECJiYmyM/Px9OnTxEVFYXQ0FAkJiZCR0cHW7ZsQevWreWOTkRUqbG5QUREREREREQQRRGLFy/Gjh070LhxY/z222/qe/7+/vD19YWGhga8vLzg4+MjY1Ii6d2/fx/Tp0/HtWvXSjzO7eXjNXt7e8yfPx9NmjSROiIRkeJw5gYRERERERERYf/+/fj5559hbm4Od3f3Ivd69uwJHR0d+Pn5Yc2aNahXr16RnR1ElV29evXwyy+/ICIiAsHBwfjjjz+QnJwMTU1NmJqaolmzZnB2doatra3cUYmIFIM7N4iIiIiIiIgIQ4cOxd27dxEUFAQzM7MSa5KSkuDi4oImTZrA399f4oRERERE/09D7gBEREREREREJL979+6hbdu2pTY2AMDc3Bz29va4efOmhMmIiIiIimNzg4iIiIiIiIigoaGBvLy8V9ZpampCQ4OPE4iIiEhe/DRCRERERERERLCxsUF4eDji4+NLrXn8+DHCwsJgY2MjYTIiIiKi4tjcICIiIiIiIiKMGDECOTk5GDt2LEJDQ1FQUKC+V1hYiHPnzmHs2LHIzs7GsGHDZExKRERExIHiRERERERERPS3+fPnIyAgAIIgQFtbGyYmJgCAlJQU5OXlQRRFDBw4EEuWLJE5KRERESkdmxtEREREREREpHbkyBHs2rULERER6hkcWlpaaNGiBUaOHIm+ffvKnJCIiIiIzQ0iIiIiIiIiKkVqaioKCgpgZGQEbW1tueMQERERqbG5QURERERERERERERE7xQOFCciIiIiIiIiIiIioncKmxtERERERERERERERPROYXODiIiIiIiIiIiIiIjeKWxuEBERERERERERERHRO4XNDSIiIiIiIiIiIiIieqewuUFERERERERERERERO8UNjeIiIiIiIiIiIiIiOidoiV3ACIiIiIiOQUGBmL27NkYOXIkJk2ahJUrV+LEiRNISUlBzZo14eTkBG9vb9SqVavI++Li4rBt2zZcvHgR8fHxyM3NhbGxMVq2bAl3d3e8//77RepnzZqFvXv3YtWqVTAzM8OqVavw+++/Iy8vDyqVCt7e3nB0dERmZiZWrVqF4OBgPHnyBLVq1YKrqysmTZoEbW3tYvljY2OxYcMGXLp0CampqTAyMoKDgwPGjx+P5s2bl+vvHRERERERkVwEURRFuUMQEREREcnlZXOje/fuuHbtGpKSkmBlZQU9PT3cvn0bAGBlZYV9+/ahWrVqAICzZ8/C29sb2dnZMDQ0RO3atZGTk4O4uDjk5eVBEAR8/fXX6Nu3r/rXedncGDJkCPbt2wdtbW3Uq1cPcXFxeP78OTQ1NbFmzRp88803uH37NurUqYPCwkI8fPgQADB48GAsXry4WPbPP/8c+fn5MDQ0RJ06dZCUlIQ///wTmpqaWLhwIYYMGSLR7yQREREREZF0eCwVERERERGAo0ePokqVKvj1119x/PhxHDx4ELt374aenh7i4+Ph7+8PAMjNzcXs2bORnZ2NMWPG4Pz589i3bx+Cg4Nx6tQpdOjQAaIoYvXq1SX+Onv27EHXrl1x5swZ7N27F6dOncJ7772HgoICeHl5ISMjA7/++isOHz6Mo0ePYubMmQCAvXv3Ii0tTf1/JyoqCp9//jkAYP78+bh06RICAwNx7tw5fPnll9DQ0MCCBQsQHR1dvr9xREREREREMmBzg4iIiIjob8uXL0ezZs3Ur1u3bo0+ffoAAK5evQoAuHbtGjIzM2FmZobPPvsMOjo66noTExN4e3sDAO7du4fCwsJiv4aRkRGWLFmCqlWrAgCqVq2KESNGAAAKCwuxYMECvPfee+r60aNHQ0dHBwUFBeqdJACwatUq5OfnY+LEiRg5ciQ0NP76aC8IAoYMGQIPDw/k5+dj7dq1b+X3hoiIiIiIqCJhc4OIiIiICFDPy/i3+vXrAwAyMjIAAHZ2doiMjMSRI0egqalZrF5PTw/AX42KnJycYvft7OzUjY2XLC0tAQBaWlrFZnVoaWnB2NgYAPDixQsAQHZ2Ns6dOwcA6ubLv708Euv8+fPIz88vsYaIiIiIiOhdxYHiRERERERAsYHhL+nq6gIACgoKil2/fv06bty4gYcPH+Lhw4e4desW7t27p64paeeGmZlZsWsvB4VXrVq1yE6Qf99/OS7vwYMHyMvLAwDMmTNHvWvjn17+2pmZmXj8+DGsrKxK/N9HRERERET0LmJzg4iIiIgI/99AeB3h4eH46quvcP36dfU1QRBQt25duLq64rfffiv1vfr6+v9TTuD/d5EAwJUrV15Z//z58//51yQiIiIiIqpI2NwgIiIiInoDt27dwrhx45Cbmwt7e3v069cPNjY2aNiwIapWrYp79+6V2dx4G142SPT19XH58uVy/bWIiIiIiIgqIjY3iIiIiIjewPbt25Gbm4v27dtj06ZNxeZuJCUllXsGa2traGhoIDMzE0lJSTA3Ny9Wk5GRgevXr8PKygpWVlYQBKHccxEREREREUmFA8WJiIiIiN5AfHw8AMDGxqbEgeK//PKL+r//PafjbalatSrs7e0BALt27SqxZsuWLRg9ejRGjx5d4uwPIiIiIiKidxmbG0REREREb6BevXoAgKCgIDx48EB9/dmzZ1iyZAkOHjyovpaTk1NuOT755BMIgoANGzZg27Zt6kaKKIrYt28f1q5dCwDw8PAosQlDRERERET0LuOxVEREREREb2Ds2LE4cOAAnjx5gt69e6N+/foQBAH3799Hbm4uVCoVkpKSkJaWhidPnsDU1LRccrRv3x6zZs3C0qVLsXjxYqxatQrW1tZISkpCcnIyAKB///4YPXp0ufz6REREREREcuLODSIiIiKiN2BtbY39+/djwIABsLCwwP3795GYmAiVSoXZs2djz549+OCDDwAAJ0+eLNcsY8aMQUBAAPr06QMdHR3ExsYiKysLDg4OWLp0KZYuXcpZG0REREREVCkJoiiKcocgIiIiIiIiIiIiIiJ6Xdy5QURERERERERERERE7xQ2N4iIiIiIiIiIiIiI6J3C5gYREREREREREREREb1T2NwgIiIiIiIiIiIiIqJ3CpsbRERERERERERERET0TmFzg4iIiIiIiIiIiIiI3ilsbhARERERERERERER0TuFzQ0iIiIiIiIiIiIiInqnsLlBRERERERERERERETvFDY3iIiIiIiIiIiIiIjoncLmBhERERERERERERERvVP+D6XeFcWE3/YuAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 1626.82x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sources_df_small = sources_df[~sources_df[\"name\"].isin(big_sources)]\n",
    "p = sns.catplot(data=sources_df_small, kind=\"bar\", x=\"name\", y=\"count\", hue=\"type\", ci=\"sd\", \n",
    "                palette=\"dark\", alpha=.6, height=10, aspect=2)\n",
    "p.set_xticklabels(rotation=90)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "605305f2",
   "metadata": {},
   "outputs": [],
   "source": [
    "# check gtp fails\n",
    "\n",
    "cur = conn.cursor()\n",
    "cur.execute(\"\"\"\n",
    "SELECT \n",
    "    dc.name AS claim_name, \n",
    "    dc.nomenclature AS claim_name_nomenclature, \n",
    "    dc.primary_name AS claim_primary_name, \n",
    "    s.full_name AS source, \n",
    "    d.concept_id AS grouped_id\n",
    "FROM drugs d\n",
    "LEFT JOIN drug_claims dc ON d.id = dc.drug_id\n",
    "LEFT JOIN sources s ON dc.source_id = s.id\n",
    "\"\"\")\n",
    "old_unnormalized_drugs = cur.fetchall()\n",
    "cur.close()\n",
    "\n",
    "for group in old_unnormalized_drugs:\n",
    "    if group[3] == \"Guide to Pharmacology\":\n",
    "        if (q.normalize(group[0]).match_type == 0) and (q.normalize(group[2]).match_type == 0):\n",
    "            print((group[0], group[2]))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9cc220ea",
   "metadata": {},
   "source": [
    "# Distribution of claims over previously-grouped drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "832bb8c3",
   "metadata": {},
   "outputs": [],
   "source": [
    "cur = conn.cursor()\n",
    "cur.execute(\"\"\"\n",
    "SELECT \n",
    "    dc.name AS claim_name, \n",
    "    dc.nomenclature AS claim_name_nomenclature, \n",
    "    dc.primary_name AS claim_primary_name, \n",
    "    s.full_name AS source, \n",
    "    d.concept_id AS grouped_id\n",
    "FROM drugs d\n",
    "LEFT JOIN drug_claims dc ON d.id = dc.drug_id\n",
    "LEFT JOIN sources s ON dc.source_id = s.id\n",
    "\"\"\")\n",
    "grouped_claims = cur.fetchall()\n",
    "cur.close()\n",
    "\n",
    "groups = {}\n",
    "for claim in grouped_claims:\n",
    "    if not claim[4] in groups:\n",
    "        groups[claim[4]] = 1\n",
    "    else:\n",
    "        groups[claim[4]] += 1\n",
    "\n",
    "groups_df = pd.DataFrame([[k, v] for k, v in groups.items()], columns=[\"concept_id\", \"count\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "28682d42",
   "metadata": {},
   "outputs": [],
   "source": [
    "normed_groups = {}\n",
    "fails = 0\n",
    "for claim in grouped_claims:\n",
    "    norm_response = q.normalize(claim[2])\n",
    "    if norm_response.match_type > 0:\n",
    "        therapy_id = norm_response.therapy_descriptor.therapy_id\n",
    "        if therapy_id in normed_groups:\n",
    "            normed_groups[therapy_id] += 1\n",
    "        else:\n",
    "            normed_groups[therapy_id] = 1\n",
    "    elif claim[0] != claim[2]:\n",
    "        norm_response = q.normalize(claim[0])\n",
    "        if norm_response.match_type > 0:\n",
    "            therapy_id = norm_response.therapy_descriptor.therapy_id\n",
    "            if therapy_id in normed_groups:\n",
    "                normed_groups[therapy_id] += 1\n",
    "            else:\n",
    "                normed_groups[therapy_id] = 1\n",
    "    else:\n",
    "        fails += 1\n",
    "normed_groups_df = pd.DataFrame([[k, v] for k, v in normed_groups.items()], columns=[\"concept_id\", \"count\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "c3a9987f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>dgidbv4 grouper</th>\n",
       "      <td>14449.0</td>\n",
       "      <td>2.454772</td>\n",
       "      <td>1.816824</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>therapy normalizer</th>\n",
       "      <td>14886.0</td>\n",
       "      <td>2.378476</td>\n",
       "      <td>1.961772</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>25.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      count      mean       std  min  25%  50%  75%   max\n",
       "dgidbv4 grouper     14449.0  2.454772  1.816824  1.0  2.0  2.0  3.0  20.0\n",
       "therapy normalizer  14886.0  2.378476  1.961772  1.0  1.0  2.0  2.0  25.0"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame([groups_df[\"count\"].describe(), normed_groups_df[\"count\"].describe()], index=[\"dgidbv4 grouper\", \"therapy normalizer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "58b7c290",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x720 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.set()\n",
    "fig, ax = plt.subplots(1, 2, figsize=(20, 10))\n",
    "p = sns.histplot(groups_df, ax=ax[0], x=\"count\", binwidth=1)\n",
    "p.set_xlabel(\"# of claims in drug group\", fontsize=15)\n",
    "p.set_ylabel(\"frequency\", fontsize=15)\n",
    "p.set_title(\"Drug Group Claim Distribution Using Drug Grouper\", fontsize=20)\n",
    "ax[0].set_xticks(range(0, max(groups_df[\"count\"]) + 1, 2))\n",
    "\n",
    "p = sns.histplot(groups_df[groups_df[\"count\"] > 3], ax=ax[1], x=\"count\", binwidth=1)\n",
    "p.set_xlabel(\"# of claims in drug group\", fontsize=15)\n",
    "p.set_ylabel(\"frequency\", fontsize=15)\n",
    "p.set_title(\"Same plot for # claims > 3\", fontsize=20)\n",
    "ax[1].set_xticks(range(4, max(groups_df[\"count\"]) + 1, 2))\n",
    "None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "a28c0831",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x720 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.set()\n",
    "fig, ax = plt.subplots(1, 2, figsize=(20, 10))\n",
    "p = sns.histplot(normed_groups_df, ax=ax[0], x=\"count\", binwidth=1)\n",
    "p.set_xlabel(\"# of claims in drug group\", fontsize=15)\n",
    "p.set_ylabel(\"frequency\", fontsize=15)\n",
    "p.set_title(\"Drug Group Claim Distribution Using Normalizer\", fontsize=20)\n",
    "ax[0].set_xticks(range(0, max(normed_groups_df[\"count\"]) + 1, 2))\n",
    "\n",
    "p = sns.histplot(normed_groups_df[normed_groups_df[\"count\"] > 3], ax=ax[1], x=\"count\", binwidth=1)\n",
    "p.set_xlabel(\"# of claims in drug group\", fontsize=15)\n",
    "p.set_ylabel(\"frequency\", fontsize=15)\n",
    "p.set_title(\"Same plot for # claims > 3\", fontsize=20)\n",
    "ax[1].set_xticks(range(4, max(normed_groups_df[\"count\"]) + 1, 2))\n",
    "None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "484148fa",
   "metadata": {},
   "outputs": [],
   "source": [
    "# diagnostic work\n",
    "check_norm_groups = {}\n",
    "check_groups = {}\n",
    "for claim in grouped_claims:\n",
    "    if not claim[4] in check_groups:\n",
    "        check_groups[claim[4]] = [claim[2].lower()]\n",
    "    else:\n",
    "        check_groups[claim[4]].append(claim[2].lower())\n",
    "    \n",
    "    norm_response = q.normalize(claim[2])\n",
    "    if norm_response.match_type > 0:\n",
    "        if norm_response.therapy_descriptor.therapy_id in check_norm_groups:\n",
    "            check_norm_groups[norm_response.therapy_descriptor.therapy_id].append(claim[2].lower())\n",
    "        else:\n",
    "            check_norm_groups[norm_response.therapy_descriptor.therapy_id] = [claim[2].lower()]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "44b19d78",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "lvp | 8 | iuphar.ligand:2172 | 1\n",
      "carmustine | 9 | rxcui:2105 | 8\n",
      "bcnu | 9 | rxcui:2105 | 8\n",
      "dti-015 | 9 | ncit:C2602 | 1\n",
      "amg-888 | 3 | chembl:CHEMBL2109396 | 1\n",
      "nanatinostat | 4 | ncit:C78475 | 1\n",
      "chr-3996 | 4 | iuphar.ligand:8391 | 3\n",
      "lcl161 | 4 | iuphar.ligand:7912 | 3\n",
      "lcl-161 | 4 | drugbank:DB12085 | 1\n",
      "bms-536924 | 4 | iuphar.ligand:9386 | 3\n",
      "chembl:chembl401930 | 4 | chembl:CHEMBL401930 | 1\n",
      "bms-936559 | 3 | chembl:CHEMBL4297702 | 2\n",
      "mdx-1105 | 3 | ncit:C78852 | 1\n",
      "bms-908662 | 4 | drugbank:DB12854 | 1\n",
      "xl-281 | 4 | chembl:CHEMBL3545027 | 2\n",
      "xl281 | 4 | drugbank:DB05190 | 1\n",
      "o-chloroacetylcarbamoylfumagillol | 3 | ncit:C1298 | 2\n",
      "tnp-470 | 3 | drugbank:DB08633 | 1\n",
      "agm-1470 | 3 | ncit:C1298 | 2\n",
      "alpha interferon | 20 | ncit:C225 | 3\n",
      "cetuximab | 20 | rxcui:318341 | 19\n",
      "c225 | 20 | ncit:C225 | 3\n",
      "leukocyte interferon | 20 | ncit:C225 | 3\n",
      "tki258 | 13 | ncit:C62435 | 1\n",
      "dovitinib | 13 | ncit:C76199 | 12\n",
      "bedoradrine sulfate | 4 | ncit:C77933 | 2\n",
      "mn-221 | 4 | chembl:CHEMBL2218893 | 2\n",
      "cta018 | 4 | drugbank:DB05024 | 1\n",
      "lunacalcipol | 4 | iuphar.ligand:11382 | 3\n",
      "ctx | 5 | ncit:C400 | 1\n",
      "lornoxicam | 5 | rxcui:20890 | 4\n",
      "opigolix | 2 | ncit:C174927 | 1\n",
      "asp-1707 | 2 | chembl:CHEMBL3989969 | 1\n",
      "n6-cyclopentyladenosine | 4 | iuphar.ligand:380 | 3\n",
      "cyclopentyladenosine | 4 | iuphar.ligand:380 | 3\n",
      "ccpa | 4 | iuphar.ligand:374 | 1\n",
      "mercaptopurine hydrate | 4 | chembl:CHEMBL1200751 | 2\n",
      "nevanimibe hydrochloride | 2 | ncit:C170217 | 1\n",
      "atr-101 | 2 | chembl:CHEMBL542103 | 1\n",
      "dwp05195 | 3 | chembl:CHEMBL3545229 | 2\n",
      "gdc-0425 | 4 | drugbank:DB14791 | 2\n",
      "rg-7602 | 4 | chembl:CHEMBL3545007 | 2\n",
      "alfuzosin hydrochloride | 4 | rxcui:46043 | 3\n",
      "xatral | 4 | chembl:CHEMBL1723 | 1\n",
      "ox-914 | 3 | chembl:CHEMBL4297287 | 1\n",
      "ht-0712 | 3 | drugbank:DB11650 | 2\n",
      "4-isothioureidobutyronitrile | 4 | drugbank:DB13010 | 1\n",
      "thioureidobutyronitrile | 4 | ncit:C102881 | 3\n",
      "kevetrin | 4 | ncit:C102881 | 3\n",
      "margetuximab | 8 | rxcui:2473850 | 4\n",
      "mgah22 | 8 | ncit:C91733 | 4\n",
      "mkt-077 | 3 | ncit:C2731 | 2\n",
      "chembl:chembl33859 | 3 | chembl:CHEMBL33859 | 1\n",
      "rodatristat ethyl | 2 | ncit:C171781 | 1\n",
      "kar5585 | 2 | iuphar.ligand:10646 | 1\n",
      "akcea-angptl3-lrx | 2 | chembl:CHEMBL4298197 | 1\n",
      "vupanorsen | 2 | ncit:C174612 | 1\n",
      "iw-1973 | 2 | drugbank:DB16300 | 1\n",
      "praliciguat | 2 | ncit:C174906 | 1\n",
      "ralinepag | 4 | ncit:C152148 | 3\n",
      "apd-811 | 4 | chembl:CHEMBL3301604 | 1\n",
      "ab928 | 2 | iuphar.ligand:11154 | 1\n",
      "ab-928 | 2 | chembl:CHEMBL4297857 | 1\n",
      "alx-148 | 2 | chembl:CHEMBL4297880 | 1\n",
      "alx148 | 2 | iuphar.ligand:11592 | 1\n",
      "amv-564 | 2 | chembl:CHEMBL4297552 | 1\n",
      "amv564 | 2 | ncit:C135632 | 1\n",
      "azd0156 | 3 | iuphar.ligand:9942 | 2\n",
      "azd-0156 | 3 | chembl:CHEMBL4297899 | 1\n",
      "azd-5153 | 3 | chembl:CHEMBL4078100 | 1\n",
      "azd5153 | 3 | ncit:C151943 | 2\n",
      "azd5991 | 2 | iuphar.ligand:11783 | 1\n",
      "azd-5991 | 2 | drugbank:DB14792 | 1\n",
      "azd-8186 | 6 | drugbank:DB15029 | 2\n",
      "azd8186 | 6 | iuphar.ligand:8527 | 4\n",
      "coh-29 | 2 | chembl:CHEMBL4297421 | 1\n",
      "coh29 | 2 | ncit:C114976 | 1\n",
      "cyc-065 | 2 | drugbank:DB15425 | 1\n",
      "cyc065 | 2 | ncit:C123902 | 1\n",
      "cblb-502 | 4 | chembl:CHEMBL2108683 | 1\n",
      "entolimod | 4 | ncit:C99166 | 3\n",
      "7-ethyl-10-hydroxycamptothecin | 4 | ncit:C61618 | 1\n",
      "it-141 | 4 | ncit:C148511 | 1\n",
      "sn-38 | 4 | iuphar.ligand:6925 | 2\n",
      "7-ethyl-10-hydroxy-camptothecin | 4 | iuphar.ligand:6925 | 2\n",
      "am-803 | 3 | chembl:CHEMBL1922660 | 1\n",
      "fiboflapon | 3 | ncit:C169978 | 2\n",
      "acth | 8 | iuphar.ligand:1331 | 2\n",
      "corticotropin | 8 | rxcui:376 | 6\n",
      "adrenocorticotropin | 8 | rxcui:376 | 6\n",
      "ly3321367 | 2 | ncit:C137820 | 1\n",
      "ly-3321367 | 2 | chembl:CHEMBL4298022 | 1\n",
      "m2698 | 5 | chembl:CHEMBL3545003 | 3\n",
      "msc-2363318a | 5 | chembl:CHEMBL3545003 | 3\n",
      "msc2363318a | 5 | ncit:C112004 | 2\n",
      "medi4276 | 2 | ncit:C126355 | 1\n",
      "medi-4276 | 2 | chembl:CHEMBL4298032 | 1\n",
      "chembl:chembl2110360 | 3 | chembl:CHEMBL2110360 | 1\n",
      "sb-568849 | 3 | iuphar.ligand:1312 | 2\n",
      "mk2206 | 13 | ncit:C90581 | 6\n",
      "mk-2206 | 13 | iuphar.ligand:7945 | 7\n",
      "daunomycin | 10 | rxcui:3109 | 9\n",
      "daunorubicin | 10 | rxcui:3109 | 9\n",
      "daunoxome | 10 | rxcui:214468 | 1\n",
      "sl-801 | 2 | ncit:C128246 | 1\n",
      "cbs-9106 | 2 | chembl:CHEMBL4298104 | 1\n",
      "tak-243 | 3 | drugbank:DB15013 | 2\n",
      "mln7243 | 3 | ncit:C113788 | 1\n",
      "ck-101 | 2 | ncit:C132023 | 1\n",
      "rx-518 | 2 | chembl:CHEMBL4297486 | 1\n",
      "vx-680 | 8 | ncit:C61319 | 1\n",
      "tozasertib | 8 | ncit:C98053 | 7\n",
      "eptinezumab | 4 | rxcui:2282660 | 3\n",
      "ald-403 | 4 | iuphar.ligand:10694 | 1\n",
      "cep-32496 | 6 | iuphar.ligand:7880 | 4\n",
      "agerafenib | 6 | ncit:C107245 | 2\n",
      "gmx1777 | 4 | drugbank:DB05217 | 2\n",
      "teglarinad chloride | 4 | ncit:C68931 | 2\n",
      "mp-0250 | 2 | chembl:CHEMBL4298048 | 1\n",
      "mp0250 | 2 | ncit:C117236 | 1\n",
      "cediranib | 12 | ncit:C80867 | 11\n",
      "recentin | 12 | hemonc:94 | 1\n",
      "tg-02 | 6 | iuphar.ligand:9095 | 5\n",
      "zotiraciclib | 6 | ncit:C171725 | 1\n",
      "tg02 | 6 | iuphar.ligand:9095 | 5\n",
      "usl-311 | 2 | drugbank:DB15265 | 1\n",
      "usl311 | 2 | ncit:C131534 | 1\n",
      "acelarin | 2 | iuphar.ligand:7389 | 1\n",
      "fosgemcitabine palabenamide, p(rs)- | 2 | chembl:CHEMBL3126004 | 1\n",
      "iberdomide hydrochloride | 2 | ncit:C141516 | 1\n",
      "raf265 | 9 | ncit:C61311 | 3\n",
      "raf-265 | 9 | drugbank:DB05984 | 1\n",
      "chir-265 | 9 | iuphar.ligand:5674 | 5\n",
      "progesterone | 13 | rxcui:8727 | 10\n",
      "mpa | 13 | iuphar.ligand:4595 | 1\n",
      "progestin | 13 | ncit:C776 | 2\n",
      "gl-0817 | 2 | ncit:C129968 | 1\n",
      "biropepimut-s | 2 | ncit:C166968 | 1\n",
      "m7824 | 2 | ncit:C124229 | 1\n",
      "m-7824 | 2 | chembl:CHEMBL4298024 | 1\n",
      "onc201 | 3 | ncit:C113792 | 2\n",
      "onc-201 | 3 | drugbank:DB14844 | 1\n",
      "navarixin | 6 | ncit:C156730 | 5\n",
      "sch-527123 | 6 | iuphar.ligand:8497 | 2\n",
      "racemetyrosine | 3 | ncit:C74152 | 2\n",
      "sm-88 | 3 | ncit:C74152 | 2\n",
      "umbralisib tosylate | 3 | rxcui:2478438 | 1\n",
      "axelopran | 4 | ncit:C171856 | 2\n",
      "td-1211 | 4 | chembl:CHEMBL3137313 | 2\n",
      "evp-6124 | 5 | drugbank:DB11726 | 2\n",
      "encenicline | 5 | ncit:C166844 | 3\n",
      "mb07811 | 4 | drugbank:DB05192 | 3\n",
      "mb-07811 | 4 | chembl:CHEMBL471897 | 1\n",
      "x-396 | 10 | drugbank:DB13104 | 6\n",
      "ensartinib | 10 | ncit:C102754 | 4\n",
      "pidilizumab | 5 | ncit:C71014 | 3\n",
      "ct-011 | 5 | drugbank:DB05916 | 2\n",
      "epratuzumab 90y | 2 | chembl:CHEMBL2108357 | 1\n",
      "ga201 | 4 | ncit:C78838 | 2\n",
      "ro5083945 | 4 | chembl:CHEMBL2109389 | 2\n",
      "imgatuzumab | 4 | ncit:C78838 | 2\n",
      "abbv-323 | 2 | chembl:CHEMBL4298212 | 1\n",
      "ravagalimab | 2 | ncit:C170363 | 1\n",
      "medi-546 | 4 | iuphar.ligand:8258 | 1\n",
      "anifrolumab | 4 | rxcui:2565265 | 3\n",
      "gdc-0853 | 4 | ncit:C116844 | 3\n",
      "fenebrutinib | 4 | ncit:C116844 | 3\n",
      "rg7845 | 4 | drugbank:DB14785 | 1\n",
      "gsk3050002 | 2 | iuphar.ligand:9623 | 1\n",
      "gsk-3050002 | 2 | chembl:CHEMBL4297967 | 1\n",
      "glpg0259 | 3 | chembl:CHEMBL3545338 | 1\n",
      "glpg-0259 | 3 | drugbank:DB15190 | 2\n",
      "ald518 | 5 | ncit:C82359 | 4\n",
      "clazakizumab | 5 | ncit:C82359 | 4\n",
      "ald-518 | 5 | iuphar.ligand:9195 | 1\n",
      "ro4987655 | 4 | ncit:C82696 | 2\n",
      "ro-4987655 | 4 | drugbank:DB12933 | 2\n",
      "ly-674 | 5 | iuphar.ligand:2658 | 1\n",
      "ly-518674 | 5 | drugbank:DB12988 | 4\n",
      "vx-745 | 5 | drugbank:DB07138 | 3\n",
      "neflamapimod | 5 | ncit:C170207 | 2\n",
      "pf-4691502 | 8 | iuphar.ligand:7936 | 1\n",
      "pf-04691502 | 8 | drugbank:DB11974 | 7\n",
      "il-2 | 3 | iuphar.ligand:4985 | 2\n",
      "cort-125134 | 3 | ncit:C127838 | 1\n",
      "cort 125134 | 3 | chembl:CHEMBL4068611 | 2\n",
      "amiselimod hydrochloride | 3 | ncit:C142922 | 2\n",
      "mt-1303 | 3 | iuphar.ligand:9319 | 1\n",
      "rg7625 | 3 | drugbank:DB15297 | 1\n",
      "petesicatib | 3 | ncit:C174598 | 2\n",
      "pf-00547659 | 3 | iuphar.ligand:9340 | 2\n",
      "shp647 | 3 | iuphar.ligand:9340 | 2\n",
      "ontamalimab | 3 | ncit:C166947 | 1\n",
      "upadacitinib | 5 | rxcui:2196092 | 4\n",
      "abt-494 | 5 | iuphar.ligand:9246 | 1\n",
      "ly2624803 | 3 | chembl:CHEMBL3545287 | 2\n",
      "ly-2624803 | 3 | drugbank:DB15092 | 1\n",
      "m-518101 | 3 | chembl:CHEMBL3989862 | 1\n",
      "pefcalcitol | 3 | ncit:C170289 | 2\n",
      "liothyronine sodium | 5 | rxcui:142448 | 3\n",
      "picropodophyllotoxin | 4 | ncit:C87736 | 2\n",
      "picropodophyllin | 4 | ncit:C87736 | 2\n",
      "ery974 | 2 | ncit:C129936 | 1\n",
      "ery-974 | 2 | chembl:CHEMBL4297948 | 1\n",
      "mb-102 | 2 | ncit:C165435 | 1\n",
      "relmapirazin | 2 | chembl:CHEMBL1949708 | 1\n",
      "ati-7505 | 3 | chembl:CHEMBL2103858 | 1\n",
      "naronapride | 3 | ncit:C175157 | 2\n",
      "intepirdine | 5 | ncit:C166572 | 2\n",
      "sb-742457 | 5 | drugbank:DB12680 | 3\n",
      "pepinemab | 3 | ncit:C96222 | 2\n",
      "vx-15 | 3 | chembl:CHEMBL4297884 | 1\n",
      "tebentafusp | 2 | ncit:C94208 | 1\n",
      "imcgp100 | 2 | iuphar.ligand:7378 | 1\n",
      "nrx-1074 | 4 | drugbank:DB11784 | 2\n",
      "apimostinel | 4 | ncit:C169785 | 2\n",
      "rg-1662 | 4 | drugbank:DB11877 | 1\n",
      "basmisanil | 4 | ncit:C167009 | 3\n",
      "btrx-246040 | 3 | drugbank:DB16048 | 1\n",
      "gonadorelin acetate | 4 | rxcui:204193 | 2\n",
      "gnrh | 4 | chembl:CHEMBL1200511 | 2\n",
      "human interleukin-2 | 5 | drugbank:DB14865 | 1\n",
      "senrebotase | 2 | ncit:C152334 | 1\n",
      "agn-214868 | 2 | chembl:CHEMBL3137348 | 1\n",
      "cvt-6883 | 6 | drugbank:DB05936 | 3\n",
      "gs 6201 | 6 | iuphar.ligand:5615 | 3\n",
      "min-101 | 2 | chembl:CHEMBL4298043 | 1\n",
      "roluperidone hydrochloride | 2 | ncit:C170371 | 1\n",
      "viloxazine hydrochloride | 2 | rxcui:142143 | 1\n",
      "spn-812 | 2 | chembl:CHEMBL2106483 | 1\n",
      "cytisinicline | 2 | ncit:C166810 | 1\n",
      "cytisine | 2 | rxcui:1723152 | 1\n",
      "rapastinel | 4 | ncit:C152156 | 2\n",
      "glyx-13 | 4 | chembl:CHEMBL3544917 | 2\n",
      "glpg0492 | 5 | chembl:CHEMBL3545417 | 4\n",
      "dt-200 | 5 | chembl:CHEMBL3545417 | 4\n",
      "glpg-0492 | 5 | drugbank:DB12461 | 1\n",
      "asp-3026 | 7 | drugbank:DB12729 | 3\n",
      "asp3026 | 7 | ncit:C116727 | 4\n",
      "ac-480 | 9 | iuphar.ligand:7647 | 3\n",
      "bms-599626 | 9 | drugbank:DB12318 | 4\n",
      "ac480 | 9 | ncit:C48380 | 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "zalutumumab | 5 | ncit:C64620 | 4\n",
      "humax-egfr | 5 | chembl:CHEMBL2107861 | 1\n",
      "rilotumumab | 7 | ncit:C67079 | 6\n",
      "amg-102 | 7 | chembl:CHEMBL1743063 | 1\n",
      "amg 102 | 7 | ncit:C67079 | 6\n",
      "radiprodil | 4 | ncit:C152143 | 3\n",
      "rgh-896 | 4 | chembl:CHEMBL182066 | 1\n",
      "isis-sod1rx | 4 | chembl:CHEMBL3833346 | 3\n",
      "biib067 | 4 | chembl:CHEMBL3833346 | 3\n",
      "tofersen | 4 | ncit:C166584 | 1\n",
      "pf-06252616 | 3 | drugbank:DB15083 | 1\n",
      "domagrozumab | 3 | ncit:C166800 | 2\n",
      "epicatechin | 2 | drugbank:DB12039 | 1\n",
      "(+)-epicatechin | 2 | chembl:CHEMBL129482 | 1\n",
      "venglustat | 4 | ncit:C152852 | 2\n",
      "gz402671 | 4 | drugbank:DB14966 | 2\n",
      "genz-682452 | 4 | drugbank:DB14966 | 2\n",
      "lmi070 | 2 | chembl:CHEMBL4290141 | 1\n",
      "branaplam | 2 | ncit:C174824 | 1\n",
      "shr-1314 | 2 | iuphar.ligand:9296 | 1\n",
      "vunakizumab | 2 | ncit:C152923 | 1\n",
      "bi655130 | 2 | chembl:CHEMBL4297911 | 1\n",
      "spesolimab | 2 | ncit:C166849 | 1\n",
      "gsk2140944 | 3 | drugbank:DB12134 | 1\n",
      "gepotidacin | 3 | ncit:C170025 | 2\n",
      "sna-120 | 3 | drugbank:DB16280 | 2\n",
      "pegcantratinib | 3 | ncit:C170295 | 1\n",
      "ct-327 | 3 | drugbank:DB16280 | 2\n",
      "acc-001 | 2 | chembl:CHEMBL2108058 | 1\n",
      "vanutide cridificar | 2 | ncit:C152829 | 1\n",
      "chf4227 | 3 | chembl:CHEMBL3545355 | 2\n",
      "hms5552 | 2 | chembl:CHEMBL4297508 | 1\n",
      "dorzagliatin | 2 | ncit:C169919 | 1\n",
      "efinopegdutide | 2 | ncit:C169932 | 1\n",
      "jnj-64565111 | 2 | drugbank:DB15077 | 1\n",
      "medi0382 | 2 | chembl:CHEMBL4297630 | 1\n",
      "cotadutide | 2 | ncit:C174890 | 1\n",
      "ac-201 | 5 | rxcui:22759 | 2\n",
      "diacerein | 5 | ncit:C166759 | 3\n",
      "bcx-3408 | 3 | chembl:CHEMBL269864 | 1\n",
      "ulodesine | 3 | ncit:C152793 | 2\n",
      "belnacasan | 3 | ncit:C171755 | 2\n",
      "vx-765 | 3 | drugbank:DB05507 | 1\n",
      "astuprotimut-r | 5 | ncit:C78478 | 4\n",
      "gsk1572932a | 5 | ncit:C91714 | 1\n",
      "mage-a3 | 5 | ncit:C78478 | 4\n",
      "zagotenemab | 2 | ncit:C171842 | 1\n",
      "ly3303560 | 2 | iuphar.ligand:10471 | 1\n",
      "pco371 | 2 | chembl:CHEMBL3976807 | 1\n",
      "pco-371 | 2 | drugbank:DB14946 | 1\n",
      "empesertib | 3 | ncit:C116074 | 1\n",
      "bay-1161909 | 3 | chembl:CHEMBL3545425 | 2\n",
      "pf-02545920 | 3 | drugbank:DB08387 | 1\n",
      "mardepodect | 3 | ncit:C170150 | 2\n",
      "ck-2017357 | 3 | iuphar.ligand:8280 | 1\n",
      "tirasemtiv | 3 | ncit:C152657 | 2\n",
      "denenicokin | 3 | ncit:C62492 | 2\n",
      "il-21 | 3 | iuphar.ligand:4987 | 1\n",
      "durvalumab | 8 | rxcui:1919503 | 7\n",
      "medi4736 | 8 | ncit:C103194 | 1\n",
      "quercetin-3'-o-phosphate | 3 | drugbank:DB12937 | 1\n",
      "lim-0705 | 3 | chembl:CHEMBL4297397 | 2\n",
      "inclacumab | 3 | ncit:C174603 | 1\n",
      "ro-4905417 | 3 | chembl:CHEMBL2109488 | 2\n",
      "ace-041 | 7 | ncit:C88296 | 6\n",
      "delantercept | 7 | chembl:CHEMBL2109662 | 1\n",
      "dalantercept | 7 | ncit:C88296 | 6\n",
      "apamistamab iodine i-131 | 2 | chembl:CHEMBL4297997 | 1\n",
      "iomab-b | 2 | ncit:C2527 | 1\n",
      "dipraglurant | 4 | ncit:C171677 | 3\n",
      "adx-48621 | 4 | drugbank:DB12733 | 1\n",
      "ta-8995 | 2 | chembl:CHEMBL3785197 | 1\n",
      "obicetrapib | 2 | ncit:C175167 | 1\n",
      "pa-799 | 5 | iuphar.ligand:7743 | 3\n",
      "ch5132799 | 5 | ncit:C158603 | 1\n",
      "ch-5132799 | 5 | drugbank:DB13051 | 1\n",
      "azd-7762 | 7 | drugbank:DB12242 | 3\n",
      "azd7762 | 7 | iuphar.ligand:7713 | 4\n",
      "medi-528 | 4 | iuphar.ligand:8934 | 2\n",
      "enokizumab | 4 | ncit:C97929 | 2\n",
      "azd7687 | 3 | iuphar.ligand:7827 | 2\n",
      "azd-7687 | 3 | drugbank:DB14949 | 1\n",
      "at-13148 | 4 | chembl:CHEMBL3544960 | 2\n",
      "at13148 | 4 | ncit:C101786 | 2\n",
      "fevipiprant | 4 | ncit:C166588 | 3\n",
      "qaw-039 | 4 | drugbank:DB12011 | 1\n",
      "pimasertib hydrochloride | 3 | ncit:C166935 | 1\n",
      "xl-888 | 4 | drugbank:DB12981 | 1\n",
      "xl888 | 4 | ncit:C79835 | 3\n",
      "cilmostim | 3 | ncit:C169847 | 1\n",
      "m-csf | 3 | iuphar.ligand:4905 | 2\n",
      "quilizumab | 4 | ncit:C152116 | 3\n",
      "memp1972a | 4 | drugbank:DB15176 | 1\n",
      "tpa | 6 | ncit:C866 | 1\n",
      "alteplase | 6 | rxcui:8410 | 5\n",
      "17-aag | 11 | ncit:C37899 | 10\n",
      "tanespimycin | 11 | ncit:C37899 | 10\n",
      "cnf1010 | 11 | chembl:CHEMBL109480 | 1\n",
      "il-10 | 3 | iuphar.ligand:4975 | 2\n",
      "interleukin-10 | 3 | rxcui:1311299 | 1\n",
      "fp-1039 | 6 | iuphar.ligand:11581 | 3\n",
      "gsk3052230 | 6 | ncit:C77970 | 3\n",
      "nn9924 | 7 | chembl:CHEMBL4524066 | 1\n",
      "liraglutide | 7 | rxcui:475968 | 6\n",
      "cg100649 | 4 | drugbank:DB12399 | 2\n",
      "polmacoxib | 4 | ncit:C170335 | 2\n",
      "cg-100649 | 4 | drugbank:DB12399 | 2\n",
      "ly-2216684 | 3 | chembl:CHEMBL2103857 | 1\n",
      "edivoxetine | 3 | ncit:C166706 | 2\n",
      "aeb071 | 5 | ncit:C80631 | 1\n",
      "sotrastaurin | 5 | ncit:C80630 | 4\n",
      "ccx-168 | 3 | iuphar.ligand:9450 | 1\n",
      "avacopan | 3 | rxcui:2572100 | 2\n",
      "cnv-2197944 | 4 | drugbank:DB15229 | 1\n",
      "cnv2197944 | 4 | chembl:CHEMBL3545172 | 3\n",
      "gm-csf | 4 | iuphar.ligand:4942 | 3\n",
      "regramostim | 4 | ncit:C170366 | 1\n",
      "asp-015k | 5 | drugbank:DB11708 | 2\n",
      "peficitinib | 5 | ncit:C170291 | 3\n",
      "asp015k | 5 | drugbank:DB11708 | 2\n",
      "apatinib | 5 | hemonc:40 | 2\n",
      "rivoceranib | 5 | ncit:C152237 | 3\n",
      "sb-656933 | 3 | drugbank:DB12135 | 1\n",
      "elubrixin | 3 | ncit:C174724 | 2\n",
      "selurampanel | 4 | ncit:C152327 | 3\n",
      "bgg-492 | 4 | chembl:CHEMBL3545042 | 1\n",
      "morphine sulfate | 2 | rxcui:30236 | 1\n",
      "morphine sulfate hydrate | 2 | chembl:CHEMBL2103744 | 1\n",
      "evt401 | 3 | chembl:CHEMBL3707396 | 2\n",
      "ng2-73 | 4 | chembl:CHEMBL2103791 | 1\n",
      "adipiplon | 4 | ncit:C76933 | 3\n",
      "biib074 | 4 | chembl:CHEMBL3544913 | 2\n",
      "gsk1014802 | 4 | chembl:CHEMBL3544913 | 2\n",
      "vixotrigine | 4 | ncit:C152899 | 1\n",
      "raxatrigine | 4 | drugbank:DB11706 | 1\n",
      "scy-635 | 3 | drugbank:DB12451 | 2\n",
      "scy 635 | 3 | chembl:CHEMBL1269597 | 1\n",
      "anti-pd-l1 | 11 | chembl:CHEMBL3707227 | 2\n",
      "rg-7446 | 11 | chembl:CHEMBL3707227 | 2\n",
      "rg7420 | 18 | rxcui:1722365 | 11\n",
      "gdc-0973 | 18 | ncit:C68923 | 7\n",
      "xl518 | 18 | ncit:C68923 | 7\n",
      "cobimetinib | 18 | rxcui:1722365 | 11\n",
      "at9283 | 7 | drugbank:DB05169 | 4\n",
      "at-9283 | 7 | iuphar.ligand:7949 | 3\n",
      "human growth hormone | 2 | wikidata:Q58526200 | 1\n",
      "cs-7017 | 3 | ncit:C64764 | 1\n",
      "efatutazone hydrochloride | 3 | chembl:CHEMBL3545279 | 2\n",
      "mln-4760 | 4 | iuphar.ligand:7866 | 2\n",
      "gl1001 | 4 | iuphar.ligand:7866 | 2\n",
      "ore-1001 | 4 | drugbank:DB12271 | 2\n",
      "somatrogon | 2 | ncit:C152396 | 1\n",
      "mod-4023 | 2 | chembl:CHEMBL4297830 | 1\n",
      "chembl:chembl38288 | 3 | iuphar.ligand:126 | 1\n",
      "way-100135 | 3 | iuphar.ligand:79 | 2\n",
      "chembl:chembl1256797 | 3 | chembl:CHEMBL1256797 | 1\n",
      "brl-54443 | 3 | iuphar.ligand:3927 | 2\n",
      "sns-032 | 7 | drugbank:DB05969 | 3\n",
      "bms-387032 | 7 | iuphar.ligand:5670 | 4\n",
      "rg-7420 | 6 | chembl:CHEMBL3330650 | 2\n",
      "gdc-0623 | 6 | drugbank:DB11982 | 4\n",
      "eleclazine | 3 | ncit:C174857 | 2\n",
      "gs-6615 | 3 | drugbank:DB12394 | 1\n",
      "ramatercept | 3 | ncit:C152151 | 1\n",
      "ace-031 | 3 | chembl:CHEMBL2108674 | 2\n",
      "ngx267 | 3 | drugbank:DB05152 | 1\n",
      "ngx-267 | 3 | chembl:CHEMBL4297408 | 2\n",
      "gsk-610677 | 3 | chembl:CHEMBL3544968 | 2\n",
      "gsk1278863 | 3 | drugbank:DB11682 | 1\n",
      "daprodustat | 3 | ncit:C169877 | 2\n",
      "at7519 | 6 | ncit:C64761 | 2\n",
      "at-7519 | 6 | drugbank:DB08142 | 4\n",
      "gsk-2636771 | 7 | drugbank:DB11795 | 6\n",
      "gsk2636771 | 7 | drugbank:DB11795 | 6\n",
      "it-139 | 3 | chembl:CHEMBL4297410 | 2\n",
      "nkp-1339 | 3 | ncit:C97948 | 1\n",
      "azd8683 | 3 | chembl:CHEMBL3545222 | 2\n",
      "ags-22m6e | 4 | rxcui:2268306 | 2\n",
      "asg-22me | 4 | chembl:CHEMBL3301589 | 2\n",
      "enfortumab vedotin | 4 | rxcui:2268306 | 2\n",
      "ro4929097 | 7 | iuphar.ligand:7338 | 5\n",
      "rg-4733 | 7 | drugbank:DB11870 | 1\n",
      "ro-4929097 | 7 | chembl:CHEMBL4297422 | 1\n",
      "stimuvax | 3 | chembl:CHEMBL3039544 | 1\n",
      "emepepimut-s | 3 | ncit:C2195 | 2\n",
      "via-3196 | 5 | chembl:CHEMBL3261331 | 2\n",
      "mgl-3196 | 5 | drugbank:DB12914 | 2\n",
      "resmetirom | 5 | ncit:C170368 | 1\n",
      "bleselumab | 2 | ncit:C171700 | 1\n",
      "askp-1240 | 2 | chembl:CHEMBL3990028 | 1\n",
      "methazolamide | 9 | rxcui:6826 | 8\n",
      "vvp-808 | 9 | chembl:CHEMBL19 | 1\n",
      "idalopirdine | 4 | ncit:C166835 | 3\n",
      "lu-ae58054 | 4 | drugbank:DB11957 | 1\n",
      "piromelatine | 2 | ncit:C170326 | 1\n",
      "neu-p11 | 2 | chembl:CHEMBL4297523 | 1\n",
      "cerlapirdine | 4 | ncit:C169839 | 3\n",
      "sam-531 | 4 | drugbank:DB12229 | 1\n",
      "aee788 | 6 | iuphar.ligand:7643 | 3\n",
      "aee-788 | 6 | drugbank:DB12558 | 3\n",
      "prx-302 | 3 | chembl:CHEMBL2364656 | 2\n",
      "prx302 | 3 | chembl:CHEMBL2364656 | 2\n",
      "topsalysin | 3 | ncit:C64779 | 1\n",
      "dihydrotestosterone | 5 | ncit:C29619 | 3\n",
      "dht | 5 | ncit:C29618 | 1\n",
      "androstanolone | 5 | wikidata:Q31686490 | 1\n",
      "am-111 | 3 | iuphar.ligand:9101 | 2\n",
      "brimapitide, c-terminal acid | 3 | chembl:CHEMBL4297348 | 1\n",
      "am-101 | 3 | chembl:CHEMBL2364609 | 1\n",
      "arq-092 | 3 | iuphar.ligand:9429 | 1\n",
      "miransertib | 3 | ncit:C99172 | 2\n",
      "chembl:chembl379218 | 2 | iuphar.ligand:5655 | 1\n",
      "a-674563 | 2 | drugbank:DB08568 | 1\n",
      "alectinib | 12 | rxcui:1727455 | 11\n",
      "ch5424802 | 12 | rxcui:1727455 | 11\n",
      "emd-1201081 | 2 | chembl:CHEMBL4297993 | 1\n",
      "imo-2055 | 2 | drugbank:DB06181 | 1\n",
      "beta-lapachone | 6 | ncit:C28694 | 4\n",
      "lapachone | 6 | ncit:C28694 | 4\n",
      "mb-12066 | 6 | chembl:CHEMBL15192 | 2\n",
      "arq-501 | 6 | chembl:CHEMBL15192 | 2\n",
      "raltitrexed | 10 | rxcui:196239 | 9\n",
      "tomudex | 10 | rxcui:196239 | 9\n",
      "zd1694 | 10 | ncit:C1804 | 1\n",
      "setmelanotide | 5 | rxcui:2469247 | 4\n",
      "rm-493 | 5 | iuphar.ligand:9272 | 1\n",
      "tesmilifene hydrochloride | 2 | ncit:C952 | 1\n",
      "dapsone | 6 | rxcui:3108 | 5\n",
      "hemoclar | 3 | chembl:CHEMBL1201516 | 2\n",
      "sp-54 | 3 | chembl:CHEMBL1201516 | 2\n",
      "pentosan polysulfate sodium | 3 | rxcui:134413 | 1\n",
      "interferon gama-1b | 3 | rxcui:5882 | 2\n",
      "interferon gamma-1b | 3 | rxcui:5882 | 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "l-lysine | 3 | ncit:C95739 | 1\n",
      "lysine | 3 | rxcui:6536 | 2\n",
      "antithrombin alfa | 2 | rxcui:1009 | 1\n",
      "kw-3357 | 2 | chembl:CHEMBL1201554 | 1\n",
      "ly3009120 | 5 | iuphar.ligand:8943 | 3\n",
      "ly-3009120 | 5 | chembl:CHEMBL3545195 | 2\n",
      "pi-88 | 5 | drugbank:DB05808 | 3\n",
      "muparfostat | 5 | ncit:C38690 | 2\n",
      "tmc-649128 | 2 | drugbank:DB15152 | 1\n",
      "tmc649128 | 2 | chembl:CHEMBL4297499 | 1\n",
      "rovatirelin | 2 | ncit:C152262 | 1\n",
      "kps-0373 | 2 | chembl:CHEMBL4297622 | 1\n",
      "enarodustat | 2 | ncit:C169944 | 1\n",
      "jtz-951 | 2 | drugbank:DB14985 | 1\n",
      "mrx-4 | 3 | iuphar.ligand:10796 | 2\n",
      "contezolid acefosamil | 3 | ncit:C169864 | 1\n",
      "pf-5190457 | 3 | drugbank:DB14870 | 1\n",
      "pf-05190457 | 3 | iuphar.ligand:9060 | 2\n",
      "modithromycin | 2 | ncit:C174586 | 1\n",
      "edp-420 | 2 | chembl:CHEMBL263886 | 1\n",
      "insulin-like growth factor 1 | 6 | iuphar.ligand:2495 | 1\n",
      "mecasermin | 6 | rxcui:274403 | 5\n",
      "o6-benzylguanine | 3 | ncit:C1306 | 1\n",
      "6-o-benzylguanine | 3 | drugbank:DB11919 | 2\n",
      "chembl:chembl379975 | 2 | chembl:CHEMBL379975 | 1\n",
      "zarnestra | 8 | hemonc:496 | 1\n",
      "tipifarnib | 8 | ncit:C1703 | 7\n",
      "sgs742 | 2 | iuphar.ligand:1085 | 1\n",
      "sgs-742 | 2 | drugbank:DB05010 | 1\n",
      "mb07803 | 3 | chembl:CHEMBL4297400 | 2\n",
      "mb-07803 | 3 | drugbank:DB05053 | 1\n",
      "ly2181308 | 3 | drugbank:DB05141 | 2\n",
      "gataparsen | 3 | ncit:C175071 | 1\n",
      "andrographolide | 4 | ncit:C61637 | 2\n",
      "hmpl-004 | 4 | chembl:CHEMBL186141 | 2\n",
      "tregalizumab | 5 | ncit:C152722 | 3\n",
      "bt-061 | 5 | iuphar.ligand:9864 | 2\n",
      "gw406381 | 2 | iuphar.ligand:9850 | 1\n",
      "gw-406381 | 2 | drugbank:DB12009 | 1\n",
      "bkt140 | 6 | chembl:CHEMBL3545348 | 2\n",
      "t140 | 6 | iuphar.ligand:853 | 1\n",
      "bl-8040 | 6 | ncit:C88309 | 3\n",
      "motixafortide | 6 | ncit:C88309 | 3\n",
      "timapiprant | 5 | ncit:C152633 | 1\n",
      "oc000459 | 5 | iuphar.ligand:9277 | 4\n",
      "oc-000459 | 5 | iuphar.ligand:9277 | 4\n",
      "ly2090314 | 5 | iuphar.ligand:7958 | 2\n",
      "ly-2090314 | 5 | drugbank:DB11913 | 3\n",
      "pf-3893787 | 5 | iuphar.ligand:8985 | 1\n",
      "pf-03893787 | 5 | drugbank:DB15027 | 3\n",
      "adriforant | 5 | ncit:C169765 | 1\n",
      "toreforant | 4 | ncit:C152698 | 3\n",
      "jnj-38518168 | 4 | drugbank:DB12522 | 1\n",
      "metribolone | 2 | ncit:C166564 | 1\n",
      "methyltrienolone | 2 | drugbank:DB02998 | 1\n",
      "gsk933776 | 3 | chembl:CHEMBL2109300 | 2\n",
      "mepazine | 2 | iuphar.ligand:9782 | 1\n",
      "pecazine | 2 | ncit:C76052 | 1\n",
      "ly-2228820 | 6 | ncit:C105853 | 2\n",
      "ralimetinib | 6 | ncit:C143046 | 4\n",
      "ly2228820 | 6 | ncit:C105853 | 2\n",
      "nebentan | 4 | ncit:C81108 | 2\n",
      "xl418 | 4 | drugbank:DB05204 | 2\n",
      "xl-418 | 4 | chembl:CHEMBL3544935 | 2\n",
      "syn-120 | 2 | chembl:CHEMBL1082508 | 1\n",
      "landipirdine | 2 | ncit:C170092 | 1\n",
      "delparantag | 2 | ncit:C169885 | 1\n",
      "pmx-60056 | 2 | chembl:CHEMBL2107820 | 1\n",
      "vatelizumab | 4 | ncit:C152838 | 3\n",
      "sar-339658 | 4 | chembl:CHEMBL1743086 | 1\n",
      "pd-0325901 | 6 | drugbank:DB07101 | 5\n",
      "pd0325901 | 6 | iuphar.ligand:7935 | 1\n",
      "zp-1848 | 3 | iuphar.ligand:10885 | 2\n",
      "glepaglutide | 3 | ncit:C166765 | 1\n",
      "zp1848 | 3 | iuphar.ligand:10885 | 2\n",
      "datp | 2 | drugbank:DB03222 | 1\n",
      "chembl:chembl335538 | 2 | iuphar.ligand:1760 | 1\n",
      "phm | 5 | iuphar.ligand:2274 | 1\n",
      "vasoactive intestinal peptide | 5 | rxcui:1942960 | 1\n",
      "vip | 5 | iuphar.ligand:1152 | 1\n",
      "phi | 5 | iuphar.ligand:2273 | 1\n",
      "phv | 5 | iuphar.ligand:2275 | 1\n",
      "amg319 | 3 | iuphar.ligand:8917 | 1\n",
      "amg-319 | 3 | chembl:CHEMBL3545048 | 2\n",
      "v3381 | 4 | chembl:CHEMBL3707400 | 1\n",
      "indantadol | 4 | ncit:C83796 | 2\n",
      "ar-12286 | 5 | iuphar.ligand:8911 | 2\n",
      "verosudil | 5 | ncit:C152866 | 3\n",
      "a-3309 | 4 | drugbank:DB12486 | 1\n",
      "elobixibat | 4 | ncit:C171820 | 3\n",
      "ni-0401 | 4 | chembl:CHEMBL1743020 | 3\n",
      "foralumab | 4 | ncit:C95785 | 1\n",
      "pf-00477736 | 5 | chembl:CHEMBL3545137 | 3\n",
      "pf-477736 | 5 | drugbank:DB12611 | 2\n",
      "azd3759 | 2 | ncit:C118289 | 1\n",
      "azd-3759 | 2 | drugbank:DB14795 | 1\n",
      "aus-131 | 4 | chembl:CHEMBL198877 | 3\n",
      "equol | 4 | rxcui:1803717 | 1\n",
      "canagliflozin hydrate | 2 | chembl:CHEMBL4594217 | 1\n",
      "bgt226 | 4 | ncit:C74073 | 3\n",
      "ati-355 | 2 | chembl:CHEMBL1742987 | 1\n",
      "atinumab | 2 | ncit:C97942 | 1\n",
      "3,4-dichloroisocoumarin | 2 | drugbank:DB04459 | 1\n",
      "chembl:chembl24983 | 2 | chembl:CHEMBL24983 | 1\n",
      "medroxyprogesterone acetate | 7 | rxcui:1000112 | 3\n",
      "medroxyprogesterone | 7 | rxcui:6691 | 4\n",
      "chembl:chembl338404 | 2 | chembl:CHEMBL338404 | 1\n",
      "ro-166491 | 2 | chembl:CHEMBL1256177 | 1\n",
      "silychristin | 2 | chembl:CHEMBL130493 | 1\n",
      "silicristin | 2 | ncit:C74268 | 1\n",
      "25-hydroxycholesterol | 3 | drugbank:DB04705 | 2\n",
      "chembl:chembl169046 | 3 | iuphar.ligand:2885 | 1\n",
      "decoglurant | 3 | ncit:C166865 | 2\n",
      "ro-4995819 | 3 | chembl:CHEMBL3301593 | 1\n",
      "satralizumab | 3 | rxcui:2391541 | 1\n",
      "sa-237 | 3 | iuphar.ligand:9093 | 2\n",
      "sa237 | 3 | iuphar.ligand:9093 | 2\n",
      "basimglurant | 4 | ncit:C166619 | 3\n",
      "rg-7090 | 4 | drugbank:DB11833 | 1\n",
      "abaloparatide | 4 | rxcui:1921069 | 3\n",
      "ba-058 | 4 | chembl:CHEMBL3301581 | 1\n",
      "iph-2102 | 4 | chembl:CHEMBL2109500 | 1\n",
      "lirilumab | 4 | ncit:C103820 | 3\n",
      "ll-37 | 3 | drugbank:DB16532 | 1\n",
      "cyclic adenosine monophosphate | 3 | drugbank:DB02527 | 2\n",
      "chembl:chembl2005186 | 2 | iuphar.ligand:9558 | 1\n",
      "kd-025 | 2 | rxcui:2564025 | 1\n",
      "ly377604 | 3 | chembl:CHEMBL2012520 | 2\n",
      "ly-377604 | 3 | drugbank:DB12858 | 1\n",
      "elenbecestat | 4 | ncit:C169934 | 3\n",
      "e-2609 | 4 | iuphar.ligand:9818 | 1\n",
      "p505-15 | 4 | iuphar.ligand:8070 | 2\n",
      "prt-2607 | 4 | chembl:CHEMBL3545138 | 2\n",
      "prt-062607 | 4 | iuphar.ligand:8070 | 2\n",
      "ly2881835 | 3 | chembl:CHEMBL3545086 | 2\n",
      "ly-2881835 | 3 | drugbank:DB15046 | 1\n",
      "azd3199 | 3 | chembl:CHEMBL3545103 | 2\n",
      "balipodect | 2 | ncit:C166905 | 1\n",
      "tak-063 | 2 | chembl:CHEMBL3989972 | 1\n",
      "gsk-2586881 | 2 | chembl:CHEMBL4297887 | 1\n",
      "gsk2586881 | 2 | iuphar.ligand:11320 | 1\n",
      "clorgiline | 4 | ncit:C77522 | 3\n",
      "clorgyline | 4 | drugbank:DB04017 | 1\n",
      "su-14813 | 4 | iuphar.ligand:5712 | 2\n",
      "su-014813 | 4 | chembl:CHEMBL1721885 | 2\n",
      "uk-432097 | 3 | drugbank:DB12691 | 1\n",
      "uk432097 | 3 | iuphar.ligand:8420 | 2\n",
      "rv001 | 5 | chembl:CHEMBL1743079 | 1\n",
      "teprotumumab | 5 | rxcui:2274802 | 4\n",
      "cvt-3619 | 3 | iuphar.ligand:5593 | 1\n",
      "gs-9667 | 3 | chembl:CHEMBL3545011 | 2\n",
      "cenicriviroc | 5 | ncit:C166464 | 4\n",
      "tbr-652 | 5 | ncit:C169838 | 1\n",
      "osi-774 | 20 | rxcui:477320 | 3\n",
      "erlotinib | 20 | rxcui:337525 | 19\n",
      "mk-3102 | 5 | drugbank:DB11992 | 1\n",
      "omarigliptin | 5 | ncit:C174662 | 4\n",
      "fluphenazine dihydrochloride | 2 | chembl:CHEMBL1448187 | 1\n",
      "penicillin | 4 | drugsatfda.anda:060307 | 2\n",
      "flavin adenine dinucleotide | 2 | ncit:C80888 | 1\n",
      "flavin adenin dinucleotide | 2 | rxcui:1314412 | 1\n",
      "acriflavine | 3 | rxcui:249 | 2\n",
      "silymarin | 3 | rxcui:9794 | 2\n",
      "silybin a | 3 | chembl:CHEMBL431701 | 1\n",
      "f-351 | 2 | chembl:CHEMBL4297288 | 1\n",
      "hydronidone | 2 | drugbank:DB06299 | 1\n",
      "pf-04217903 | 8 | drugbank:DB12848 | 6\n",
      "pf-4217903 | 8 | chembl:CHEMBL2001019 | 2\n",
      "bxt-51072 | 2 | chembl:CHEMBL4297259 | 1\n",
      "alt-2074 | 2 | drugbank:DB05631 | 1\n",
      "tiplimotide | 2 | ncit:C152648 | 1\n",
      "nbi-5788 | 2 | chembl:CHEMBL2108869 | 1\n",
      "pefloxacin mesylate | 2 | rxcui:262299 | 1\n",
      "tak-935 | 2 | iuphar.ligand:11517 | 1\n",
      "soticlestat | 2 | ncit:C166470 | 1\n",
      "bms-986094 | 2 | drugbank:DB11966 | 1\n",
      "inx-189 | 2 | chembl:CHEMBL1209734 | 1\n",
      "imab362 | 4 | iuphar.ligand:9209 | 1\n",
      "claudiximab | 4 | ncit:C85475 | 3\n",
      "zolbetuximab | 4 | ncit:C85475 | 3\n",
      "sar-125844 | 4 | drugbank:DB15382 | 3\n",
      "sar125844 | 4 | ncit:C97511 | 1\n",
      "chembl:chembl553939 | 3 | chembl:CHEMBL553939 | 1\n",
      "snx-5422 | 3 | drugbank:DB06070 | 2\n",
      "mongersen sodium | 2 | ncit:C170192 | 1\n",
      "ged-0301 | 2 | iuphar.ligand:8277 | 1\n",
      "seltorexant | 3 | ncit:C152326 | 2\n",
      "min-202 | 3 | iuphar.ligand:9308 | 1\n",
      "pegbelfermin | 2 | ncit:C174833 | 1\n",
      "bms-986036 | 2 | drugbank:DB15365 | 1\n",
      "bisegliptin | 3 | ncit:C171768 | 1\n",
      "krp-104 | 3 | chembl:CHEMBL4297624 | 2\n",
      "spd-557 | 3 | chembl:CHEMBL3545035 | 1\n",
      "revexepride | 3 | ncit:C152202 | 2\n",
      "serotonin | 3 | rxcui:1311214 | 2\n",
      "5-hydroxytryptamine | 3 | iuphar.ligand:5 | 1\n",
      "chembl:chembl285063 | 2 | chembl:CHEMBL285063 | 1\n",
      "pd-168393 | 2 | drugbank:DB07662 | 1\n",
      "cp-80794 | 2 | chembl:CHEMBL60550 | 1\n",
      "terlakiren | 2 | ncit:C152568 | 1\n",
      "d-serine | 4 | ncit:C61739 | 2\n",
      "(d)-serine | 4 | rxcui:1742747 | 2\n",
      "hmr-1556 | 2 | iuphar.ligand:2590 | 1\n",
      "chembl:chembl298475 | 2 | chembl:CHEMBL298475 | 1\n",
      "uc-781 | 2 | drugbank:DB05871 | 1\n",
      "uc 781 | 2 | chembl:CHEMBL54893 | 1\n",
      "co-101 | 2 | chembl:CHEMBL3039516 | 1\n",
      "gemcitabine elaidate | 2 | ncit:C79803 | 1\n",
      "taribavirin hydrochloride | 2 | ncit:C77929 | 1\n",
      "viramidine | 2 | chembl:CHEMBL2107375 | 1\n",
      "gsk-364735 | 2 | drugbank:DB13119 | 1\n",
      "s-364735 | 2 | chembl:CHEMBL1256978 | 1\n",
      "ucn-01 | 4 | chembl:CHEMBL574737 | 3\n",
      "xl228 | 5 | drugbank:DB05184 | 3\n",
      "xl-228 | 5 | chembl:CHEMBL3545085 | 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "placulumab | 4 | ncit:C170329 | 2\n",
      "art621 | 4 | chembl:CHEMBL2108739 | 2\n",
      "fibroblast growth factor-1 | 3 | rxcui:1591916 | 1\n",
      "fgf-1 | 3 | iuphar.ligand:4923 | 2\n",
      "bms-564929 | 2 | drugbank:DB07286 | 1\n",
      "chembl:chembl229264 | 2 | chembl:CHEMBL229264 | 1\n",
      "metastat | 3 | chembl:CHEMBL2104970 | 1\n",
      "col-3 | 3 | ncit:C2454 | 2\n",
      "incyclinide | 3 | ncit:C2454 | 2\n",
      "uk-396082 | 2 | iuphar.ligand:8657 | 1\n",
      "uk-396,082 | 2 | drugbank:DB12099 | 1\n",
      "pf-3758309 | 4 | iuphar.ligand:8937 | 2\n",
      "pf-03758309 | 4 | drugbank:DB11775 | 2\n",
      "vercirnon | 4 | ncit:C152858 | 3\n",
      "verecimon | 4 | drugbank:DB15250 | 1\n",
      "e7820 | 2 | chembl:CHEMBL4297376 | 1\n",
      "e-7820 | 2 | drugbank:DB12505 | 1\n",
      "gsk2606414 | 3 | iuphar.ligand:6740 | 2\n",
      "chembl:chembl2171124 | 3 | chembl:CHEMBL2171124 | 1\n",
      "regn910 | 4 | chembl:CHEMBL2108678 | 1\n",
      "nesvacumab | 4 | ncit:C95712 | 2\n",
      "regn-910 | 4 | iuphar.ligand:8457 | 1\n",
      "lbr-101 | 3 | iuphar.ligand:9208 | 1\n",
      "fremanezumab | 3 | rxcui:2056691 | 2\n",
      "canertinib | 8 | ncit:C77588 | 6\n",
      "ci-1033 | 8 | ncit:C1880 | 4\n",
      "abicipar pegol | 3 | ncit:C174693 | 1\n",
      "mp-0112 | 3 | chembl:CHEMBL4297684 | 1\n",
      "mp0112 | 3 | iuphar.ligand:8371 | 1\n",
      "medi4893 | 2 | chembl:CHEMBL3989997 | 1\n",
      "suvratoxumab | 2 | ncit:C152484 | 1\n",
      "nomacopan | 2 | ncit:C167012 | 1\n",
      "rev-576 | 2 | chembl:CHEMBL4297928 | 1\n",
      "asp-4058 | 3 | drugbank:DB11819 | 2\n",
      "asp4058 | 3 | iuphar.ligand:9569 | 1\n",
      "lc-150444 | 3 | chembl:CHEMBL3707235 | 1\n",
      "gemigliptin | 3 | ncit:C118446 | 2\n",
      "vobarilizumab | 2 | ncit:C152901 | 1\n",
      "alx-0061 | 2 | iuphar.ligand:8363 | 1\n",
      "sym-021 | 2 | chembl:CHEMBL4298114 | 1\n",
      "sym021 | 2 | ncit:C142865 | 1\n",
      "atevirdine | 2 | ncit:C73840 | 1\n",
      "atevirdine mesylate | 2 | ncit:C73148 | 1\n",
      "cd-np | 4 | drugbank:DB11777 | 1\n",
      "cenderitide | 4 | ncit:C171663 | 3\n",
      "bermekimab | 3 | ncit:C95708 | 2\n",
      "ra-18c3 | 3 | ncit:C95708 | 2\n",
      "xilonix | 3 | chembl:CHEMBL2109653 | 1\n",
      "azd4017 | 4 | iuphar.ligand:7695 | 1\n",
      "azd-4017 | 4 | drugbank:DB14875 | 3\n",
      "avacincaptad pegol sodium | 3 | ncit:C142940 | 1\n",
      "arc-1905 | 3 | chembl:CHEMBL4297889 | 2\n",
      "arc1905 | 3 | chembl:CHEMBL4297889 | 2\n",
      "itrazole | 6 | chembl:CHEMBL64391 | 1\n",
      "itraconazole | 6 | rxcui:28031 | 5\n",
      "tas-103 | 2 | ncit:C1733 | 1\n",
      "chembl:chembl488755 | 2 | chembl:CHEMBL488755 | 1\n",
      "cgm-097 | 3 | chembl:CHEMBL3601398 | 1\n",
      "cgm097 | 3 | ncit:C104280 | 2\n",
      "ach-3102 | 2 | chembl:CHEMBL3544977 | 1\n",
      "odalasvir | 2 | ncit:C174815 | 1\n",
      "danirixin | 4 | ncit:C169874 | 3\n",
      "gsk1325756 | 4 | drugbank:DB11922 | 1\n",
      "sar-650984 | 3 | hemonc:284 | 1\n",
      "isatuximab | 3 | rxcui:2282018 | 2\n",
      "asapiprant | 3 | ncit:C171866 | 2\n",
      "s-555739 | 3 | chembl:CHEMBL3545043 | 1\n",
      "atesidorsen | 2 | ncit:C171735 | 1\n",
      "atl1103 | 2 | chembl:CHEMBL3989982 | 1\n",
      "bpn14770 | 3 | iuphar.ligand:10451 | 2\n",
      "bpn-14770 | 3 | drugbank:DB14790 | 1\n",
      "onyx-015 | 2 | ncit:C2830 | 1\n",
      "lontucirev (replicating adenovirus) | 2 | chembl:CHEMBL2108619 | 1\n",
      "rvx-208 | 3 | drugbank:DB12000 | 2\n",
      "apabetalone | 3 | ncit:C171748 | 1\n",
      "ly-517717 | 3 | drugbank:DB05713 | 2\n",
      "chembl:chembl1271162 | 3 | chembl:CHEMBL1271162 | 1\n",
      "reveglucosidase alfa | 2 | ncit:C152201 | 1\n",
      "bmn-701 | 2 | chembl:CHEMBL3707295 | 1\n",
      "ammonium trichlorotellurate | 3 | ncit:C1006 | 1\n",
      "as101 | 3 | iuphar.ligand:437 | 2\n",
      "cdp-7657 | 3 | drugbank:DB16131 | 2\n",
      "dapirolizumab pegol | 3 | ncit:C174737 | 1\n",
      "mf101 | 4 | drugbank:DB05052 | 3\n",
      "mf-101 | 4 | wikidata:Q6816906 | 1\n",
      "atu-027 | 3 | drugbank:DB12171 | 2\n",
      "atu027 | 3 | ncit:C84847 | 1\n",
      "nadh | 2 | rxcui:7222 | 1\n",
      "chembl:chembl1161866 | 2 | chembl:CHEMBL1161866 | 1\n",
      "tarafenacin | 4 | ncit:C87644 | 3\n",
      "svt-40776 | 4 | chembl:CHEMBL1779046 | 1\n",
      "dextromethorphan hydrobromide monohydrate | 3 | chembl:CHEMBL1256818 | 2\n",
      "dextromethorphan hydrobromide | 3 | rxcui:102490 | 1\n",
      "dexanabinol | 5 | ncit:C99381 | 3\n",
      "hu-210 | 5 | iuphar.ligand:731 | 2\n",
      "atecegatran metoxil | 2 | ncit:C166758 | 1\n",
      "azd-0837 | 2 | drugbank:DB12507 | 1\n",
      "ilginatinib | 4 | ncit:C98109 | 1\n",
      "ns-018 | 4 | drugbank:DB12784 | 3\n",
      "stx107 | 4 | chembl:CHEMBL3545037 | 3\n",
      "fibrinolysin, human | 5 | rxcui:4388 | 4\n",
      "plasmin | 5 | rxcui:4388 | 4\n",
      "fibrinolysin | 5 | ncit:C171921 | 1\n",
      "dg3173 | 3 | drugbank:DB12777 | 1\n",
      "veldoreotide | 3 | ncit:C152846 | 2\n",
      "azd-1775 | 9 | ncit:C91725 | 5\n",
      "adavosertib | 9 | ncit:C91725 | 5\n",
      "mk-1775 | 9 | drugbank:DB11740 | 4\n",
      "dexmecamylamine | 4 | ncit:C166871 | 2\n",
      "tc-5214 | 4 | chembl:CHEMBL2103881 | 2\n",
      "xl019 | 5 | drugbank:DB05243 | 3\n",
      "xl-019 | 5 | chembl:CHEMBL3545328 | 2\n",
      "srx246 | 3 | chembl:CHEMBL244243 | 2\n",
      "amp-579 | 3 | chembl:CHEMBL1950650 | 1\n",
      "amp579 | 3 | chembl:CHEMBL3545163 | 2\n",
      "aew-541 | 6 | chembl:CHEMBL551064 | 3\n",
      "nvp-aew541 | 6 | iuphar.ligand:8067 | 3\n",
      "pf-04950615 | 5 | iuphar.ligand:7730 | 1\n",
      "bococizumab | 5 | ncit:C166723 | 4\n",
      "diethylpropion hydrochloride | 3 | rxcui:81998 | 2\n",
      "seroxat | 4 | chembl:CHEMBL1708 | 1\n",
      "gsk1059615 | 4 | iuphar.ligand:9826 | 2\n",
      "gsk-1059615 | 4 | drugbank:DB11962 | 2\n",
      "ademetionine | 3 | ncit:C100098 | 2\n",
      "s-adenosylmethionine | 3 | rxcui:9504 | 1\n",
      "pivanex | 3 | ncit:C1344 | 1\n",
      "an-9 | 3 | drugbank:DB05103 | 2\n",
      "diapep277 | 3 | drugbank:DB06651 | 1\n",
      "diapep-277 | 3 | chembl:CHEMBL4297934 | 2\n",
      "ac430 | 5 | iuphar.ligand:9177 | 3\n",
      "ac-430 | 5 | drugbank:DB12535 | 2\n",
      "ly2590443 | 3 | chembl:CHEMBL3545220 | 2\n",
      "gepirone | 3 | ncit:C74193 | 2\n",
      "org-13011 | 3 | chembl:CHEMBL284092 | 1\n",
      "afq056 | 3 | drugbank:DB13004 | 1\n",
      "mavoglurant | 3 | ncit:C170154 | 2\n",
      "azd6738 | 5 | ncit:C111993 | 4\n",
      "ceralasertib | 5 | ncit:C111993 | 4\n",
      "azd-6738 | 5 | iuphar.ligand:9390 | 1\n",
      "mkc-1 | 3 | ncit:C2507 | 1\n",
      "enmd-981693 | 3 | chembl:CHEMBL52885 | 2\n",
      "gsk2256098 | 4 | drugbank:DB16106 | 1\n",
      "gsk-2256098 | 4 | chembl:CHEMBL3544967 | 3\n",
      "bms-936557 | 4 | iuphar.ligand:9047 | 3\n",
      "mdx-1100 | 4 | iuphar.ligand:9047 | 3\n",
      "eldelumab | 4 | ncit:C166466 | 1\n",
      "fe 202767 | 3 | chembl:CHEMBL3545167 | 2\n",
      "e-10030 | 4 | chembl:CHEMBL3301576 | 2\n",
      "pegpleranib sodium | 4 | ncit:C170304 | 2\n",
      "azd8835 | 3 | iuphar.ligand:8915 | 2\n",
      "azd-8835 | 3 | chembl:CHEMBL3894518 | 1\n",
      "tt-232 | 2 | drugbank:DB12088 | 1\n",
      "tln-232 | 2 | chembl:CHEMBL539934 | 1\n",
      "mycophenolate mofetil | 4 | rxcui:68149 | 3\n",
      "mmf | 4 | rxcui:1546433 | 1\n",
      "saline | 2 | ncit:C821 | 1\n",
      "muplestim | 3 | ncit:C174613 | 1\n",
      "interleukin-3 | 3 | rxcui:1311225 | 2\n",
      "cdc-801 | 3 | drugbank:DB15640 | 1\n",
      "cc-1088 | 3 | ncit:C2210 | 2\n",
      "bl22 | 3 | chembl:CHEMBL2109352 | 1\n",
      "cat-3888 | 3 | ncit:C1842 | 1\n",
      "cx516 | 3 | drugbank:DB06247 | 2\n",
      "cx-516 | 3 | iuphar.ligand:4165 | 1\n",
      "glucose-6-phosphate | 2 | rxcui:1541246 | 1\n",
      "chembl:chembl257975 | 2 | chembl:CHEMBL257975 | 1\n",
      "chembl:chembl35482 | 3 | iuphar.ligand:5241 | 1\n",
      "pd-98059 | 3 | ncit:C1625 | 2\n",
      "raseglurant | 4 | ncit:C152157 | 2\n",
      "adx10059 | 4 | drugbank:DB05070 | 2\n",
      "ucb-1184197 | 2 | chembl:CHEMBL4297363 | 1\n",
      "cdp323 | 2 | drugbank:DB05092 | 1\n",
      "int131 | 3 | chembl:CHEMBL1236924 | 2\n",
      "amg-131 | 3 | drugbank:DB05490 | 1\n",
      "ardenermin | 2 | ncit:C171895 | 1\n",
      "baff | 2 | iuphar.ligand:5069 | 1\n",
      "lanabecestat | 4 | ncit:C170091 | 3\n",
      "azd3293 | 4 | chembl:CHEMBL3989948 | 1\n",
      "atabecestat | 3 | ncit:C166553 | 2\n",
      "jnj-54861911 | 3 | drugbank:DB15307 | 1\n",
      "ravidasvir | 3 | ncit:C152158 | 1\n",
      "c5a | 3 | iuphar.ligand:3576 | 1\n",
      "c5a des-arg | 3 | iuphar.ligand:574 | 1\n",
      "ema401 | 3 | iuphar.ligand:8374 | 2\n",
      "ema-401 | 3 | iuphar.ligand:8374 | 2\n",
      "olodanrigan | 3 | ncit:C174823 | 1\n",
      "jnj-28312141 | 2 | iuphar.ligand:5689 | 1\n",
      "chembl:chembl1908395 | 2 | chembl:CHEMBL1908395 | 1\n",
      "tbo-filgrastim | 10 | rxcui:1433764 | 8\n",
      "g-csf | 10 | rxcui:70167 | 3\n",
      "filgrastim-sndz | 10 | rxcui:1433764 | 8\n",
      "filgrastim | 10 | rxcui:1433764 | 8\n",
      "sgn-75 | 2 | chembl:CHEMBL2108672 | 1\n",
      "vorsetuzumab mafodotin | 2 | ncit:C88315 | 1\n",
      "biib-021 | 3 | ncit:C62517 | 1\n",
      "biib021 | 3 | drugbank:DB12359 | 2\n",
      "ly-2874455 | 5 | drugbank:DB13022 | 2\n",
      "ly2874455 | 5 | iuphar.ligand:8104 | 3\n",
      "tpa023 | 2 | iuphar.ligand:4327 | 1\n",
      "mk-0777 | 2 | drugbank:DB12238 | 1\n",
      "adp-597 | 2 | drugbank:DB12084 | 1\n",
      "jnj-38431055 | 2 | iuphar.ligand:5727 | 1\n",
      "mk5108 | 6 | ncit:C90585 | 2\n",
      "mk-5108 | 6 | drugbank:DB12556 | 4\n",
      "gsk2586184 | 4 | iuphar.ligand:9697 | 1\n",
      "solcitinib | 4 | ncit:C152385 | 3\n",
      "chembl:chembl2062804 | 2 | chembl:CHEMBL2062804 | 1\n",
      "cep-33779 | 2 | iuphar.ligand:9387 | 1\n",
      "e-6201 | 5 | drugbank:DB11687 | 2\n",
      "e6201 | 5 | iuphar.ligand:7836 | 3\n",
      "etrasimod | 3 | ncit:C166965 | 2\n",
      "apd-334 | 3 | drugbank:DB14766 | 1\n",
      "r-406 | 3 | iuphar.ligand:5706 | 1\n",
      "tamatinib | 3 | drugbank:DB07159 | 2\n",
      "gnf-pf-1919 | 2 | iuphar.ligand:8482 | 1\n",
      "chembl:chembl576409 | 2 | chembl:CHEMBL576409 | 1\n",
      "pentamidine diisethionate | 2 | chembl:CHEMBL361506 | 1\n",
      "dibromotyrosine | 2 | drugbank:DB07637 | 1\n",
      "las101057 | 3 | chembl:CHEMBL1672627 | 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "echinacea, unspecified | 2 | chembl:CHEMBL4297943 | 1\n",
      "echinacea | 2 | rxcui:228041 | 1\n",
      "ppl-100 | 3 | drugbank:DB05961 | 2\n",
      "tmb-607 | 3 | chembl:CHEMBL168640 | 1\n",
      "(s)-3,5-dihydroxyphenylglycine | 2 | drugbank:DB04228 | 1\n",
      "chembl:chembl39221 | 2 | chembl:CHEMBL39221 | 1\n",
      "chembl:chembl1794051 | 3 | chembl:CHEMBL1794051 | 1\n",
      "azd7009 | 3 | chembl:CHEMBL3545040 | 2\n",
      "chembl:chembl600360 | 2 | chembl:CHEMBL600360 | 1\n",
      "gnf-pf-5029 | 2 | chembl:CHEMBL1198140 | 1\n",
      "mk-886 | 2 | drugbank:DB16739 | 1\n",
      "chembl:chembl29097 | 2 | iuphar.ligand:2655 | 1\n",
      "atl-313 | 3 | drugbank:DB12295 | 1\n",
      "evodenoson | 3 | ncit:C169974 | 2\n",
      "aclidinium bromide | 3 | rxcui:1303097 | 2\n",
      "denufosol tetrasodium | 3 | ncit:C171672 | 2\n",
      "ins-37217 | 3 | chembl:CHEMBL1767407 | 1\n",
      "hexamethyl pararosaniline | 2 | chembl:CHEMBL459265 | 1\n",
      "ispaghula | 3 | rxcui:104129 | 2\n",
      "psyllium | 3 | rxcui:104129 | 2\n",
      "psyllium seed husks | 3 | wikidata:Q430675 | 1\n",
      "chembl:chembl1222035 | 2 | chembl:CHEMBL1222035 | 1\n",
      "ici-164384 | 2 | drugbank:DB03860 | 1\n",
      "alx1-11 | 3 | chembl:CHEMBL2108078 | 1\n",
      "prt-201 | 3 | chembl:CHEMBL3545070 | 1\n",
      "vonapanitase | 3 | ncit:C152909 | 2\n",
      "chembl:chembl1256998 | 2 | chembl:CHEMBL1256998 | 1\n",
      "bibt986 | 2 | chembl:CHEMBL1270156 | 1\n",
      "tanogitran | 2 | ncit:C90705 | 1\n",
      "ro-5126766 | 4 | chembl:CHEMBL3264002 | 1\n",
      "rg-7304 | 4 | chembl:CHEMBL3545081 | 3\n",
      "idecabtagene vicleucel | 2 | rxcui:2536430 | 1\n",
      "bb2121 | 2 | ncit:C117729 | 1\n",
      "lenzilumab | 4 | ncit:C125081 | 2\n",
      "kb-003 | 4 | iuphar.ligand:8935 | 2\n",
      "pf-04965842 | 4 | drugbank:DB14973 | 2\n",
      "abrocitinib | 4 | ncit:C166985 | 2\n",
      "pan-90806 | 6 | iuphar.ligand:7881 | 4\n",
      "osi-632 | 6 | iuphar.ligand:7881 | 4\n",
      "cp-547632 | 6 | ncit:C93263 | 2\n",
      "abt-308 | 2 | chembl:CHEMBL4297864 | 1\n",
      "cendakimab | 2 | ncit:C174792 | 1\n",
      "tilsotolimod | 2 | ncit:C152632 | 1\n",
      "imo-2125 | 2 | ncit:C125080 | 1\n",
      "dm-choc-pen | 2 | ncit:C90539 | 1\n",
      "4-demethyl-4-cholesteryloxycarbonylpenclomedine | 2 | drugbank:DB15075 | 1\n",
      "gsk461364 | 7 | ncit:C70948 | 4\n",
      "gsk-461364 | 7 | iuphar.ligand:5684 | 3\n",
      "gsk-461364a | 7 | iuphar.ligand:5684 | 3\n",
      "hypericum | 2 | chembl:CHEMBL2108102 | 1\n",
      "st. john's wort | 2 | rxcui:1310069 | 1\n",
      "bamosiran | 3 | ncit:C171793 | 1\n",
      "syl040012 | 3 | chembl:CHEMBL4298113 | 2\n",
      "syl-040012 | 3 | chembl:CHEMBL4298113 | 2\n",
      "linaprazan | 2 | ncit:C82307 | 1\n",
      "azd-0865 | 2 | chembl:CHEMBL497011 | 1\n",
      "chembl:chembl319118 | 2 | chembl:CHEMBL319118 | 1\n",
      "cp-122721 | 2 | drugbank:DB05421 | 1\n",
      "nrx195183 | 3 | chembl:CHEMBL107430 | 2\n",
      "irx-5183 | 3 | drugbank:DB05653 | 1\n",
      "e5555 | 4 | drugbank:DB12046 | 1\n",
      "atopaxar | 4 | ncit:C169794 | 3\n",
      "atx08-001 | 3 | chembl:CHEMBL3545278 | 2\n",
      "fk-614 | 3 | drugbank:DB12557 | 1\n",
      "pol6326 | 3 | chembl:CHEMBL3545105 | 2\n",
      "rep8839 | 2 | drugbank:DB05224 | 1\n",
      "bederocin | 2 | ncit:C77580 | 1\n",
      "cpl-7075 | 3 | drugbank:DB12193 | 1\n",
      "lenabasum | 3 | ncit:C174799 | 2\n",
      "poly-iclc | 2 | ncit:C1198 | 1\n",
      "hiltonol | 2 | chembl:CHEMBL4297559 | 1\n",
      "regrelor disodium | 4 | ncit:C80841 | 2\n",
      "a-582941 | 2 | iuphar.ligand:3995 | 1\n",
      "chembl:chembl526281 | 2 | chembl:CHEMBL526281 | 1\n",
      "ly-2811376 | 3 | drugbank:DB13065 | 2\n",
      "ly2811376 | 3 | iuphar.ligand:6936 | 1\n",
      "va-106483 | 2 | chembl:CHEMBL518043 | 1\n",
      "fedovapagon | 2 | ncit:C169975 | 1\n",
      "gsk233705 | 2 | chembl:CHEMBL2308782 | 1\n",
      "chembl:chembl506495 | 2 | chembl:CHEMBL506495 | 1\n",
      "gal-b5 | 2 | iuphar.ligand:6107 | 1\n",
      "tro-19622 | 3 | iuphar.ligand:8542 | 1\n",
      "olesoxime | 3 | ncit:C174604 | 2\n",
      "mk-5442 | 2 | chembl:CHEMBL2105731 | 1\n",
      "encaleret sulfate | 2 | ncit:C167017 | 1\n",
      "elnd005 | 3 | ncit:C122987 | 2\n",
      "scyllitol | 3 | ncit:C122987 | 2\n",
      "sofituzumab vedotin | 2 | ncit:C106119 | 1\n",
      "dmuc-5754a | 2 | chembl:CHEMBL3545372 | 1\n",
      "e6005 | 2 | chembl:CHEMBL3989967 | 1\n",
      "lotamilast | 2 | ncit:C170131 | 1\n",
      "ly-2456302 | 3 | drugbank:DB12341 | 2\n",
      "ly2456302 | 3 | drugbank:DB12341 | 2\n",
      "aticaprant | 3 | ncit:C170144 | 1\n",
      "sym-004 | 2 | chembl:CHEMBL2109388 | 1\n",
      "futuximab | 2 | ncit:C152971 | 1\n",
      "chembl:chembl2052019 | 2 | chembl:CHEMBL2052019 | 1\n",
      "zd-7288 | 2 | iuphar.ligand:2359 | 1\n",
      "selepressin | 3 | ncit:C152319 | 2\n",
      "fe-202158 | 3 | drugbank:DB12495 | 1\n",
      "as-902330 | 2 | chembl:CHEMBL2108302 | 1\n",
      "sprifermin | 2 | ncit:C152422 | 1\n",
      "ronopterin | 2 | ncit:C152249 | 1\n",
      "vas-203 | 2 | chembl:CHEMBL1230245 | 1\n",
      "mavatrep | 3 | ncit:C170153 | 2\n",
      "jnj-39439335 | 3 | chembl:CHEMBL2364618 | 1\n",
      "gsk-2245035 | 3 | chembl:CHEMBL4297492 | 1\n",
      "gsk2245035 | 3 | drugbank:DB16076 | 2\n",
      "vapreotide acetate | 2 | ncit:C95320 | 1\n",
      "octastatin | 2 | chembl:CHEMBL2218872 | 1\n",
      "chlorotoxin | 2 | drugbank:DB15210 | 1\n",
      "tm-601 | 2 | chembl:CHEMBL4298122 | 1\n",
      "azd-4877 | 4 | drugbank:DB11671 | 2\n",
      "azd4877 | 4 | iuphar.ligand:7708 | 2\n",
      "thiourea, n-(5-bromo-2-pyridinyl)-n'-(2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl)- | 2 | chembl:CHEMBL398891 | 1\n",
      "pt-112 | 2 | ncit:C121375 | 1\n",
      "incb9471 | 3 | chembl:CHEMBL1688243 | 1\n",
      "incb-9471 | 3 | drugbank:DB12960 | 2\n",
      "gedivumab | 2 | ncit:C166943 | 1\n",
      "rg7745 | 2 | chembl:CHEMBL4298040 | 1\n",
      "somavaratan | 2 | ncit:C152398 | 1\n",
      "vrs-317 | 2 | chembl:CHEMBL3707323 | 1\n",
      "lomibuvir | 2 | ncit:C166650 | 1\n",
      "vx-222 | 2 | chembl:CHEMBL3039503 | 1\n",
      "n-sulfoglucosamine sulfohydrolase recombinant | 2 | drugbank:DB12722 | 1\n",
      "hgt-1410 | 2 | chembl:CHEMBL4297976 | 1\n",
      "instiladrin | 2 | chembl:CHEMBL3990041 | 1\n",
      "nadofaragene firadenovec | 2 | ncit:C71011 | 1\n",
      "qpi-1002 | 2 | chembl:CHEMBL4297574 | 1\n",
      "teprasiran | 2 | ncit:C152565 | 1\n",
      "ly2584702 | 4 | iuphar.ligand:8248 | 1\n",
      "ly-2584702 | 4 | drugbank:DB12690 | 3\n",
      "chembl:chembl112750 | 2 | chembl:CHEMBL112750 | 1\n",
      "beta-acetyldigoxin | 2 | chembl:CHEMBL2074725 | 1\n",
      "ct-1578 | 4 | chembl:CHEMBL3544962 | 3\n",
      "sb-1578 | 4 | drugbank:DB15294 | 1\n",
      "gw274150 | 3 | iuphar.ligand:9849 | 2\n",
      "gw-274150 | 3 | drugbank:DB12237 | 1\n",
      "trelagliptin | 2 | ncit:C152723 | 1\n",
      "syr-472 | 2 | chembl:CHEMBL1650443 | 1\n",
      "sch-900776 | 4 | chembl:CHEMBL2386889 | 3\n",
      "mk-8776 | 4 | drugbank:DB11899 | 1\n",
      "alirocumab | 6 | rxcui:1659152 | 5\n",
      "regn727 | 6 | iuphar.ligand:6744 | 1\n",
      "regn-727 | 6 | rxcui:1659152 | 5\n",
      "eflornithine hydrochloride | 2 | rxcui:81945 | 1\n",
      "trabodenoson | 4 | ncit:C152705 | 2\n",
      "ino-8875 | 4 | chembl:CHEMBL3545407 | 2\n",
      "sb-262470 | 3 | iuphar.ligand:716 | 2\n",
      "chembl:chembl180672 | 3 | iuphar.ligand:716 | 2\n",
      "nps-2143 | 3 | drugbank:DB05695 | 1\n",
      "krp-203 | 3 | ncit:C106368 | 1\n",
      "krp203 | 3 | chembl:CHEMBL3545101 | 2\n",
      "arc-239 | 2 | iuphar.ligand:524 | 1\n",
      "chembl:chembl362051 | 2 | chembl:CHEMBL362051 | 1\n",
      "vatiquinone | 3 | ncit:C152840 | 2\n",
      "epi-743 | 3 | chembl:CHEMBL1812161 | 1\n",
      "ganitumab | 6 | ncit:C71531 | 4\n",
      "amg-479 | 6 | chembl:CHEMBL1743024 | 2\n",
      "rabacfosadine | 2 | rxcui:2003595 | 1\n",
      "gs-9219 | 2 | chembl:CHEMBL1823518 | 1\n",
      "nvp-auy922 | 5 | iuphar.ligand:9261 | 2\n",
      "luminespib | 5 | ncit:C71467 | 3\n",
      "ly2979165 | 3 | chembl:CHEMBL3544939 | 2\n",
      "pevonedistat | 4 | ncit:C77906 | 3\n",
      "mln-4924 | 4 | chembl:CHEMBL1231160 | 1\n",
      "spebrutinib besylate | 4 | ncit:C141425 | 2\n",
      "recilisib | 3 | ncit:C152168 | 2\n",
      "udp-glucose | 2 | iuphar.ligand:1783 | 1\n",
      "uridine diphosphate glucose | 2 | drugbank:DB01861 | 1\n",
      "pafuramidine maleate | 2 | ncit:C81703 | 1\n",
      "cnto-1959 | 3 | iuphar.ligand:7998 | 1\n",
      "guselkumab | 3 | rxcui:1928588 | 2\n",
      "etoposide phosphate | 3 | rxcui:24614 | 2\n",
      "ly-2623091 | 3 | drugbank:DB15367 | 1\n",
      "ly2623091 | 3 | chembl:CHEMBL3545275 | 2\n",
      "botulinum toxin type a purified neurotoxin complex | 2 | chembl:CHEMBL1201574 | 1\n",
      "e7090 | 2 | ncit:C118672 | 1\n",
      "e-7090 | 2 | iuphar.ligand:11414 | 1\n",
      "ro-5045337 | 5 | drugbank:DB14793 | 4\n",
      "ro5045337 | 5 | ncit:C91724 | 1\n",
      "rg7112 | 5 | drugbank:DB14793 | 4\n",
      "gsk2941266 | 6 | chembl:CHEMBL3545404 | 1\n",
      "ccx354 | 6 | iuphar.ligand:10164 | 4\n",
      "ccx-354 | 6 | drugbank:DB12963 | 1\n",
      "gefapixant | 5 | ncit:C166945 | 3\n",
      "af-219 | 5 | iuphar.ligand:9540 | 2\n",
      "lithium citrate | 2 | rxcui:52105 | 1\n",
      "codeine phosphate | 2 | rxcui:2672 | 1\n",
      "codeine phosphate hydrate | 2 | chembl:CHEMBL1201099 | 1\n",
      "reolysin | 5 | chembl:CHEMBL3545069 | 4\n",
      "pelareorep | 5 | ncit:C60774 | 1\n",
      "chembl:chembl3397300 | 6 | chembl:CHEMBL3397300 | 1\n",
      "volanesorsen sodium | 2 | ncit:C152905 | 1\n",
      "albumin human | 2 | rxcui:2054166 | 1\n",
      "albumin | 2 | chembl:CHEMBL1201451 | 1\n",
      "chembl:chembl1743358 | 2 | chembl:CHEMBL1743358 | 1\n",
      "4-ipomeanol | 2 | ncit:C976 | 1\n",
      "td-1792 | 2 | chembl:CHEMBL4297645 | 1\n",
      "cefilavancin | 2 | ncit:C169833 | 1\n",
      "chembl:chembl1236539 | 2 | iuphar.ligand:7907 | 1\n",
      "7-hydroxystaurosporine | 2 | ncit:C1271 | 1\n",
      "forskolin | 3 | drugbank:DB02587 | 1\n",
      "colforsin | 3 | ncit:C166496 | 2\n",
      "agi-1067 | 2 | chembl:CHEMBL83626 | 1\n",
      "succinobucol | 2 | ncit:C75299 | 1\n",
      "osi-461 | 2 | drugbank:DB05415 | 1\n",
      "ly2886721 | 3 | iuphar.ligand:6475 | 2\n",
      "ly-2886721 | 3 | drugbank:DB12547 | 1\n",
      "corticotropin-releasing factor | 3 | iuphar.ligand:913 | 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "corticotropin releasing hormone | 3 | wikidata:Q386664 | 1\n",
      "corticotrophin-releasing hormone | 3 | iuphar.ligand:912 | 1\n",
      "qav-680 | 4 | drugbank:DB11658 | 1\n",
      "qav680 | 4 | iuphar.ligand:8996 | 3\n",
      "bq123 | 3 | iuphar.ligand:997 | 1\n",
      "bq-123 | 3 | drugbank:DB12054 | 2\n",
      "ljn452 | 3 | drugbank:DB16343 | 1\n",
      "tropifexor | 3 | ncit:C152764 | 2\n",
      "glpg-0974 | 3 | drugbank:DB15406 | 1\n",
      "glpg0974 | 3 | iuphar.ligand:8417 | 2\n",
      "glpg-1205 | 2 | drugbank:DB15346 | 1\n",
      "glpg1205 | 2 | iuphar.ligand:10171 | 1\n",
      "ly-2875358 | 5 | iuphar.ligand:7748 | 1\n",
      "emibetuzumab | 5 | ncit:C95732 | 4\n",
      "jnj-40411813 | 4 | drugbank:DB12059 | 3\n",
      "adx-71149 | 4 | iuphar.ligand:8946 | 1\n",
      "gsk1521498 | 3 | iuphar.ligand:9287 | 2\n",
      "gsk-1521498 | 3 | drugbank:DB12886 | 1\n",
      "bradanicline | 5 | ncit:C169814 | 4\n",
      "tc-5619 | 5 | drugbank:DB06090 | 1\n",
      "abt-299 | 2 | iuphar.ligand:1849 | 1\n",
      "chembl:chembl317090 | 2 | chembl:CHEMBL317090 | 1\n",
      "azd6482 | 4 | iuphar.ligand:8059 | 2\n",
      "azd-6482 | 4 | drugbank:DB14980 | 2\n",
      "somatostatin | 3 | rxcui:9939 | 2\n",
      "srif-14 | 3 | iuphar.ligand:2019 | 1\n",
      "rwj-56423 | 2 | drugbank:DB02812 | 1\n",
      "chembl:chembl256892 | 2 | iuphar.ligand:9333 | 1\n",
      "chembl:chembl2392553 | 2 | iuphar.ligand:9403 | 1\n",
      "chembl:chembl467987 | 2 | chembl:CHEMBL467987 | 1\n",
      "2-hydroxyestradiol | 2 | ncit:C120474 | 1\n",
      "di17e6 | 3 | chembl:CHEMBL2109621 | 1\n",
      "abituzumab | 3 | ncit:C82422 | 2\n",
      "p-phenylenediamine | 2 | rxcui:1362740 | 1\n",
      "chembl:chembl403741 | 2 | chembl:CHEMBL403741 | 1\n",
      "chembl:chembl329040 | 2 | chembl:CHEMBL329040 | 1\n",
      "carbenoxolone sodium | 2 | rxcui:2018 | 1\n",
      "carbenoxolone disodium | 2 | chembl:CHEMBL1697717 | 1\n",
      "chembl:chembl488910 | 2 | chembl:CHEMBL488910 | 1\n",
      "ko-143 | 2 | iuphar.ligand:10007 | 1\n",
      "sar-566658 | 3 | chembl:CHEMBL2109635 | 2\n",
      "sar566658 | 3 | ncit:C95764 | 1\n",
      "azd9496 | 3 | ncit:C122834 | 2\n",
      "azd-9496 | 3 | drugbank:DB15138 | 1\n",
      "alx-101 | 3 | iuphar.ligand:9625 | 1\n",
      "rovazolac | 3 | ncit:C152263 | 2\n",
      "sar-156597 | 2 | chembl:CHEMBL4298097 | 1\n",
      "romilkimab | 2 | ncit:C174791 | 1\n",
      "apx005m | 2 | ncit:C123734 | 1\n",
      "apx-005m | 2 | chembl:CHEMBL4297888 | 1\n",
      "8h9 | 2 | ncit:C170251 | 1\n",
      "8h9 131i | 2 | chembl:CHEMBL2109310 | 1\n",
      "carmoterol | 4 | ncit:C171749 | 3\n",
      "ta-2005 | 4 | drugbank:DB15784 | 1\n",
      "sergliflozin etabonate | 2 | ncit:C78129 | 1\n",
      "sergliflozin | 2 | iuphar.ligand:4587 | 1\n",
      "trevogrumab | 2 | ncit:C152733 | 1\n",
      "sar391786 | 2 | iuphar.ligand:8929 | 1\n",
      "pf-04191834 | 3 | iuphar.ligand:9054 | 1\n",
      "pf-4191834 | 3 | drugbank:DB11645 | 2\n",
      "chembl:chembl442494 | 3 | chembl:CHEMBL442494 | 1\n",
      "srif-28 | 3 | iuphar.ligand:2020 | 2\n",
      "drisapersen | 3 | ncit:C166984 | 2\n",
      "gsk2402968 | 3 | chembl:CHEMBL2108735 | 1\n",
      "glassia | 2 | rxcui:535 | 1\n",
      ".alpha.1-proteinase inhibitor human | 2 | chembl:CHEMBL4297879 | 1\n",
      "sq-109 | 3 | drugbank:DB05186 | 2\n",
      "sq109 | 3 | iuphar.ligand:7997 | 1\n",
      "cx1739 | 3 | chembl:CHEMBL3707399 | 2\n",
      "mk-0731 | 2 | drugbank:DB08037 | 1\n",
      "chembl:chembl481931 | 2 | chembl:CHEMBL481931 | 1\n",
      "gsk249320 | 2 | chembl:CHEMBL3545317 | 1\n",
      "refanezumab | 2 | ncit:C152172 | 1\n",
      "technetium tc-99m trofolastat chloride | 2 | ncit:C152532 | 1\n",
      "99mtc-mip-1404 | 2 | ncit:C116887 | 1\n",
      "rg-7603 | 3 | chembl:CHEMBL2331680 | 2\n",
      "gdc-0349 | 3 | drugbank:DB13072 | 1\n",
      "brazikumab | 2 | ncit:C166795 | 1\n",
      "amg-139 | 2 | iuphar.ligand:9293 | 1\n",
      "medi3902 | 2 | chembl:CHEMBL4298031 | 1\n",
      "gremubamab | 2 | ncit:C166690 | 1\n",
      "tanzisertib | 4 | ncit:C152510 | 3\n",
      "cc-930 | 4 | drugbank:DB11798 | 1\n",
      "adomeglivant | 3 | ncit:C166989 | 2\n",
      "ly-2409021 | 3 | chembl:CHEMBL3707351 | 1\n",
      "emi-137 | 2 | chembl:CHEMBL4297745 | 1\n",
      "ge-137 | 2 | iuphar.ligand:8585 | 1\n",
      "galicaftor | 2 | ncit:C170018 | 1\n",
      "abbv-2222 | 2 | chembl:CHEMBL4101487 | 1\n",
      "tavilermide | 3 | ncit:C174759 | 1\n",
      "mim-d3 | 3 | chembl:CHEMBL3544981 | 2\n",
      "sr16234 | 3 | chembl:CHEMBL3545210 | 2\n",
      "tas-108 | 3 | drugbank:DB05966 | 1\n",
      "phe377 | 3 | chembl:CHEMBL3545148 | 2\n",
      "lorecivivint | 3 | ncit:C166713 | 2\n",
      "sm-04690 | 3 | chembl:CHEMBL4297639 | 1\n",
      "scy-641 | 2 | chembl:CHEMBL3707272 | 1\n",
      "ruclosporin | 2 | ncit:C152272 | 1\n",
      "azd2624 | 4 | drugbank:DB11692 | 2\n",
      "azd4901 | 4 | drugbank:DB11692 | 2\n",
      "pavinetant | 4 | ncit:C166698 | 2\n",
      "lisocabtagene maraleucel | 2 | rxcui:2479136 | 1\n",
      "jcar017 | 2 | ncit:C125192 | 1\n",
      "chembl:chembl414640 | 2 | chembl:CHEMBL414640 | 1\n",
      "kni-272 | 2 | ncit:C29140 | 1\n",
      "deldeprevir | 2 | ncit:C166876 | 1\n",
      "ach-2684 | 2 | chembl:CHEMBL3040582 | 1\n",
      "bi-836845 | 3 | chembl:CHEMBL4297850 | 1\n",
      "xentuzumab | 3 | ncit:C106118 | 2\n",
      "gsk1292263 | 2 | chembl:CHEMBL3187503 | 1\n",
      "gsk-1292263 | 2 | drugbank:DB12627 | 1\n",
      "guaiacol hydrochloride | 2 | chembl:CHEMBL224145 | 1\n",
      "pixykine | 2 | chembl:CHEMBL2108438 | 1\n",
      "milodistim | 2 | ncit:C1477 | 1\n",
      "t3d-959 | 4 | chembl:CHEMBL3545176 | 3\n",
      "db959 | 4 | chembl:CHEMBL3545176 | 3\n",
      "ag-024322 | 3 | ncit:C52182 | 1\n",
      "ag-24322 | 3 | drugbank:DB13035 | 2\n",
      "mrs-2179 | 2 | iuphar.ligand:1720 | 1\n",
      "chembl:chembl129841 | 2 | chembl:CHEMBL129841 | 1\n",
      "lx3305 | 4 | iuphar.ligand:9851 | 3\n",
      "lx2931 | 4 | iuphar.ligand:9851 | 3\n",
      "lx-2931 | 4 | drugbank:DB06297 | 1\n",
      "rg7935 | 2 | chembl:CHEMBL4298077 | 1\n",
      "prasinezumab | 2 | ncit:C174831 | 1\n",
      "huhmfg1 | 4 | chembl:CHEMBL2109637 | 2\n",
      "as1402 | 4 | ncit:C38697 | 1\n",
      "as-1402 | 4 | chembl:CHEMBL2108341 | 1\n",
      "xl-765 | 6 | ncit:C71704 | 5\n",
      "sar245409 | 6 | ncit:C71704 | 5\n",
      "voxtalisib | 6 | ncit:C71704 | 5\n",
      "xl765 | 6 | drugbank:DB05241 | 1\n",
      "serelaxin | 3 | ncit:C152342 | 2\n",
      "rlx030 | 3 | chembl:CHEMBL2108358 | 1\n",
      "estrogens | 2 | rxcui:4100 | 1\n",
      "estrone sodium sulfate | 2 | ncit:C61942 | 1\n",
      "ac0010ma | 2 | ncit:C118671 | 1\n",
      "abivertinib maleate | 2 | ncit:C169756 | 1\n",
      "pyy3-36 | 2 | drugbank:DB05004 | 1\n",
      "peptide yy human (3-36) | 2 | chembl:CHEMBL4297971 | 1\n",
      "azd-1480 | 7 | drugbank:DB12588 | 3\n",
      "azd1480 | 7 | iuphar.ligand:5933 | 4\n",
      "mk3207 | 3 | chembl:CHEMBL1910936 | 2\n",
      "mk-3207 | 3 | drugbank:DB12424 | 1\n",
      "norepinephrine bitartrate | 4 | rxcui:7508 | 1\n",
      "noradrenaline | 4 | iuphar.ligand:484 | 3\n",
      "hcg | 3 | iuphar.ligand:1160 | 1\n",
      "choriogonadotropin alfa | 3 | rxcui:283550 | 2\n",
      "valbenazine tosylate | 3 | rxcui:1923002 | 1\n",
      "sar-405838 | 3 | drugbank:DB12541 | 2\n",
      "sar405838 | 3 | ncit:C106120 | 1\n",
      "verucerfont | 4 | ncit:C152869 | 3\n",
      "gsk561679 | 4 | drugbank:DB12512 | 1\n",
      "abt-761 | 3 | ncit:C64176 | 2\n",
      "atreleuton | 3 | ncit:C64176 | 2\n",
      "via-2291 | 3 | chembl:CHEMBL59356 | 1\n",
      "tofogliflozin | 4 | ncit:C152675 | 2\n",
      "ro-4998452 | 4 | chembl:CHEMBL2105711 | 2\n",
      "tofogliflozin hydrate | 4 | chembl:CHEMBL2105711 | 2\n",
      "mor-103 | 5 | iuphar.ligand:11132 | 2\n",
      "otilimab | 5 | ncit:C170271 | 3\n",
      "gsk3196165 | 5 | ncit:C170271 | 3\n",
      "mor103 | 5 | ncit:C170271 | 3\n",
      "defactinib | 3 | ncit:C79809 | 2\n",
      "pratosartan | 4 | ncit:C72935 | 3\n",
      "resatorvid | 4 | ncit:C87682 | 3\n",
      "tak-242 | 4 | iuphar.ligand:9036 | 1\n",
      "tak-779 | 3 | iuphar.ligand:783 | 2\n",
      "chembl:chembl41275 | 3 | chembl:CHEMBL41275 | 1\n",
      "ave-1625 | 3 | drugbank:DB05750 | 1\n",
      "drinabant | 3 | ncit:C166890 | 2\n",
      "litronesib | 3 | ncit:C88328 | 2\n",
      "ly-2523355 | 3 | chembl:CHEMBL2105661 | 1\n",
      "agatolimod | 4 | ncit:C166862 | 2\n",
      "cipargamin | 3 | ncit:C169853 | 1\n",
      "nitd609 | 3 | drugbank:DB12306 | 2\n",
      "kae609 | 3 | drugbank:DB12306 | 2\n",
      "diacetylmorphine | 2 | ncit:C424 | 1\n",
      "heroin | 2 | rxcui:3304 | 1\n",
      "azd-3839 | 3 | drugbank:DB12368 | 2\n",
      "azd3839 | 3 | iuphar.ligand:6931 | 1\n",
      "chembl:chembl1084513 | 2 | chembl:CHEMBL1084513 | 1\n",
      "sb-423562 | 2 | iuphar.ligand:9476 | 1\n",
      "skf-83959 | 3 | iuphar.ligand:8443 | 2\n",
      "chembl:chembl520992 | 3 | chembl:CHEMBL520992 | 1\n",
      "azd1656 | 3 | iuphar.ligand:7701 | 2\n",
      "azd-1656 | 3 | drugbank:DB14810 | 1\n",
      "rosiptor | 3 | ncit:C152258 | 2\n",
      "aqx-1125 | 3 | drugbank:DB13012 | 1\n",
      "srt2104 | 2 | iuphar.ligand:9515 | 1\n",
      "srt-2104 | 2 | drugbank:DB12186 | 1\n",
      "chembl:chembl2448578 | 2 | chembl:CHEMBL2448578 | 1\n",
      "sq-29548 | 2 | iuphar.ligand:1980 | 1\n",
      "sanguinarium | 3 | ncit:C81358 | 2\n",
      "sanguinarine | 3 | rxcui:1537755 | 1\n",
      "pd-123319 | 2 | iuphar.ligand:597 | 1\n",
      "chembl:chembl157946 | 2 | chembl:CHEMBL157946 | 1\n",
      "l-733060 | 2 | chembl:CHEMBL1256740 | 1\n",
      "chembl:chembl27006 | 2 | chembl:CHEMBL27006 | 1\n",
      "alphaprodine hydrochloride | 2 | rxcui:7433 | 1\n",
      "chembl:chembl287327 | 2 | chembl:CHEMBL287327 | 1\n",
      "l-689560 | 2 | iuphar.ligand:4239 | 1\n",
      "2x-121 | 4 | drugbank:DB16063 | 2\n",
      "e7449 | 4 | ncit:C102746 | 2\n",
      "mibg | 3 | rxcui:14448 | 1\n",
      "iobenguane | 3 | ncit:C87757 | 2\n",
      "chembl:chembl174588 | 2 | chembl:CHEMBL174588 | 1\n",
      "jnj-16259685 | 2 | iuphar.ligand:1385 | 1\n",
      "gw7604 | 2 | chembl:CHEMBL1091137 | 1\n",
      "chembl:chembl195515 | 2 | chembl:CHEMBL195515 | 1\n",
      "chembl:chembl303336 | 2 | chembl:CHEMBL303336 | 1\n",
      "l-687384 | 2 | chembl:CHEMBL1256916 | 1\n",
      "chembl:chembl135561 | 2 | chembl:CHEMBL135561 | 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tenovin-6 | 2 | chembl:CHEMBL1945130 | 1\n",
      "chembl:chembl595354 | 2 | chembl:CHEMBL595354 | 1\n",
      "chembl:chembl2333445 | 2 | chembl:CHEMBL2333445 | 1\n",
      "skf-89976a | 2 | iuphar.ligand:4705 | 1\n",
      "chembl:chembl543557 | 2 | chembl:CHEMBL543557 | 1\n",
      "cpg-52852 | 2 | drugbank:DB12476 | 1\n",
      "pf-4878691 | 2 | iuphar.ligand:9025 | 1\n",
      "rg7596 | 3 | rxcui:2174090 | 2\n",
      "dcds-4501a | 3 | chembl:CHEMBL3301582 | 1\n",
      "polatuzumab vedotin | 3 | rxcui:2174090 | 2\n",
      "sjg-136 | 2 | drugbank:DB11965 | 1\n",
      "bn-2629 | 2 | chembl:CHEMBL16498 | 1\n",
      "ciluprevir | 2 | ncit:C76016 | 1\n",
      "biln-2061 | 2 | chembl:CHEMBL297884 | 1\n",
      "iowh-032 | 2 | drugbank:DB12959 | 1\n",
      "iowh032 | 2 | chembl:CHEMBL4297392 | 1\n",
      "aceneuramic acid | 2 | ncit:C80777 | 1\n",
      "ux-001 | 2 | chembl:CHEMBL152452 | 1\n",
      "chembl:chembl228043 | 2 | chembl:CHEMBL228043 | 1\n",
      "lfm-a13 | 2 | iuphar.ligand:9262 | 1\n",
      "mn-305 | 4 | drugbank:DB05339 | 2\n",
      "osemozotan | 4 | ncit:C91059 | 2\n",
      "evogliptin | 2 | ncit:C171769 | 1\n",
      "da-1229 | 2 | chembl:CHEMBL1779710 | 1\n",
      "sm101 | 3 | chembl:CHEMBL4298105 | 2\n",
      "sm-101 | 3 | chembl:CHEMBL4298105 | 2\n",
      "valziflocept | 3 | ncit:C152824 | 1\n",
      "liquirtigenin | 2 | chembl:CHEMBL252642 | 1\n",
      "liquiritigenin | 2 | iuphar.ligand:8899 | 1\n",
      "amenamevir | 2 | ncit:C90782 | 1\n",
      "asp-2151 | 2 | chembl:CHEMBL4297592 | 1\n",
      "latiglutenase | 2 | ncit:C175102 | 1\n",
      "alv-003 | 2 | chembl:CHEMBL3137344 | 1\n",
      "chembl:chembl456145 | 2 | iuphar.ligand:5784 | 1\n",
      "mk-0354 | 2 | drugbank:DB05939 | 1\n",
      "chembl:chembl104264 | 3 | drugbank:DB07995 | 2\n",
      "h-89 | 3 | drugbank:DB07995 | 2\n",
      "deoxycholic acid | 2 | rxcui:3194 | 1\n",
      "atx-101 | 2 | drugbank:DB05780 | 1\n",
      "pf-3463275 | 3 | iuphar.ligand:9057 | 1\n",
      "pf-03463275 | 3 | drugbank:DB11993 | 2\n",
      "epofolate | 2 | drugbank:DB12266 | 1\n",
      "bms-753493 | 2 | chembl:CHEMBL4297749 | 1\n",
      "apl-2 | 2 | ncit:C121135 | 1\n",
      "pegcetacoplan | 2 | rxcui:2557372 | 1\n",
      "blz-100 | 2 | chembl:CHEMBL3990023 | 1\n",
      "tozuleristide | 2 | drugbank:DB15375 | 1\n",
      "ciliary neurotrophic factor | 2 | drugbank:DB05344 | 1\n",
      "nt-501 | 2 | chembl:CHEMBL4298063 | 1\n",
      "dusquetide | 2 | ncit:C113437 | 1\n",
      "imx-942 | 2 | chembl:CHEMBL3545314 | 1\n",
      "smp-986 | 3 | chembl:CHEMBL3545165 | 1\n",
      "afacifenacin | 3 | ncit:C90741 | 2\n",
      "ppi-668 | 2 | chembl:CHEMBL3545312 | 1\n",
      "ravidasvir hydrochloride | 2 | ncit:C152159 | 1\n",
      "gsk961081 | 3 | chembl:CHEMBL3039518 | 1\n",
      "batefenterol | 3 | ncit:C166503 | 2\n",
      "fosfestrol | 3 | rxcui:25284 | 1\n",
      "diethylstilbestrol diphosphate | 3 | chembl:CHEMBL1200598 | 2\n",
      "gsk-2269557 | 3 | chembl:CHEMBL3545250 | 2\n",
      "gsk2269557 | 3 | drugbank:DB16253 | 1\n",
      "arc-19499 | 2 | drugbank:DB15285 | 1\n",
      "bax-499 | 2 | chembl:CHEMBL4297890 | 1\n",
      "ro-23-7553 | 3 | ncit:C1883 | 1\n",
      "ilx23-7553 | 3 | chembl:CHEMBL284121 | 2\n",
      "spd602 | 3 | chembl:CHEMBL487465 | 2\n",
      "fbs-0701 | 3 | chembl:CHEMBL487465 | 2\n",
      "deferitazole | 3 | ncit:C166753 | 1\n",
      "adl5945 | 3 | chembl:CHEMBL3039511 | 1\n",
      "bevenopran | 3 | ncit:C169810 | 2\n",
      "srx251 | 3 | chembl:CHEMBL3545146 | 2\n",
      "human fsh | 2 | chembl:CHEMBL1201692 | 1\n",
      "ritobegron | 4 | ncit:C87677 | 2\n",
      "kuc-7483 | 4 | chembl:CHEMBL2107773 | 2\n",
      "brilanestrant | 3 | ncit:C106235 | 2\n",
      "arn-810 | 3 | ncit:C106235 | 2\n",
      "gdc-0810 | 3 | drugbank:DB12253 | 1\n",
      "linzagolix | 3 | ncit:C148479 | 1\n",
      "klh-2109 | 3 | chembl:CHEMBL3668014 | 2\n",
      "suvn-502 | 3 | drugbank:DB06140 | 2\n",
      "masupirdine | 3 | ncit:C175121 | 1\n",
      "mabt5102a | 4 | iuphar.ligand:6934 | 1\n",
      "crenezumab | 4 | ncit:C174789 | 3\n",
      "gancotamab | 4 | ncit:C170020 | 1\n",
      "mm-302 | 4 | ncit:C96038 | 3\n",
      "azd3514 | 3 | chembl:CHEMBL2346976 | 2\n",
      "azd8055 | 6 | iuphar.ligand:7714 | 3\n",
      "azd-8055 | 6 | drugbank:DB12774 | 3\n",
      "sar260301 | 5 | iuphar.ligand:8793 | 3\n",
      "sar-260301 | 5 | chembl:CHEMBL3545008 | 2\n",
      "alpha-tocopherol | 2 | ncit:C74960 | 1\n",
      "myeloperoxidase | 2 | chembl:CHEMBL2107858 | 1\n",
      "diethyldithiocarbamate | 2 | rxcui:1427193 | 1\n",
      "ditiocarb | 2 | ncit:C432 | 1\n",
      "mannomustine | 2 | ncit:C2070 | 1\n",
      "bcm | 2 | chembl:CHEMBL460283 | 1\n",
      "bms-936564 | 4 | iuphar.ligand:9161 | 1\n",
      "ulocuplumab | 4 | ncit:C95755 | 3\n",
      "tetrasul | 2 | drugbank:DB12838 | 1\n",
      "v-101 | 2 | chembl:CHEMBL1365576 | 1\n",
      "osi-7904 | 2 | chembl:CHEMBL169896 | 1\n",
      "osi-7904l | 2 | drugbank:DB05457 | 1\n",
      "brl-52537 | 2 | chembl:CHEMBL1256835 | 1\n",
      "chembl:chembl71294 | 2 | chembl:CHEMBL71294 | 1\n",
      "nktr-181 | 4 | drugbank:DB14146 | 2\n",
      "oxycodegol | 4 | ncit:C170277 | 2\n",
      "4-hydroxytamoxifen | 2 | iuphar.ligand:2817 | 1\n",
      "ono-9054 | 3 | drugbank:DB12043 | 2\n",
      "sepetaprost | 3 | ncit:C152337 | 1\n",
      "chembl:chembl1257083 | 2 | chembl:CHEMBL1257083 | 1\n",
      "ro-84304 | 2 | iuphar.ligand:4300 | 1\n",
      "5-aminoisoquinoline | 2 | drugbank:DB04605 | 1\n",
      "chembl:chembl216973 | 2 | chembl:CHEMBL216973 | 1\n",
      "nastorazepide calcium | 2 | ncit:C61329 | 1\n",
      "z-360 | 2 | iuphar.ligand:907 | 1\n",
      "2,4,6-tribromophenol | 2 | drugbank:DB02417 | 1\n",
      "chembl:chembl220087 | 2 | chembl:CHEMBL220087 | 1\n",
      "cfg-920 | 2 | chembl:CHEMBL4297485 | 1\n",
      "cfg920 | 2 | ncit:C102855 | 1\n",
      "n'-(2-hydroxybenzylidene)isonicotinohydrazide | 2 | chembl:CHEMBL201761 | 1\n",
      "salinazid | 2 | ncit:C152288 | 1\n",
      "chembl:chembl1096339 | 2 | chembl:CHEMBL1096339 | 1\n",
      "4-(2-aminoethyl)benzenesulfonyl fluoride | 2 | drugbank:DB07347 | 1\n",
      "(s)-fluoxetine | 2 | drugbank:DB08544 | 1\n",
      "chembl:chembl1169388 | 2 | chembl:CHEMBL1169388 | 1\n",
      "chembl:chembl291143 | 2 | chembl:CHEMBL291143 | 1\n",
      "a-77636 | 2 | iuphar.ligand:9637 | 1\n",
      "adc3680 | 3 | chembl:CHEMBL3545343 | 2\n",
      "sar3419 | 4 | ncit:C71009 | 2\n",
      "coltuximab ravtansine | 4 | ncit:C71009 | 2\n",
      "sar-3419 | 4 | chembl:CHEMBL2109286 | 2\n",
      "gs-9620 | 2 | chembl:CHEMBL2424780 | 1\n",
      "vesatolimod | 2 | ncit:C152870 | 1\n",
      "talacotuzumab | 3 | ncit:C102784 | 2\n",
      "csl-362 | 3 | chembl:CHEMBL4297837 | 1\n",
      "cgp-74514a | 2 | iuphar.ligand:5945 | 1\n",
      "chembl:chembl1256911 | 2 | chembl:CHEMBL1256911 | 1\n",
      "frovocimab | 2 | ncit:C175068 | 1\n",
      "ly3015014 | 2 | chembl:CHEMBL4298016 | 1\n",
      "nic5-15 | 3 | chembl:CHEMBL493737 | 2\n",
      "methylinositol | 3 | rxcui:1435864 | 1\n",
      "biib-033 | 4 | iuphar.ligand:8923 | 1\n",
      "opicinumab | 4 | ncit:C170259 | 3\n",
      "gsk-2251052 | 2 | chembl:CHEMBL3549142 | 1\n",
      "epetraborole | 2 | ncit:C166950 | 1\n",
      "td-9855 | 2 | chembl:CHEMBL4297646 | 1\n",
      "ampreloxetine | 2 | ncit:C166483 | 1\n",
      "cfz533 | 3 | iuphar.ligand:9802 | 2\n",
      "iscalimab | 3 | ncit:C175096 | 1\n",
      "netarsudil dimesylate | 2 | chembl:CHEMBL4594251 | 1\n",
      "eti-204 | 2 | chembl:CHEMBL3544926 | 1\n",
      "obiltoxaximab | 2 | rxcui:1746906 | 1\n",
      "smt-c1100 | 2 | drugbank:DB12888 | 1\n",
      "ezutromid | 2 | ncit:C166897 | 1\n",
      "risuteganib | 2 | ncit:C166449 | 1\n",
      "alg-1001 | 2 | chembl:CHEMBL4297529 | 1\n",
      "chembl:chembl28324 | 2 | iuphar.ligand:4235 | 1\n",
      "kn-62 | 2 | iuphar.ligand:6001 | 1\n",
      "gc-1008 | 4 | chembl:CHEMBL1743022 | 1\n",
      "fresolimumab | 4 | ncit:C63546 | 3\n",
      "av-412 | 5 | drugbank:DB06021 | 2\n",
      "mp-412 | 5 | chembl:CHEMBL3545002 | 3\n",
      "guaiazulen | 2 | drugbank:DB13329 | 1\n",
      "guaiazulene | 2 | rxcui:26290 | 1\n",
      "2',3'-dideoxyadenosine | 2 | ncit:C429 | 1\n",
      "chembl:chembl23094 | 2 | chembl:CHEMBL23094 | 1\n",
      "chembl:chembl517186 | 2 | chembl:CHEMBL517186 | 1\n",
      "n-deacetylcolchiceine | 2 | ncit:C1264 | 1\n",
      "cetylpyridinium chloride hydrate | 2 | chembl:CHEMBL2003538 | 1\n",
      "setrusumab | 2 | ncit:C152352 | 1\n",
      "bps-804 | 2 | iuphar.ligand:9202 | 1\n",
      "tenapanor hydrochloride | 3 | rxcui:2199673 | 2\n",
      "rdx-5791 | 3 | iuphar.ligand:8449 | 1\n",
      "abt-492 | 2 | rxcui:1927663 | 1\n",
      "delafloxacin meglumine | 2 | rxcui:1927662 | 1\n",
      "artemifone | 2 | chembl:CHEMBL516268 | 1\n",
      "artemisone | 2 | ncit:C87431 | 1\n",
      "ab-meca | 2 | iuphar.ligand:416 | 1\n",
      "chembl:chembl609245 | 2 | chembl:CHEMBL609245 | 1\n",
      "cerc-301 | 3 | drugbank:DB12063 | 2\n",
      "rislenemdaz | 3 | ncit:C152228 | 1\n",
      "prx-102 | 2 | chembl:CHEMBL4297801 | 1\n",
      "pegunigalsidase alfa | 2 | ncit:C175187 | 1\n",
      "rad-1901 | 2 | chembl:CHEMBL4297509 | 1\n",
      "sintilimab | 2 | ncit:C132992 | 1\n",
      "ibi-308 | 2 | chembl:CHEMBL4297829 | 1\n",
      "nav5001 | 2 | chembl:CHEMBL4297407 | 1\n",
      "altropane i-123 | 2 | drugbank:DB15144 | 1\n",
      "as-013 | 2 | chembl:CHEMBL2104574 | 1\n",
      "ecraprost | 2 | ncit:C76397 | 1\n",
      "azd3161 | 3 | chembl:CHEMBL3545208 | 2\n",
      "rg-101 | 2 | chembl:CHEMBL3990019 | 1\n",
      "temavirsen sodium | 2 | ncit:C152552 | 1\n",
      "ly3164530 | 2 | ncit:C118281 | 1\n",
      "ly-3164530 | 2 | chembl:CHEMBL4298018 | 1\n",
      "lanopepden | 2 | ncit:C166453 | 1\n",
      "gsk1322322 | 2 | chembl:CHEMBL3301608 | 1\n",
      "gdc-0917 | 2 | drugbank:DB12336 | 1\n",
      "cudc-427 | 2 | ncit:C103825 | 1\n",
      "biib054 | 3 | chembl:CHEMBL3833330 | 2\n",
      "cinpanemab | 3 | ncit:C169852 | 1\n",
      "val-083 | 2 | ncit:C99224 | 1\n",
      "dianhydrogalactitol | 2 | ncit:C425 | 1\n",
      "kp201 | 2 | chembl:CHEMBL3137310 | 1\n",
      "benzhydrocodone hydrochloride | 2 | rxcui:2122776 | 1\n",
      "azd-4785 | 3 | chembl:CHEMBL4297900 | 1\n",
      "azd4785 | 3 | ncit:C147521 | 2\n",
      "isosorbide | 2 | rxcui:6057 | 1\n",
      "at-101 | 2 | ncit:C78348 | 1\n",
      "asulacrine | 2 | ncit:C91758 | 1\n",
      "ci-921 | 2 | ncit:C1050 | 1\n",
      "inosine | 2 | rxcui:1483575 | 1\n",
      "ino-1001 | 2 | ncit:C61315 | 1\n",
      "mln-1202 | 4 | iuphar.ligand:8921 | 2\n",
      "plozalizumab | 4 | ncit:C88308 | 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ct-7001 | 2 | chembl:CHEMBL4297488 | 1\n",
      "icec0942 | 2 | iuphar.ligand:9903 | 1\n",
      "cr6086 | 2 | drugbank:DB16111 | 1\n",
      "cr-6086 | 2 | chembl:CHEMBL3920982 | 1\n",
      "a-349821 | 2 | iuphar.ligand:1217 | 1\n",
      "a-349,821 | 2 | chembl:CHEMBL27979 | 1\n",
      "azd1236 | 2 | iuphar.ligand:7844 | 1\n",
      "azd-1236 | 2 | drugbank:DB11961 | 1\n",
      "sch-486757 | 2 | drugbank:DB12782 | 1\n",
      "sch486757 | 2 | iuphar.ligand:8869 | 1\n",
      "chembl:chembl435323 | 2 | chembl:CHEMBL435323 | 1\n",
      "dvdavp | 2 | iuphar.ligand:2183 | 1\n",
      "3-hydroxyanthranilic acid | 2 | drugbank:DB03644 | 1\n",
      "chembl:chembl445304 | 2 | chembl:CHEMBL445304 | 1\n",
      "aicar | 2 | drugbank:DB01700 | 1\n",
      "chembl:chembl483849 | 2 | chembl:CHEMBL483849 | 1\n",
      "chembl:chembl1673039 | 2 | chembl:CHEMBL1673039 | 1\n",
      "domatinostat | 3 | ncit:C96797 | 1\n",
      "4sc-202 | 3 | drugbank:DB13101 | 2\n",
      "omidenepag isopropyl | 2 | ncit:C170254 | 1\n",
      "de-117 | 2 | chembl:CHEMBL4297666 | 1\n",
      "cyclophosphamide hydrate | 2 | chembl:CHEMBL1200796 | 1\n",
      "sulfobromophthalein sodium | 2 | rxcui:203200 | 1\n",
      "chembl:chembl277863 | 2 | chembl:CHEMBL277863 | 1\n",
      "sb-269970 | 2 | drugbank:DB13988 | 1\n",
      "chembl:chembl282199 | 2 | iuphar.ligand:3233 | 1\n",
      "ezn-2279 | 3 | chembl:CHEMBL3990026 | 1\n",
      "elapegademase | 3 | rxcui:2059218 | 2\n",
      "tv-45070 | 3 | chembl:CHEMBL3707218 | 2\n",
      "xen-402 | 3 | chembl:CHEMBL3707218 | 2\n",
      "funapide | 3 | ncit:C174600 | 1\n",
      "rgi-7000 | 2 | chembl:CHEMBL384200 | 1\n",
      "krn-7000 | 2 | drugbank:DB12232 | 1\n",
      "naphthalene-1,2-diol | 2 | drugbank:DB07610 | 1\n",
      "chembl:chembl204543 | 2 | chembl:CHEMBL204543 | 1\n",
      "ykp-10a | 3 | chembl:CHEMBL4297620 | 1\n",
      "solriamfetol | 3 | rxcui:2121751 | 2\n",
      "sc-67655 | 2 | iuphar.ligand:8889 | 1\n",
      "chembl:chembl1790415 | 2 | chembl:CHEMBL1790415 | 1\n",
      "chembl:chembl1256182 | 2 | chembl:CHEMBL1256182 | 1\n",
      "2-(2-aminoethyl)isothiourea dihydrobromide | 2 | chembl:CHEMBL1256025 | 1\n",
      "orphenadrine hydrochloride | 3 | rxcui:202723 | 1\n",
      "orphenadrine (chloride) | 3 | chembl:CHEMBL1201023 | 2\n",
      "chembl:chembl131171 | 2 | iuphar.ligand:3522 | 1\n",
      "rp-67580 | 2 | drugbank:DB16742 | 1\n",
      "chembl:chembl214393 | 2 | iuphar.ligand:5125 | 1\n",
      "uridine-5'-monophosphate | 2 | drugbank:DB03685 | 1\n",
      "nis-793 | 2 | chembl:CHEMBL4298057 | 1\n",
      "nis793 | 2 | ncit:C132250 | 1\n",
      "gosuranemab | 2 | ncit:C175078 | 1\n",
      "biib092 | 2 | chembl:CHEMBL3990042 | 1\n",
      "recombinant human lecithin:cholesterol acyltransferase | 2 | drugbank:DB14833 | 1\n",
      "medi6012 | 2 | chembl:CHEMBL4297868 | 1\n",
      "hqk-1004 | 2 | ncit:C88290 | 1\n",
      "arginine butyrate | 2 | ncit:C2570 | 1\n",
      "azd5312 | 2 | ncit:C116326 | 1\n",
      "azd-5312 | 2 | chembl:CHEMBL4297901 | 1\n",
      "censavudine | 2 | ncit:C166942 | 1\n",
      "obp-601 | 2 | chembl:CHEMBL124363 | 1\n",
      "nw-3509 | 3 | chembl:CHEMBL3678076 | 2\n",
      "evenamide | 3 | ncit:C174804 | 1\n",
      "pegapamodutide | 2 | ncit:C170294 | 1\n",
      "ly2944876 | 2 | chembl:CHEMBL3990012 | 1\n",
      "tg-2349 | 2 | chembl:CHEMBL4297647 | 1\n",
      "furaprevir | 2 | ncit:C166437 | 1\n",
      "mgd007 | 2 | ncit:C118442 | 1\n",
      "mgd-007 | 2 | chembl:CHEMBL4298038 | 1\n",
      "gsk-690693 | 4 | drugbank:DB12745 | 2\n",
      "gsk690693 | 4 | iuphar.ligand:5196 | 2\n",
      "mln3126 | 3 | chembl:CHEMBL3545268 | 2\n",
      "yspsl | 2 | drugbank:DB06256 | 1\n",
      "torapsel | 2 | ncit:C152697 | 1\n",
      "su-9516 | 3 | drugbank:DB03428 | 1\n",
      "debio-1347 | 3 | drugbank:DB12903 | 1\n",
      "debio1347 | 3 | ncit:C111988 | 2\n",
      "phenserine, (+)- | 2 | chembl:CHEMBL4297417 | 1\n",
      "posiphen | 2 | drugbank:DB15317 | 1\n",
      "chembl:chembl1290115 | 2 | chembl:CHEMBL1290115 | 1\n",
      "vinorelbine tartrate | 3 | rxcui:114527 | 1\n",
      "chembl:chembl2347958 | 2 | chembl:CHEMBL2347958 | 1\n",
      "ro5028442 | 2 | iuphar.ligand:8529 | 1\n",
      "ro-5028442 | 2 | drugbank:DB12721 | 1\n",
      "psb-10211 | 2 | iuphar.ligand:9539 | 1\n",
      "chembl:chembl1672105 | 2 | chembl:CHEMBL1672105 | 1\n",
      "opaganib | 2 | ncit:C98278 | 1\n",
      "abc-294640 | 2 | iuphar.ligand:6624 | 1\n",
      "bay-613606 | 2 | iuphar.ligand:9693 | 1\n",
      "chembl:chembl541400 | 2 | chembl:CHEMBL541400 | 1\n",
      "chembl:chembl461579 | 2 | chembl:CHEMBL461579 | 1\n",
      "gnf-pf-254 | 2 | iuphar.ligand:5919 | 1\n",
      "metitepine | 3 | ncit:C166815 | 2\n",
      "methiothepin | 3 | iuphar.ligand:89 | 1\n",
      "chembl:chembl54918 | 2 | iuphar.ligand:4614 | 1\n",
      "5-fluorouridine | 2 | drugbank:DB01629 | 1\n",
      "interleukin 15, recombinant non-glycosylated | 2 | chembl:CHEMBL4297989 | 1\n",
      "il-15 | 2 | iuphar.ligand:4981 | 1\n",
      "l-161982 | 2 | iuphar.ligand:1952 | 1\n",
      "chembl:chembl1179743 | 2 | chembl:CHEMBL1179743 | 1\n",
      "chembl:chembl1082552 | 2 | chembl:CHEMBL1082552 | 1\n",
      "asp-8374 | 2 | chembl:CHEMBL4297894 | 1\n",
      "asp8374 | 2 | ncit:C141421 | 1\n",
      "inarigivir soproxil | 2 | ncit:C166642 | 1\n",
      "sb-9200 | 2 | chembl:CHEMBL1076930 | 1\n",
      "gs-9451 | 2 | chembl:CHEMBL2013174 | 1\n",
      "vedroprevir | 2 | ncit:C152843 | 1\n",
      "cmx-157 | 2 | chembl:CHEMBL515564 | 1\n",
      "tenofovir exalidex | 2 | ncit:C152560 | 1\n",
      "naag | 2 | ncit:C83847 | 1\n",
      "spaglumic acid | 2 | ncit:C72084 | 1\n",
      "sonedenoson | 3 | ncit:C84176 | 2\n",
      "mre-0094 | 3 | chembl:CHEMBL1950553 | 1\n",
      "cs-8958 | 2 | chembl:CHEMBL467058 | 1\n",
      "laninamivir octanoate | 2 | drugbank:DB11888 | 1\n",
      "imgn-853 | 2 | chembl:CHEMBL3545132 | 1\n",
      "mirvetuximab soravtansine | 2 | ncit:C102566 | 1\n",
      "bta-798 | 2 | chembl:CHEMBL2062774 | 1\n",
      "vapendavir | 2 | ncit:C152831 | 1\n",
      "reldesemtiv | 2 | ncit:C166781 | 1\n",
      "ck-2127107 | 2 | drugbank:DB15256 | 1\n",
      "linerixibat | 2 | ncit:C166652 | 1\n",
      "gsk2330672 | 2 | chembl:CHEMBL2387408 | 1\n",
      "insulin peglispro | 3 | ncit:C166970 | 2\n",
      "ly2605541 | 3 | chembl:CHEMBL2108569 | 1\n",
      "afp464 | 2 | ncit:C48370 | 1\n",
      "afp-464 | 2 | chembl:CHEMBL4297875 | 1\n",
      "tak-438 | 2 | ncit:C151949 | 1\n",
      "vonoprazan fumurate | 2 | chembl:CHEMBL2064032 | 1\n",
      "selicrelumab | 2 | ncit:C119740 | 1\n",
      "cp-870893 | 2 | chembl:CHEMBL2109477 | 1\n",
      "sar408701 | 2 | ncit:C117229 | 1\n",
      "sar-408701 | 2 | chembl:CHEMBL4298098 | 1\n",
      "benzodepa | 2 | ncit:C1759 | 1\n",
      "ab-103 | 2 | chembl:CHEMBL504088 | 1\n",
      "ly-2828360 | 3 | chembl:CHEMBL3545033 | 1\n",
      "ly2828360 | 3 | drugbank:DB16074 | 2\n",
      "lidocaine hydrochloride | 2 | rxcui:142440 | 1\n",
      "pha-848125ac | 2 | chembl:CHEMBL4297668 | 1\n",
      "milciclib maleate | 2 | ncit:C88312 | 1\n",
      "adl5747 | 3 | iuphar.ligand:9003 | 2\n",
      "b27pd | 2 | drugbank:DB16289 | 1\n",
      "peptide b27pd | 2 | chembl:CHEMBL4297903 | 1\n",
      "mifamurtide sodium hydrate | 2 | chembl:CHEMBL2107354 | 1\n",
      "mifamurtide | 2 | ncit:C1394 | 1\n",
      "mk-499 | 2 | iuphar.ligand:2607 | 1\n",
      "chembl:chembl52627 | 2 | chembl:CHEMBL52627 | 1\n",
      "neuromedin s-33 | 2 | iuphar.ligand:1468 | 1\n",
      "3-deazaadenosine | 2 | drugbank:DB04546 | 1\n",
      "chembl:chembl202701 | 2 | iuphar.ligand:5115 | 1\n",
      "l-750667 | 2 | iuphar.ligand:978 | 1\n",
      "chembl:chembl1256738 | 2 | chembl:CHEMBL1256738 | 1\n",
      "cytidine 3'-phosphate | 2 | drugbank:DB01961 | 1\n",
      "chembl:chembl258728 | 2 | chembl:CHEMBL258728 | 1\n",
      "gw405833 | 2 | iuphar.ligand:11149 | 1\n",
      "chembl:chembl73711 | 2 | chembl:CHEMBL73711 | 1\n",
      "levopropoxyphene napsylate | 2 | rxcui:402519 | 1\n",
      "levopropoxyphene napsylate anhydrous | 2 | ncit:C90775 | 1\n",
      "chembl:chembl412982 | 2 | chembl:CHEMBL412982 | 1\n",
      "men-10376 | 2 | iuphar.ligand:2116 | 1\n",
      "chembl:chembl284609 | 2 | chembl:CHEMBL284609 | 1\n",
      "skf-89626 | 2 | chembl:CHEMBL1256191 | 1\n",
      "sitogluside | 2 | ncit:C90816 | 1\n",
      "daucosterol | 2 | chembl:CHEMBL506678 | 1\n",
      "piperidine-2,3-dicarboxylic acid | 2 | chembl:CHEMBL124460 | 1\n",
      "chembl:chembl431504 | 2 | chembl:CHEMBL431504 | 1\n",
      "u-101958 | 2 | iuphar.ligand:5781 | 1\n",
      "chembl:chembl64119 | 2 | chembl:CHEMBL64119 | 1\n",
      "remtolumab | 2 | ncit:C152189 | 1\n",
      "abt-122 | 2 | iuphar.ligand:9597 | 1\n",
      "enoticumab | 2 | ncit:C82367 | 1\n",
      "regn-421 | 2 | chembl:CHEMBL2109385 | 1\n",
      "f-627 | 2 | ncit:C102854 | 1\n",
      "benegrastim | 2 | chembl:CHEMBL4297950 | 1\n",
      "usistapide | 2 | ncit:C152809 | 1\n",
      "jnj-16269110 | 2 | chembl:CHEMBL2103860 | 1\n",
      "elafibranor | 2 | ncit:C166574 | 1\n",
      "gft-505 | 2 | drugbank:DB05187 | 1\n",
      "cjm112 | 2 | ncit:C146808 | 1\n",
      "cjm-112 | 2 | chembl:CHEMBL4297926 | 1\n",
      "hu5f9-g4 | 2 | hemonc:257 | 1\n",
      "magrolimab | 2 | ncit:C117730 | 1\n",
      "glpg0187 | 2 | ncit:C96223 | 1\n",
      "glpg-0187 | 2 | drugbank:DB12297 | 1\n",
      "cannabinoids | 2 | chembl:CHEMBL3833333 | 1\n",
      "nabiximols | 2 | ncit:C71037 | 1\n",
      "tebanicline tosylate | 2 | ncit:C75076 | 1\n",
      "tebanicline | 2 | ncit:C77852 | 1\n",
      "dapagliflozin propylene glycol | 2 | chembl:CHEMBL2103802 | 1\n",
      "fk-888 | 2 | iuphar.ligand:2114 | 1\n",
      "chembl:chembl417572 | 2 | chembl:CHEMBL417572 | 1\n",
      "cisapride monohydrate | 2 | rxcui:221077 | 1\n"
     ]
    }
   ],
   "source": [
    "for group in check_groups.values():\n",
    "    orig_len = len(group)\n",
    "    for member in set(group):\n",
    "        for concept_id, normed_group in check_norm_groups.items():\n",
    "            if member in normed_group and orig_len > len(normed_group):\n",
    "                print(f\"{member} | {orig_len} | {concept_id} | {len(normed_group)}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "1022cf6c",
   "metadata": {},
   "outputs": [],
   "source": [
    "cur = conn.cursor()\n",
    "cur.execute(\"\"\"\n",
    "SELECT \n",
    "    dc.name AS claim_name, \n",
    "    dc.nomenclature AS claim_name_nomenclature, \n",
    "    dc.primary_name AS claim_primary_name, \n",
    "    s.full_name AS source, \n",
    "    d.concept_id AS grouped_id\n",
    "FROM drug_claims dc\n",
    "LEFT JOIN drugs d ON dc.drug_id = d.id\n",
    "LEFT JOIN sources s ON dc.source_id = s.id\n",
    "\"\"\")\n",
    "total_grouped_claims = cur.fetchall()\n",
    "cur.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "cd8cdc17",
   "metadata": {},
   "outputs": [],
   "source": [
    "import uuid\n",
    "\n",
    "total_groups = {}\n",
    "for claim in total_grouped_claims:\n",
    "    if claim[4] is None:\n",
    "        total_groups[uuid.uuid1()] = 1\n",
    "    elif not (claim[4] in total_groups):\n",
    "        total_groups[claim[4]] = 1\n",
    "    else:\n",
    "        total_groups[claim[4]] += 1\n",
    "\n",
    "total_groups_df = pd.DataFrame([[k, v] for k, v in total_groups.items()], columns=[\"concept_id\", \"count\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "630bb04d",
   "metadata": {},
   "outputs": [],
   "source": [
    "total_normed_groups = {}\n",
    "total_fails = 0\n",
    "for claim in total_grouped_claims:\n",
    "    norm_response = q.normalize(claim[2])\n",
    "    if norm_response.match_type > 0:\n",
    "        therapy_id = norm_response.therapy_descriptor.therapy_id\n",
    "        if therapy_id in total_normed_groups:\n",
    "            total_normed_groups[therapy_id] += 1\n",
    "        else:\n",
    "            total_normed_groups[therapy_id] = 1\n",
    "    elif claim[0] != claim[2]:\n",
    "        norm_response = q.normalize(claim[0])\n",
    "        if norm_response.match_type > 0:\n",
    "            therapy_id = norm_response.therapy_descriptor.therapy_id\n",
    "            if therapy_id in total_normed_groups:\n",
    "                total_normed_groups[therapy_id] += 1\n",
    "            else:\n",
    "                total_normed_groups[therapy_id] = 1\n",
    "    else:\n",
    "        total_normed_groups[uuid.uuid1()] = 1\n",
    "total_normed_groups_df = pd.DataFrame([[k, v] for k, v in total_normed_groups.items()], columns=[\"concept_id\", \"count\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "b729a656",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>dgidbv4 grouper</th>\n",
       "      <td>30521.0</td>\n",
       "      <td>1.688706</td>\n",
       "      <td>1.445758</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>20.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>therapy normalizer</th>\n",
       "      <td>28151.0</td>\n",
       "      <td>1.800043</td>\n",
       "      <td>1.673526</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>29.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      count      mean       std  min  25%  50%  75%   max\n",
       "dgidbv4 grouper     30521.0  1.688706  1.445758  1.0  1.0  1.0  2.0  20.0\n",
       "therapy normalizer  28151.0  1.800043  1.673526  1.0  1.0  1.0  2.0  29.0"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame([total_groups_df[\"count\"].describe(), total_normed_groups_df[\"count\"].describe()], index=[\"dgidbv4 grouper\", \"therapy normalizer\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cf9a9050",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "therapy-normalization",
   "language": "python",
   "name": "therapy-normalization"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
